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ABSTRACT 
YVONNE MARIE GOLIGHTLY:  Osteoarthritis and Injury of the Knee and Hip  
(Under the direction of Stephen W. Marshall, PhD) 
 
Context:   Osteoarthritis (OA) is one of the most common causes of disability in the 
United States, but effective interventions for this disease are limited.  Difficulty with 
defining OA, including the lack of sensitive measures of incident OA, hinders the 
development of successful treatments.  Biomarkers of cartilage turnover and 
inflammation may be important, sensitive indicators of OA, but biomarker levels may 
be influenced by joint injury.  Additionally, previous efforts to examine injury as a risk 
factor for OA, either with cross-sectional or longitudinal study designs, have resulted in 
a wide range of estimates.  Understanding the association between injury and OA and 
exploring new, sensitive measures of OA have important clinical implications for 
patients who have sustained joint injuries, for those seeking treatment for OA, and for 
identifying participants for clinical trials of OA. 
Objectives:  This research was conducted in a large, community based sample to: 1) 
determine whether the biomarkers of cartilage oligomeric matrix protein (COMP), 
hyaluronan (HA), high-sensitivity C-reactive protein (hsCRP), and keratan sulfate (KS) 
predict incident radiographic OA at the knee and whether their associations vary by 
lower extremity injury history, 2) examine the hazard of incident OA of the knee and 
hip by history of injury, and 3) compare prevalence and hazard estimates from cross-
sectional and longitudinal designs.  
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Methods:   A longitudinal community-based cohort completed baseline (1991-1997) 
clinical evaluation and identical follow-up assessment (1999-2003; median follow-up 
time = 5.6 years, range=3.0-13.1 years) for OA.  The OA outcomes examined for 
Objectives 1 were: radiographic OA (Kellgren-Lawrence [K-L] grade of 2 or greater), 
osteophyte (OST) formation, and joint space narrowing (JSN), and for Objectives 2 and 
3 were: radiographic OA (based on K-L grade), chronic joint symptoms, radiographic 
OA or symptoms, and radiographic OA with symptoms.  History of knee injury or hip 
injury was based on self-report.  Baseline serum COMP, HA, hsCRP, and KS were 
measured for 803 participants.  The study groups with injury data comprised 1,570 
participants with linked baseline and follow-up knee radiographs and 1,446 participants 
with linked hip radiographs.  Among participants with biomarker data, linked baseline 
and follow-up radiographs were available for 542 knees at risk for incident OA, 349 
knees at risk for incident osteophyte (OST) formation, and 440 knees at risk for incident 
joint space narrowing (JSN).  For biomarker analyses, Cox regression models were used 
to estimate the hazard ratio (HR) for a 1-unit increase in the natural log of each 
biomarker, adjusting for age, race, gender, and body mass index and exploring history 
of lower extremity injury and chronic knee symptoms as potential modifiers.  For injury 
and OA analyses, Cox regression models were used to determine the hazard of incident 
knee and hip OA outcomes and logistic regression models were use to estimate the 
prevalence of knee and hip OA outcomes.   
Results:   The hazard of incident knee OA and incident knee OST increased with higher 
baseline lnCOMP levels, and the hazard of incident knee JSN also increased with higher 
lnCOMP levels and higher lnHA levels.  Higher levels of lnhsCRP and lnKS did not 
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predict the incident knee outcomes.  Neither history of lower extremity injury nor 
chronic knee symptoms was a strong modifier of these associations.  The hazard of 
incident knee radiographic OA and OA or symptoms was higher among participants 
with knee injury at baseline compared to those without injury.  Injury to the knee was 
associated with incident ipsilateral and contralateral radiographic knee OA.  Hip injury 
also predicted a higher hazard of hip radiographic OA outcomes, although precision 
was lower for the hip analyses due to small numbers of outcomes. HR and odds ratio 
(OR) patterns were similar for some knee injury-OA associations, but the OR estimates 
tended to be higher than the HR estimates.  The pattern of HRs and ORs is less clear for 
the hip due to low numbers for the longitudinal analysis.       
Conclusions: Higher baseline lnCOMP and lnHA levels predicted incident knee OA, 
OST, and JSN, but history of lower extremity injury did not modify the association.  
The hazard of incident radiographic knee and hip OA was higher in those with a history 
of injury compared to those without injury.  Knee injury predicted an increased hazard 
of incident radiographic knee OA in the ipsilateral joint and the contralateral joint. 
Estimates calculated from a cross-sectional analysis may provide a fair approximation 
of the incidence of radiographic knee OA by knee injury status, but further research 
over a longer follow-up period, particularly for the hip, is needed to help clarify these 
comparisons.    
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I.  Introduction 
 Osteoarthritis (OA) is a major public health problem, affecting 27 million 
Americans (Helmick, Felson, Lawrence, Gabriel, Hirsch, Kwoh, Liang, Kremers, Mayes, 
Merkel, Pillemer, Reveille & Stone, 2008),  and one of the most common causes of 
disability in the United States (CDC, 2009).   Unfortunately, effective interventions for 
this disease are limited and efforts to develop successful interventions are hindered by a 
difficulty in clearly defining OA, as well as the lack of sensitive measures of incident 
OA.  Biomarkers (markers of the biological process of cartilage degradation and 
inflammation) may predict the development of OA and may aid in understanding the long 
term effects of joint injury.  In studies of individuals with acute injury, certain biomarker 
levels have been shown to be elevated (Lohmander, Saxne & Heinegard, 1994).  In other 
studies, these same biomarkers are higher among those who develop OA compared to 
those without OA (Lohmander et al., 1994; Clark, Jordan, Vilim, Renner, Dragomir, Luta 
& Kraus, 1999; Dragomir, Kraus, Renner, Lutas, Clark, Vilim, Hochberg, Helmick & 
Jordan, 2002).   Previous studies have examined the levels of biomarkers after knee 
injury and in radiographic knee OA in cross-sectional analyses or longitudinally in small 
samples or clinical studies, but studies have not assessed longitudinally in population-
based cohorts whether specific biomarkers may predict the development of OA or 
whether joint injury history may play a role in this association.   
 The biomedical community recognizes joint injuries as a likely cause of OA, but 
epidemiologic studies for this relationship provide a wide range of estimates. Cross-
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sectional studies suggest an association between knee injury and knee OA (Davis, 
Ettinger, Neuhaus, Cho & Hauck, 1989; Sowers, Lachance, Hochberg & Jamadar, 2000), 
but longitudinal studies present inconsistent results and a wide range of estimates 
(Felson, Zhang, Hannan, Naimark, Weissman, Aliabadi & Levy, 1997; Hart, Doyle & 
Spector, 1999; Gelber, Hochberg, Mead, Wang, Wigley & Klag, 2000; Wilder, Hall, 
Barrett & Lemrow, 2002; Toivanen, Heliovaara, Impivaara, Arokoski, Knekt, Lauren & 
Kroger, 2010).  The evidence for hip injury and OA suggests an association, but precision 
of estimates is limited by smaller numbers of participants with hip injury and OA (Tepper 
& Hochberg, 1993; Cooper, Inskip, Crof, Campbell, Smith, McLaren & Coggon, 1998; 
Gelber et al., 2000).  Exploring several definitions of OA (radiographic- or symptom-
based), ipsilateral (same limb) and contralateral (opposite limbs) injury-OA associations, 
and comparing estimates generated from cross-sectional and longitudinal analyses may 
help resolve questions from prior injury-OA studies.  A better understanding of the 
injury-OA association has important clinical implications for patients who have sustained 
joint injuries, for those seeking treatment for OA, and for identifying participants for 
clinical trials in OA.    
 The research described in this document addressed these areas by: 1) determining 
whether four serum biomarkers predict incident radiographic OA at the knee, 2) 
examining whether the biomarker-OA associations vary by injury history at the knee or 
hip, and 3) examining the association between injury and different OA outcome 
definitions (including ipsilateral and contralateral associations) with cross-sectional and 
longitudinal designs of a large, community-based bi-racial population.
  
 
 
 
 
II.   Background and Significance 
A.    Public Health Significance 
A.1.  Biomarkers of Osteoarthritis and Injury History 
 By the time patients have OA features observable on radiography, the disease 
may have progressed to a point where few options are available for the treatment of OA.  
Early identification of knee OA by changes in biomarker levels may allow for timely 
interventions that can slow or prevent progression of the disease.  As summarized in 
Table 2.1, likely biomarkers of incident knee OA in men and women are those prognostic 
of: 1) incident knee OA in women: serum high-sensitivity C-reactive protein (hsCRP) 
(Spector, Hart, Nandra, Doyle, Mackillop, Gallimore & Pepys, 1997; Sowers, Jannausch, 
Stein, Jamadar, Hochberg & Lachance, 2002); 2) incident hip OA: serum cartilage 
oligomeric matrix protein (COMP) (Kelman, Lui, Yao, Krumme, Nevitt & Lane, 2006)); 
3) progressive knee OA: serum COMP (Sharif, Saxne, Shepstone, Kirwan, Elson, 
Heinegard & Dieppe, 1995) and serum hyaluronan (HA) (Sharif, George, Shepstone, 
Knudson, Thonar, Cushnaghan & Dieppe, 1995), or 4) altered early in the course of knee 
injury: serum keratan sulfate (KS) (Wakitani S, Nawata M, Kawaguchi A, Okabe T, 
Takaoka K, Tsuchiya T, Nakaoka R, Masuda H & Miyazaki K, 2007; Wakitani, Nawata, 
Kawaguchi, Okabe, Takaoka, Tsuchiya, Nakaoka, Masuda & Miyazaki, 2007).   
 Particular attention may be required to target those individuals with increased 
biomarker levels and a history of injury to the knee since biomarker levels may be 
elevated and remain elevated for years after injury (Lohmander et al., 1994).  Prior 
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studies have not assessed longitudinally in bi-racial population-based cohorts whether the 
biomarkers of COMP, HA, hsCRP, and KS may predict the development of OA or how 
injury history may play a role in this association.  
A.2.  Injury and Osteoarthritis 
 The incidence of OA is expected to increase significantly over the next few 
decades (CDC, 2003).  Identifying and targeting patients who are at the highest risk for 
the development of OA is critical for administering treatments to prevent or slow the 
progression of OA.  Joint injury is suspected to be an important risk factor.  Although 
previous research indicates that joint injury may be associated with OA risk, there are 
critical areas that still need to be examined.  First, most studies have focused on knee OA, 
with fewer examining hip OA.  The association between injury and OA may vary by joint 
site because of the differences in joint structure, the typical mechanisms for injury to that 
joint, and the joint’s tendency to develop OA.  Furthermore, few studies have examined 
the association of injury and OA longitudinally.  Examining this relationship over time 
helps illustrate potential mechanisms of this association.  Finally, it is unknown whether 
prevalence studies of injury and OA provide reasonable estimates of the association.  
Potentially, this knowledge could guide research on injury and OA of all joint sites.  If 
prevalence studies provide comparable estimates of association to longitudinal studies, it 
may be efficient and appropriate to use prevalence studies for joint injury and OA 
research.  Alternatively, if estimates of the joint injury-OA association are not 
comparable between cross-sectional and longitudinal designs, then longitudinal studies 
may be recommended for joint injury and OA research. 
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B.  Literature Review 
B.1. Osteoarthritis 
 Arthritis (joint inflammation) and other rheumatic conditions (conditions 
involving joints, soft tissues and connective tissues), or AORC, affect 21.6% (46 million) 
of adults in the United States (Helmick et al., 2008).  Two-thirds of patients with AORC 
are younger than 65 years of age, and more than 60% are female.  By 2030, a projected 
40% increase in the number of people with arthritis will elevate the total to nearly 67 
million adults (Helmick et al., 2008).  More than 100 types of AORC exist, and the most 
common forms include OA, rheumatoid arthritis, lupus, fibromyalgia, and gout. 
 OA is the most common form of AORC, affecting nearly 59% (27 million) of 
persons with AORC (Helmick et al., 2008).  Other medical terms for OA include 
degenerative joint disease, osteoarthrosis, degenerative arthritis, and hypertrophic 
arthritis.  OA is a degenerative joint disorder characterized by the breakdown of cartilage 
and formation of osteophytes, or bone spurs. Cartilage is a dense connective tissue made 
of chondrocytes, which produce an extracellular matrix of collagen and elastin fibers and 
ground substance (primarily proteoglycan).  Three types of cartilage are found in the 
body that vary by the relative amount of collagen and elastin fibers and ground substance: 
elastic cartilage, hyaline cartilage, and fibrocartilage.  Hyaline cartilage, or articular 
(joint) cartilage, cushions the ends of the bones and allows easy movement of joints.  The 
breakdown of hyaline cartilage may lead to rubbing of bony articular surfaces together, 
causing pain, stiffness, and loss of range of motion.  A sequence of events for 
development of OA may include: 1) loss of hyaline cartilage (hereafter referred to as 
cartilage) elasticity, 2) bone growth occurs either as a thickening or osteophyte (bone 
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spur) in response to cartilage wear, 3) bone fragments loosen and float in the joint space, 
and 4) the synovial membrane (a thin, layer of tissue lining the joint space) becomes 
inflamed, releasing cytokines (inflammation proteins) and other proteins that may further 
damage the articular cartilage. 
 OA is not typically diagnosed nor considered of clinical importance unless the 
patient is symptomatic, even with the presence of features of OA (joint space narrowing 
or osteophytes) on radiographic or magnetic resonance imaging (MRI). The American 
College of Rheumatology has established clinical criteria for diagnosing primary OA of 
the knees and hips(Altman, Asch, Bloch, Bole, Borenstein & Brandt, 1986).  Clinical OA 
of the knee is defined as knee pain with at least three of six criteria: age of 50 years or 
older, stiffness lasting less than 30 minutes, crepitus (grating or cracking of joints), bony 
tenderness, bony enlargement, and no palpable warmth (sensitivity 95%, specificity 
69%).  Clinical and laboratory knee OA includes the clinical knee OA definition plus 
laboratory findings of an erythrocyte sedimentation rate (to detect inflammation) less 
than 40 millimeters/hour, a rheumatoid factor less than 1:40 (to rule out rheumatoid 
arthritis), and a synovial fluid examination showing clear, viscous fluid with a white 
blood cell count less than 2,000/cubic millimeters (sensitivity 92%, specificity 75%).  
Clinical and radiographic knee OA includes knee pain with at least one of three criteria 
(age of 50 years or older, stiffness lasting less than 30 minutes, or crepitus) and evidence 
of osteophytes on radiographic (sensitivity 91%, specificity 86%). 
 The American College of Rheumatology defines clinical OA of the hip as hip 
pain and either: 
• hip internal rotation ≥ 15º, 
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• pain present on internal rotation of the hip,  
• morning stiffness of the hip for ≤ 60 minutes, 
• and age ≥ 50 years,  
or as: 
• hip internal rotation < 15º  
• and an erythrocyte sedimentation rate ≤ 45 millimeters/hour 
• or if no sedimentation rate, hip flexion ≤115º is substituted  
(sensitivity 86%, specificity 75%) (Altman, Alarcon, Appelrouth, Bloch, Borenstein, 
Brandt, Brown, Cooke & Daniel, 1991).  Clinical plus radiographic criteria includes hip 
pain with at least two of three criteria:  
• femoral or acetabular osteophytes, 
• superior, axial, or medial joint space narrowing,  
• and an erythrocyte sedimentation rate < 20 millimeters/hour  
(sensitivity 89%, specificity 91%). 
 
B.2. Defining Osteoarthritis in Epidemiologic Studies 
 OA is defined by radiograph or clinical measures in most epidemiologic studies. 
Radiographic OA is considered the standard measure in epidemiologic investigations.  
Measures for defining radiographic disease include the Kellgren-Lawrence (K-L) grading 
system and examination of individual radiographic features of OA.  The scoring system 
for K-L grades ranges from 0-4, with 0 indicating no characteristics of OA and 
subsequent grades indicating the successive presence of an osteophyte, joint space 
narrowing, sclerosis, and joint deformity (Kellgren & Lawrence, 1957).  Assessment of 
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the development of individual radiographic features of OA, such as osteophyte formation 
(OST) or joint space narrowing (JSN) may be a more thorough method for monitoring 
disease progression.  The Burnett atlas measures radiographic OST and JSN separately 
(Burnett, Hart, Cooper & Spector, 1994).  MRI is a sensitive imaging technique that 
provides images of multiple sections of the joint and offers a more detailed representation 
of joint tissues, such as cartilage, ligaments, and menisci, than radiography.  MRI is more 
time-intensive and expensive than radiography, and thus, is not used in larger population 
studies.  Additionally, there is a lack of accepted and widely validated scoring systems 
for MRI.  Measurement of systemic and local biological markers (biomarkers) of joint 
metabolism is currently under investigation as a promising way to refine the definition of 
OA and allow for earlier identification, before the development of irreversible or 
untreatable changes to the joint.    
 Presence of joint symptoms is clinically relevant to a definition of OA in 
epidemiologic studies because some individuals with OA features on radiograph or MRI 
may not have clinical symptoms (Cibere, 2006).  Symptomatic OA is often defined as the 
presence of pain, aching, or stiffness in a joint with evidence of radiographic OA 
(Murphy, Schwartz, Helmick, Renner, Tudor, Koch, Dragomir, Kalsbeek, Luta & Jordan, 
2008; Allen, Chen, Callahan, Golightly, Helmick, Renner & Jordan, 2010; Callahan, 
Shreffler, Siaton, Helmick, Schoster, Schwartz, Chen, Renner & Jordan, 2010; Harvey, 
Yang, Cooke, Segal, Lane, Lewis & Felson, 2010). 
 Self-report of arthritis is a simple measure to collect but the least valid method to 
ascertain OA disease status in epidemiologic studies.  Self-report of physician-diagnosed 
OA has been found to be the most valid of the different methods of questionnaire 
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assessment of OA (Szoeke, Dennerstein, Wluka, Guthrie, Taffe, Clark & Cicuttini, 2008).  
This method is found in large national studies, such as the National Health Interview 
Survey (National Center for Health Statistics, Centers for Disease Control and 
Prevention) and the Behavioral Risk Factor Surveillance System (National Center for 
Chronic Disease Prevention and Health Promotion), for self-report of arthritis.   
B.3. Prevalence and Impact of Osteoarthritis 
 Arthritis is the most common cause of disability (CDC, 2001) and a leading cause of 
work limitations (Stoddard, Jans, Ripple & Kraus, 1998).  OA is one of the most frequent 
chronic pain conditions among older adults.  OA is prevalent in 26.2% of females and 
13.4% of males over the age of 70 years (Burden of Musculoskeletal Diseases, 2008).  In 
the United States, approximately 33% of persons over the age of 63 years have knee OA 
and at least 3% ages 55-74 have hip OA (Felson, Lawrence, Dieppe, Hirsch, Helmick & 
Jordan, 2000).  The Johnston County Osteoarthritis Project reported that 16.7% of adults 
45 years of age and older have symptomatic knee OA, and the National Health and 
Nutrition Examination Survey (NHANES) III from 1988-1994 reported that 12.1% of 
adults ages 60 years and older have symptomatic knee OA (Burden of Musculoskeletal 
Diseases, 2008).  By age 85 years, nearly 1 in 2 adults (46%) will develop symptomatic 
knee osteoarthritis (Murphy et al., 2008).  Symptomatic hip OA was prevalent in 9.2% of 
adults 45 years of age and older in the Johnston County Osteoarthritis Project.  
 The incidence of OA is expected to nearly double in the next several decades in the 
United States partly due to the aging of the population and the rise in obesity prevalence, 
resulting in a rapidly growing burden for our nation’s health care systems (CDC, 2003).  
In 2004, OA was the primary diagnosis for 25.1% of non-injury ambulatory care visits 
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with a primary diagnosis of AORC (11.1 million of 44.2 million AORC primary 
diagnoses in the United State for adults 18 years and older) (Burden of Musculoskeletal 
Diseases, 2008).  In that same year, AORC was the primary diagnosis for 3.1% of all 
nonfederal, short stay hospitalizations, with OA accounting for 67% of those AORC 
primary diagnoses, not including those admitted for orthopaedic procedures as the 
primary diagnosis or complications related to arthritis treatment (i.e., gastrointestinal 
bleeding from non-steroidal anti-inflammatory drug use) (Burden of Musculoskeletal 
Diseases, 2008).  Joint replacement procedures are used to treat joints with arthritis, and 
these procedures are increasingly common for treating OA of the knee and hip.  Of the 
primary diagnosis of AORC cases in 2004 in the United States, 66% involved joint 
replacement procedures Burden of Musculoskeletal Diseases, 2008).   
 Early identification of OA may help in reducing the rise of OA prevalence and 
minimizing the burden on health care in the upcoming decades.  With early detection of 
OA or the mechanisms that lead to OA, measures may be taken to either prevent or slow 
the development and progression of disease.  Increasing the understanding of OA 
epidemiology is needed to help develop strategies for identifying individuals most likely 
to develop OA, such as those with a history of joint injury or those with higher levels of 
certain serum biomarkers, and to help design interventions that target potentially treatable 
risk factors.   
B.4. Risk Factors for Osteoarthritis 
 Systemic factors and local biomechanical factors may increase the risk for OA.  Risk 
factors include older age (Felson et al., 2000), female gender(Srikanth, Fryer, Zhai, 
Winzenberg, Hosmer & Jones, 2005), family history (genetics) (Spector, Cicuttini, Baker, 
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Loughlin & Hart, 1996), obesity and overweight (Felson et al., 2000), highly physical job 
demands(Anderson & Felson, 1988; Stoddard et al., 1998; Rossignol, Leclerc, Hilliquin, 
Allaert, Rozenberg, Valat, Avouac, Coste, Savarieau & Fautrel, 2003; Rossignol, 2004; 
Rossignol, Leclerc, Allaert, Rozenberg, Valat, Avouac, Coste, Litvak & Hilliquin, 2005), 
strenuous physical activity (McAlindon, Wilson, Aliabadi, Weissman & Felson, 1999), 
malalignment of the knee joint in the frontal plane (Sharma, Song, Felson, Cahue, 
Shamiyeh & Dunlop, 2001), muscle weakness of the knee (Slemenda, Brandt, Heilman, 
Mazzuca, Braunstein, Katz & Wolinsky, 1997) and hand (Dominick, Jordan, Renner & 
Kraus, 2005), and laxity of the knee joint (Sharma, Lou, Felson, Dunlop, Kirwan-Mellis, 
Hayes, Weinrach & Buchanan, 1999).  Severe joint injuries at the knee, such as meniscal 
tears and anterior cruciate ligament (ACL) tears that may require surgical intervention, 
have been reported to significantly increase the risk for OA in previous cross-sectional 
and case-control studies (Roos, E M, Ostenberg, Roos, Ekdahl & Lohmander, 2001; 
Lohmander, Ostenberg, Englund & Roos, 2004).  In a recent report, meniscus damage in 
middle-aged to older aged adults without meniscal surgery was found to be a significant 
predictor of radiographic knee OA with an adjusted odds ratio (OR) of 5.7 (95% 
confidence interval [CI] = 3.4-9.4), although the authors did not distinguish between 
meniscal tears that may have resulted from injury versus those that may occur 
spontaneously due to early degenerative changes that lead to OA development (Englund, 
Guermazi, Roemer, Aliabadi, Yang, Lewis, Torner, Nevitt, Sack & Felson, 2009).   
B.5. Prevalence and Impact of Joint Injury 
 Injury is a leading cause of death and temporary or permanent disability.  Injuries 
that occurred in 2000 have been estimated to cost the United States over $80 billion in 
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medical care costs, including $1 billion for fatal injuries, $33.7 billion for hospitalized 
injuries, and $45.4 billion for non-hospitalized injuries (Finkelstein, Corso & Miller, 
2006).  Injuries that occurred in 2000 will cost an estimated $326 billion in productivity 
losses (i.e., loss of wages and fringe benefits) (Finkelstein et al., 2006). 
Orthopaedic injuries that may affect a joint include bone fractures, sprains (stretch 
or tear of a ligament), and strains (stretch or tear of musculotendinous tissue).  Falls, 
overexertion (sprain or strain), motor vehicle crashes, or being struck or hit by an object 
are likely contributors to joint injury.  Regardless of stage of life, everyone is vulnerable 
to these types of injuries.  Among all age groups in the United States in 2007, 27.0% of 
nonfatal injuries were from unintentional falls, followed by unintentional strikes 
by/against an object (15.3%), unintentional overexertion (11.9%), and unintentional 
motor vehicle occupant (8.9%).  Adolescents 10-14 years of age have the highest rate of 
sports and recreation related injury (CDC, 2006).  Drivers 16-19 years of age are four 
times more likely to experience a motor vehicle crash than other age groups (CDC, 
2006).  The most common cause of nonfatal injury among adults ages 20-49 years was 
unintentional falls (17%), followed by overexertion (15%) (CDC, 2006). Among adults 
50 years of age and older in 2007, 44.9% (3 million) of all nonfatal injuries were from 
falls. 
B.6.  Joint Injury and Osteoarthritis 
  A strong biological rationale exists to link injury and OA.  Injury to the soft 
tissues that support a weight bearing joint weakens their ability to attenuate forces at the 
joint.  As a result, forces transmitted to the joint surfaces are increased during daily 
activities (i.e., walking, running, and climbing stairs).  Cartilage can degenerate, resulting 
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in joint space narrowing or fragments of cartilage or other tissues in the joint.  Advanced 
cartilage degradation may lead to greater contact between the bony joint surfaces.  Bone 
may react to this increased contact pressure by developing osteophytes.  Animal models 
of meniscus damage and human studies of surgical removal of the meniscus after knee 
injury support the biological rationale of load-bearing tissue defects contributing to OA 
of the knee (Little, Smith, Ghosh & Bellenger, 1997; Roos, H, Lauren, Adalberth, Roos, 
Jonsson & Lohmander, 1998).  Smaller studies of meniscal and ACL injuries suggest an 
association between injury and OA development, although a majority of participants in 
these studies receive surgical repairs which may modify the association.  In a study of 67 
female soccer players 12 years after ACL injury, 62% had received ACL reconstructive 
surgery and 51% had radiographic evidence of knee OA (joint space narrowing or 
osteophyte formation) (Lohmander et al., 2004).  In a recent study of 58 young subjects 
(mean age 26 years, 16 females, 34 with ACL reconstructive surgery) with ACL tear 
treated within a structured rehabilitation program, consistent changes in cartilage were 
noted in the trochlea and central medial femur regardless of ACL repair status (Frobell, 
LeGraverand, Buck, Roos, Roos, Tamez-Pena, Totterman & Lohmander, 2009).  
However, the greatest changes in cartilage volume, cartilage thickness, and cartilage 
surface area were observed by MRI in knees with ACL reconstruction performed within a 
mean of 6 weeks from injury (Frobell et al., 2009).      
 The medical community recognizes joint injuries as a potential cause of OA.  
Joint injury is used in the literature as potential confounder in studies examining the 
associations between OA and other physical factors, such as obesity, physical activity, 
and limb length inequality (paired lower extremities of unequal length) (Felson et al., 
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1997; Golightly, Allen, Renner, Helmick, Salazar & Jordan, 2007).   The epidemiologic 
evidence from larger population-based studies for the relationship between injury and OA 
is rather sparse, and the mechanism of injury to disease development is not well 
understood.  Table 2.2 summarizes the larger population-based published studies on the 
relationship between injury and OA.  It is striking that no epidemiologic research on the 
association between injury and OA at joint sites other than the knee, hip, and hand exists. 
  The few larger epidemiologic studies published on injury and OA of the hip and 
hand present results suggestive of an association, although the precision of the calculated 
estimates is limited in some studies (95% CIs are wide) (Tepper & Hochberg, 1993; 
Cooper et al., 1998; Gelber et al., 2000; Sowers et al., 2000; Jones, Cooley & Stankovich, 
2002).  Cooper et al. (Cooper et al., 1998) reported that hip injury was strongly associated 
with hip OA (adjusted OR = 4.3, 95% CI = 2.2-8.4) in a case-control study of two health 
districts in England (cases=611, controls= 661).  The association between hip injury and 
OA was statistically significant in males (adjusted OR = 24.2, 95% CI = 3.84-153.10) 
and elevated but not significant in females (adjusted OR = 4.17, 95% CI = 0.50-34.71) in 
a cross-sectional analysis of 2,490 participants in the NHANES (Tepper & Hochberg, 
1993).  In a longitudinal study of 1,321 former medical students, hip injury at cohort 
entry or during follow-up increased the risk for future hip OA (relative risk = 3.50, 95% 
CI = 0.84-14.69)(Gelber et al., 2000).   The 95% CIs are notably wide in all three studies 
because of the low prevalence of hip OA.  The association between hand OA and 
previous injury was not statistically significant (adjusted OR = 1.33, 95% CI = 0.89-1.97) 
in a cross-sectional study of 1,053 African American and Caucasian southeastern 
Michigan women (Sowers et al., 2000).  In a cross-sectional study of 522 Tasmanian men 
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and women, self-report of finger fracture was associated with radiographic OA of the 
distal interphalangeal joints (adjusted OR = 2.42, 95% CI = 1.22-4.83), but not of the 
carpometacarpal joints (adjusted OR = 1.63, 95% CI = 0.86-3.10) (Jones et al., 2002).   
 Although cross-sectional studies suggest an association between knee injury and 
knee OA (Davis et al., 1989; Sowers et al., 2000), longitudinal studies present 
inconsistent results and a wide range of estimates (Felson et al., 1997; Hart et al., 1999; 
Gelber et al., 2000; Wilder et al., 2002; Toivanen et al., 2010).  In a cross-sectional study 
of 3,885 adults in the First NHANES, the OR for the association between injury and 
radiographic OA was 16.30 (95% CI=6.50-40.89) for right knee and 10.90 (95% CI = 
3.72-31.93) for the left knee (Davis et al., 1989).  Sowers et al. (Sowers et al., 2000) 
reported an association between knee injury and OA in a cross-sectional study of 
southeastern Michigan females (adjusted OR = 1.90, 95% CI = 1.17-3.07).  In the 
Framingham Study of 598 older adults, past knee injury was not associated with incident 
radiographic knee OA (adjusted OR = 0.7, 95% CI = 0.1-3.2) (Felson et al., 1997).  
Incident osteophytes (adjusted OR = 1.85, 95% CI = 0.82-4.19) and incident joint space 
narrowing (OR = 1.03, 95% CI = 0.45-2.32) at the knee were not significantly associated 
with knee injury in the Chingford Study of women after 4 years of follow-up (Hart et al., 
1999).  Both of these longitudinal studies may have had too few participants with a joint 
injury for analyses, leading to inconclusive results.  In a study of 1,321 prior medical 
students (mean age of 22 years at cohort entry, median 36 years of follow-up), the 
relative risk of self-reported knee OA by self-reported knee injury status was 5.17 (95% 
CI = 3.07-8.71) (Gelber et al., 2000).   Participants in the Clearwater Osteoarthritis Study 
with history of severe knee injury (fracture or “severe twisting of either knee with 
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resultant sprain or swelling lasting more than two weeks) were 7.4 (hazard ratio=7.4, 
95% CI=5.9-9.4) times as likely to have incident radiographic knee OA than those 
without knee injury history (Wilder et al., 2002).  Participants in this study are volunteers 
rather sampled from the population.  In the Mini-Finland Health Study, the OR is 5.1 
(95% CI = 1.4-19.0) for this 22 year follow-up study (Toivanen et al., 2010).  A major 
limitation of this study was loss-to-follow-up; only 823 of the original 8000 participants 
completed follow-up examination.    
 Strengths from previous studies of injury and OA include:  population-based 
designs (Davis et al., 1989; Tepper & Hochberg, 1993; Felson et al., 1997; Hart et al., 
1999; Sowers et al., 2000), radiographically defined OA (Davis et al., 1989; Tepper & 
Hochberg, 1993; Felson et al., 1997; Cooper et al., 1998; Hart et al., 1999; Jones et al., 
2002; Wilder et al., 2002; Toivanen et al., 2010), and longitudinal study design to ensure 
that the injury precedes the outcome of OA (Felson et al., 1997; Hart et al., 1999; Gelber 
et al., 2000; Wilder et al., 2002; Toivanen et al., 2010).  Multiple limitations are apparent 
in these studies.  Self-report of exposure or outcome status is subject to error due to 
participants not accurately reporting their status.  Gelber et al.(Gelber et al., 2000) relied 
on self-report of OA, which may be reasonably reliable in a population of former medical 
students who would be likely to know their own diagnosis history.   All studies listed in 
Table 2.1 relied on self-report of injury.  Several studies used a cross-sectional study 
design to examine the association between injury and OA (Davis et al., 1989; Tepper & 
Hochberg, 1993; Sowers et al., 2000; Jones et al., 2002).  Potentially, this approach 
increases the likelihood of recall bias since individuals with OA may be more likely to 
recall injury in a joint with OA than individuals without OA.  The longitudinal studies of 
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the knee and hip have examined primarily middle to upper socioeconomic status 
Caucasian cohorts (Felson et al., 1997; Hart et al., 1999; Gelber et al., 2000), have not 
been population-based (Hart et al., 1999; Gelber et al., 2000; Wilder et al., 2002), had 
significant attrition (Toivanen et al., 2010),  and include short follow-up periods or 
follow-up periods that do not extend far enough into the latter decades of life, when OA 
is more common (Felson et al., 1997; Hart et al., 1999; Gelber et al., 2000).   
 Overall, the epidemiologic literature suggests an association between joint injury 
and OA, but further investigation is warranted.  Epidemiologic studies need to examine 
this association in other populations and a period of time adequate to capture the event of 
OA diagnosis.  Expanding the knowledge of the injury and OA relationship may aid in 
identifying individuals at risk for development of OA and who may benefit from injury 
prevention strategies, approaches to reducing repetitive or severe injuries, or early 
interventions following injury. 
B.7. Biomarkers and Osteoarthritis 
 Biological markers, or biomarkers, were defined in1998 by the National Institute 
of Health Biomarkers Definitions Working Group as “[a] characteristic that is objectively 
measured and evaluated as an indicator of normal biologic processes, pathogenic 
processes, or pharmacologic responses to a therapeutic intervention.”  Biomarkers can be 
found in the blood, urine, or joint fluid and their levels can be used to assess the presence 
or activity of a disease.  Among likely candidates for biomarkers of OA are cartilage 
oligomeric matrix protein (COMP), hyaluronan (HA), high-sensitivity C-reactive protein 
(hsCRP), and keratan sulfate (KS). 
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 COMP is a protein found in all joint tissues and vascular smooth muscle 
(Williams & Spector, 2008).  Elevated levels of COMP in joint fluid and serum indicate a 
release of fragments of this protein and synovial inflammation, and higher levels of 
COMP have been associated with rheumatoid arthritis and primary OA (Lohmander et 
al., 1994).  Studies using plain radiographs to detect OA report that COMP is associated 
with incident and progressive OA (Clark et al., 1999; Vilím, Olejárová, Machácek, 
Gatterová, Kraus & Pavelka, 2002).  Kelman et al. (Kelman et al., 2006) reported that 
serum COMP predicted incident hip OA in women.  Vilim et al. (Vilím et al., 2002) 
reported that a change in joint space width over a 3 year period was associated with 
baseline COMP levels in 48 participants with symptomatic knee OA.   Sharif et al. 
(Sharif, Kirwan, Elson, Granell & Clarke, 2004) reported that, on average, a 1-unit 
increase in COMP levels increased the probability of radiographic progression of the 
knee by 15% in 115 patients over a 5 year period.  The Boston Osteoarthritis Knee Study 
examined the association between cartilage changes of the knee and biomarkers of 
cartilage turnover in a nested case-control study (N=80 with cartilage loss, N=80 without 
cartilage loss).  COMP was the only biomarker that predicted cartilage loss on MRI over 
a 30-month period in adjusted models.  In models adjusting for age, gender, and body 
mass index (BMI), the OR for cartilage loss was 6.35 (95% CI = 1.36-29.65) (Hunter, Li, 
LaValley, Bauer, Nevitt, DeGroot, Poole, Eyre, Guermazi, Gale & Felson, 2007).  
 HA is a glycosaminoglycan found in cartilage and synovium, and it may 
contribute to the lubrication properties of synovial fluid.  HA is found in connective 
tissues throughout the body, and serum levels of HA may vary with other medical 
disorders, including cancer, rheumatoid arthritis, liver disease, and kidney disease 
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(Elliott, Kraus, Luta, Stabler, Renner, Woodard, Dragomir, Helmick, Hochberg & Jordan, 
2005).  Sharif et al. (Sharif et al., 1995) reported that serum HA levels were significantly 
associated with longer duration of knee OA in a study of 94 patients.  Additionally, the 
investigators observed higher levels of HA in patients whose knee OA had progressed 
compared to those without disease progression over a 1 year period.  Serum HA levels 
and serum hsCRP levels (a marker of systemic inflammation) were not correlated in a 
study by Elliott et al. (Elliott et al., 2005), supporting that HA may be a marker of 
localized joint inflammation. 
 Serum hsCRP is a protein that is indicative of systemic inflammation, and it has 
been shown to be  prognostic of incident knee OA in women (Spector et al., 1997; 
Sowers et al., 2002);   In a comparison of 57 healthy volunteers to 167 patients with knee 
OA, hsCRP levels tended to be higher among those with knee OA than those without 
disease (Sharif, Elson, Dieppe & Kirwan, 1997).  In a study of 90 patients from a cohort 
of consecutive outpatients, Sharif et al. (Sharif, Shepstone, Elson, Dieppe & Kirwan, 
2000) reported that serum hsCRP at entry did not predict progression of radiographic 
knee OA between entry and five years (OR = 1.12, 95% CI = 0.81-1.55), but serum 
hsCRP at 3 years did predict progression (OR = 1.90, 95% CI = 1.01-3.28). Obesity has 
been reported to be an important confounder in the associations between hsCRP and 
radiographic OA (Elliott et al., 2005).        
KS, a glycosaminoglycan linked to cartilage proteoglycan, is a product of 
cartilage breakdown present in serum.  In a small study comparing 24 healthy volunteers, 
19 patients with knee injury, and 31 patients with knee OA, KS was associated with 
cartilage damage and was higher in patients with K-L grades of 0 or 1 than in those with 
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K-L grades of 2-4 (Wakitani et al., 2007) .  Sharif et al. (Sharif et al., 1995) reported that 
KS was not shown to be a strong prognostic marker of knee OA progression.  The 
investigators reported no significant differences in levels of KS between patients with and 
without knee OA progression (defined by changes in joint space narrowing) over a 5 year 
period in a study of 94 patients.  Bruyere et al. (Bruyere, Collette, Ethgen, Rovati, 
Giacovelli, Henrotin, Seidel & Reginster, 2003) also reported no significant association 
between KS and radiographic progression of knee joint space narrowing over 3 year 
period among 212 subjects in the placebo arm of a double-blind study. 
B.8.  Biomarkers, Osteoarthritis, and Joint Injury 
 Radiographs have been the most commonly used outcome for diagnosing and 
monitoring OA progression.  However, radiography is limited in its ability to detect and 
measure disease progression in OA because: 1) radiographs show changes in bone but 
cannot directly show cartilage changes, 2) joint space narrowing, which is used to attempt 
to assess articular cartilage changes, can be difficult to distinguish from meniscal 
anomalies, and 3) other synovial changes may not be (Bauer, Hunter, Abramson, Attur, 
Corr, Felson, Heinegård, Jordan, Kepler, Lane, Saxne, Tyree & Kraus, 2006). 
Additionally, radiography provides a two dimensional cross-section image of the joint, 
which may not capture the section of the joint that has OA features nor show the same 
part of the joint with repeated measures over time due to variable patient positioning and 
machine alignment.   MRI offers a more sensitive way to observe changes in articular 
cartilage and other joint structures, although it is more time-intensive and costly than 
radiography.  Analysis of biomarkers from serum and urine shows potential as a sensitive 
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and less costly way to monitor the development of OA and the long term effects of joint 
injury. 
 Elevated biomarker levels appear to be promising in monitoring changes in joint 
tissue turnover, detecting early OA development (Spector et al., 1997; Sowers et al., 
2002; Kelman et al., 2006), and determining progression of OA (Clark et al., 1999; Vilím 
et al., 2002; Hunter et al., 2007).  Levels of COMP tend to increase after injury, and they 
often remain elevated for years following injury (Lohmander et al., 1994).   The elevated 
biomarker levels observed after injury may be comparable to those observed in 
individuals with radiographic OA.  Previous studies have examined the levels of 
biomarkers after knee injury and in radiographic knee OA in cross-sectional analyses or 
longitudinally in small samples (Lohmander et al., 1994; Lohmander, Ionescu, Jugessur 
& Poole, 1999), but studies have not assessed longitudinally in larger population-based 
cohorts whether specific biomarkers may predict the development of OA or how joint 
injury history may play a role in this association.   
C.  Summary 
 OA is a significant public health problem and is becoming more common due to 
two important risk factors: the aging of the United States population and the obesity 
epidemic.  Methods for identifying the early stages of OA are necessary for allowing 
timely intervention, before the disease becomes severe.  Radiography and MRI have 
limitations, and biomarkers may be a cost-efficient and easy-to-administer method for 
the early identification of OA.  Because the biomarkers that potentially predict OA may 
be elevated after joint injury, the role of injury in the biomarker-radiographic OA 
association should be examined.   
 22 
 
 Injury is a common event and has been shown in prior studies to have an 
association with OA, but the epidemiologic evidence gives a wide range of estimates, 
particularly in longitudinal analyses.  Differences in study populations, time of follow-
up, and definitions of exposure and outcomes may explain some of these differences.  
Exploring different definitions of OA, examining the injury and OA association 
longitudinally in a bi-racial, community-based population, and comparing estimates 
generated from cross-sectional and longitudinal analyses may help explain differences 
in the results of prior injury-OA studies.       
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Table 2.1.  Serum biomarkers associated with OA and injury. 
Event Biomarker 
Incident Knee OA in women hsCRP 
Incident Hip OA COMP 
Progressive Knee OA COMP, HA 
Acute knee injury KS 
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Table 2.2.  Summary of published literature of the association between joint injury and OA. 
Author 
(Year) 
Population Joint Study Design Results* Additional Information 
Davis 
(1989)  
3,885 adults 
(NHANES I) 
Knee Cross-sectional OR=16.3 & 10.9 for right 
and left knee, respectively 
(95% CI 6.50-40.89 & 
3.72-31.93) 
 
<2% unilateral knee OA,  
5% bilateral knee OA 
 
Sowers 
(2000)  
1,053 Caucasian 
and African-
American 
women 
Knee 
and hand 
Cross-sectional Knee: OR= 1.90 (95% CI 
1.17-3.07) 
Hand: OR=1.33 (95% CI 
0.89-1.97) 
 
 
Adjusted for age, body 
mass index, smoking, and 
race/ethnicity 
 
Felson 
(1997)  
598 adults 
(almost all 
Caucasian), 
Framingham, 
MA 
 
Knee Longitudinal 
(7-10 years) 
OR = 0.7 (95% CI 0.1-3.2) Only 3.3% with history of 
knee injury; adjusting for 
age, sex, BMI, smoking, 
hand OA, & physical 
activity 
 
Hart 
(1999)  
Mostly 
Caucasian, 
middle-class 
cohort of 830 
women from 
England 
Knee Longitudinal (4 
years) 
Osteophytes: OR= 1.85 
(95% CI 0.82-4.19); joint 
space narrowing: OR= 
1.03 (0.45-2.32) 
 
11% with history of knee 
injury 
      
Gelber 
(2000)  
1,321 mostly 
Caucasian and 
mostly male 
former medical 
students  
Knee 
and hip 
Longitudinal 
(median of 36 
years)  
Knee:  RR=5.17 (95% CI 
3.07-8.71) 
Hip:  RR=3.50 (0.84-
14.69) 
Mean age 22 years at 
enrollment; mean age at 
end of study 61 years; 9% 
and 2% with knee & hip 
injury, respectively 
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*Odds ratio (OR), Relative Risk (RR), and Hazard Ratio (HR) > 1.0 suggests a positive association between injury and OA. 
 
Author 
(Year) 
Population Joint Study Design Results* Additional Information 
Wilder 
(2002) 
 
1,439 male and 
female 
volunteers, age 
40+ years 
Knee Longitudinal 
(25 year study; 
mean follow-up 
time not 
specified  
HR=7.4 (95% CI 5.9-9.4) Adjusted for age, gender, 
BMI at study entry, BMI 
at age 45, smoking 
Toivanen 
(2010) 
 
8,000 subjects, 
representative of 
Finnish 
population aged 
30+ years 
 
Knee Longitudinal 
(22 years) 
OR =5.1 (95% CI 1.4-19.) Significant loss-to-
follow-up: only 823 
participants at follow-up 
visit 
Tepper 
(1993)  
2,490 subjects 
aged 55-74 years 
(NHANES I) 
 
Hip Cross-sectional OR =7.84 (95% CI 2.11-
29.10)  
 
Adjusted for sex, age, 
race, and education 
Cooper 
(1998)  
611 cases and 
661 controls in 
England 
Hip Case-control OR=4.3 (95% CI 2.2-8.4)  
  
Hip injury was more 
closely associated with 
unilateral than bilateral 
hip OA 
 
Jones 
(2002)  
522 male and 
female subjects 
from Tasmania 
Hand 
(digital 
fracture) 
Cross-sectional OR=2.42 (95% CI 1.22-
4.83) 
Adjusted for age, sex, 
age-sex interaction, BMI, 
family status 
  
 
 
 
 
III.  Statement of Specific Aims 
This research addressed four questions:  
1. Do biomarkers of cartilage turnover and inflammation predict radiographic knee 
OA? 
2. Does prognostication of incident radiographic knee OA with OA-related 
biomarkers vary by lower extremity injury history or the presence of chronic joint 
symptoms? 
3. Does joint injury history predict the development of knee and hip OA, specifically 
in the ipsilateral and contralateral limbs?  
4. Are the estimates of the association between injury and OA generated by cross-
sectional designs comparable to those estimated by longitudinal designs? 
 The following specific aims were addressed to answer these questions: 
 Specific Aim 1(SA1) 
Assess whether elevated levels of biomarkers of cartilage degradation and inflammation 
predict radiographic knee OA, examining self-reported joint injury history of the knee 
and presence of chronic knee symptoms at baseline as potential covariates. 
Hypothesis  – Specific Aim 1 
Elevated levels of each biomarker examined in this study (cartilage oligomeric matrix 
protein [COMP], hyaluronan [HA], high-sensitivity C-reactive protein [hsCRP], and 
keratan sulfate [KS]) will predict radiographic knee OA.  In this study, the association 
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between each biomarker and development of OA will be more pronounced among those 
with a history of self-report joint injury of the knee or chronic knee symptoms. 
Rationale for Specific Aim 1 
Levels of COMP tend to increase after injury, and they often remain elevated for years 
following injury (Lohmander et al., 1994).   The elevated biomarker levels observed after 
injury may be comparable to those observed in individuals with radiographic OA.  Thus, 
joint injury may initiate changes in joint metabolism (increased level of biomarkers) that 
contribute to development of OA. 
Chronic joint symptoms may be an early sign of incident radiographic OA.  
Elevated biomarker levels may suggest that chronic knee symptoms precede radiographic 
disease.     
Specific Aim 2 (SA2) 
Quantify the association between knee and hip OA and self-reported joint injury history 
of the knee or hip. 
A. Longitudinally compare the hazard of incident knee and hip OA (defined as 
radiographic OA, chronic symptoms, radiographic OA or symptoms, and 
radiographic OA plus symptoms) in individuals with self-reported joint injury 
history of the knee or hip to those without prior injury. 
B. Cross-sectionally compare the prevalence of knee and hip OA (defined as 
radiographic OA, chronic symptoms, radiographic OA or symptoms, and 
radiographic OA plus symptoms) in individuals with self-reported joint injury 
history of the knee or hip relative to those without prior injury. 
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C. Compare estimates of the association of injury and OA of the knee or hip derived 
from longitudinal analyses to those from cross-sectional analyses. 
Hypothesis  – Specific Aim 2 
The cross-sectional prevalence and longitudinal hazard of knee and hip OA will be higher 
among individuals with self-reported joint injury history of the knee or hip than for those 
without prior injury.  The prevalence and hazard will be higher among those with self-
reported joint injury history than for those without prior injury, but the magnitude of the 
association will be higher among the prevalence estimates than the hazard estimates. 
Rationale for Specific Aim 2 
Injury has been shown in prior cross-sectional and longitudinal studies to be associated 
with OA of the knee and hip.  Recall bias may occur in a cross-sectional study of the 
association between injury and OA (i.e., those with OA may be more likely to recall prior 
injuries than those without OA), thus, inflating the estimate of the association. 
 
  
 
 
 
 
IV.  METHODS 
This research consisted of three components: 1) a longitudinal analysis of the association 
between biomarkers and knee OA (SA1), 2) a longitudinal analysis of the association 
between injury and OA of the knee and hip (SA2 A and C), and 3) a cross-sectional 
analysis of the association between injury and OA of the knee and hip (SA2 B and C).  
Details of each analysis are described separately.  All data were from the Johnston 
County Osteoarthritis Project.  
A. Data Acquisition: The Johnston County Osteoarthritis Project 
 The Johnston County Osteoarthritis Project is one of the largest population-based 
prospective studies of OA.  The project is conducted by investigators at the University of 
North Carolina, Chapel Hill, North Carolina and funded by the Centers for Disease 
Control (since 1990) and Prevention’s Arthritis Program and the National Institute of 
Health’s National Institute of Arthritis, Musculoskeletal and Skin Diseases (since 1993).  
The project began in the early 1990s, enrolling participants during Phase I from 1991-
1997 and Phase II 1999-2004.  The project is expected to last at least 20 years. The 
purpose of the Johnston County Osteoarthritis Project is to estimate the prevalence, 
incidence, progression, and risk factors of OA among African Americans and Caucasians 
in a rural county in North Carolina.   The Johnston County Osteoarthritis Project is the 
only population-based study to include biomarker collection from African Americans.   
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A.1. Participants 
 Details of the sampling strategy of the Johnston County Osteoarthritis project 
were described in an appendix of a paper by Jordan et al. (Jordan, Helmick, Renner, Luta, 
Dragomier, Woodard, Fang, Schwartz, Abbate, Callahan, Kalsbeek & Hochberg, 2007) 
and are summarized below.  The Johnston County Osteoarthritis Project is a probability-
based sample that was designed to be representative of the noninstitutionalized, civilian, 
age 45 years and older, African-American and Caucasian population of six townships in 
Johnston County, North Carolina: Banner, Beulah, Boon Hill, Clayton, Selma, and 
Smithfield.  These six townships were selected out of a possible 17 in Johnston County 
because they included a larger proportion of African American residents (according to 
1990 U.S. census records) than the other townships and they contained a central town 
surrounded by a mostly rural area.  One focus of the Johnston County Osteoarthritis 
Project is to examine ethnic differences in OA incidence and progression over time.  
Thus, the design included oversampling of African Americans and undersampling of 
Caucasian females aged 65 years and older.  
A.2. Sampling Design 
  The sampling design consisted of two steps: 1) selection of primary sampling 
units by stratified simple random sampling of streets, and 2) stratified subsampling of 
Caucasian women 65 years and older. 
Step 1. Stratified simple random sampling of streets as primary sampling units was 
selected. Stratification of streets and sampling rates varied by township, depending on the 
relative size of each township.  Beulah, Boon Hill, and Selma were the three smallest 
townships.  The streets in these townships were stratified as urban or rural, and all the 
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streets from each stratum were selected. Banner and Clayton were considered medium 
sized townships.   The streets in the townships were stratified as urban streets and rural 
streets, and a simple random sample of streets was selected from each stratum.  
Smithfield was the largest township, and the streets were stratified into six strata.  The 
streets were classified as African American, mixed ethnicity, and Caucasian streets.  
Most streets were either 100% African American or 100% Caucasian.  The Caucasian 
streets were classified as urban or rural, and then, the Caucasian urban streets were 
classified into three categories based on socioeconomic status (i.e., high, medium, and 
low).  These additional classifications of the Caucasian streets occurred because of the 
greater number of Caucasians than African Americans in Johnston County and because 
Caucasians tended to have greater socioeconomic diversity than African Americans (i.e., 
African Americans were more likely to have a lower socioeconomic status).  The sample 
of streets in Smithfield was selected with the restriction that all African American streets, 
all mixed ethnicity streets, and all Caucasian rural streets were included.  Out of a total of 
882 possible streets in Smithfield, 707 streets were selected. 
Step 2. The number of Caucasian women 65 years of age and older living on the selected 
streets in all six townships was much higher than the 1990 census data had suggested.   
Thus, recruitment was stopped after the number of Caucasian females surpassed a preset 
number to avoid an exceptionally large number of participants in this demographic 
subgroup.  Caucasian women 65 years or older were selected based on a subset of the 
original sample from each stratum.  Out of a total of 1725 Caucasian women 65 years of 
age and older selected in the first step, 745 were selected in the second step.  This 
stratified selection was not based on random subsampling, but data do not suggest a 
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significant difference in age between the women selected and those not selected 
(Wilcoxon test p = 0.719). 
Households were enumerated for each selected street.  Data on age, sex, ethnic 
group, and marital status of each household were collected, and age and ethnicity 
information was used to determine eligibility of each household.  Eligible households 
were visited at least 3 different times before being considered as unable to contact. 
Neighbors were able to provide information about age-eligibility of residents of 
households that could not be contacted.  If an eligible household declined participation at 
first, participation status could be changed at a later time.  Data on education, 
employment status, and knee and hip symptoms were obtained from at least one member 
of each household for approximately 90% of eligible households who declined 
participation.  A total of 14,297 households were identified, and 4,866 were eligible; 
1,583 were unable to be contacted; 1038 were vacant; 5,939 lacked persons of eligible 
age for the study; 685 included only persons physically or mentally unable to participate; 
153 had a language barrier; and the residual 33 households were categorized as 
miscellaneous (i.e., temporarily away, deceased, no eligible respondent home, 
demolished/merged/not a housing unit, vacation/second home) (Figure 4.1).  First home 
interviews were completed by 3,690 participants (76% of the eligible 4,866), and 83% 
(3,068 participants) of those who completed the interview were examined at the local 
clinic.   
 Compared with national data, the baseline sample of Johnston County 
Osteoarthritis Project has an over-representation of minority residents (20%), lower 
income households (40% have annual income less than $10,000), and individuals with 
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limited education (53% of individuals have less than a high school education).  A large 
proportion of the county’s population are employed in blue-collar, semi-skilled 
occupations (30%) and farm-related work (20%), which makes this a valuable resource 
for examining associations of occupational risks with OA.  The total Johnston County 
Osteoarthritis sample (N=4,202) is 65.7% Caucasian and 34.3% African American, 
63.3% female, and has an average age of 60.4 years. 
 Figure 4.2 offers details on the timeline for data collection in the Johnston County 
Osteoarthritis Project. The initial Johnston County Osteoarthritis sample (T0) included 
3,187 participants enrolled from 1991-1997 (Phase I).  Interview and clinical data for the 
first follow-up assessments (T1) were completed for 1,733 participants during 1999-
2004, on average 4-7 years post baseline.  An additional 1,015 participants were enrolled 
during Phase II (T1*) from 2003-2004.  Phase III data collection is currently being 
conducted to obtain follow-up assessments (T2) on participants from the original T0 
sample and the T1* sample. 
A.3. Data Collected 
  The Johnston County Osteoarthritis project included an initial general health 
interview (i.e., participant’s health, medical illnesses, jobs, and arthritis) conducted in the 
home, lasting 60-90 minutes.  Participants completed a physical examination at the 
Johnston County Osteoarthritis Project Research Clinic in Smithfield, North Carolina.  
The clinic examination took approximately 2 hours and included blood pressure 
measurement; measurement of height and weight; waist and hip circumference; 
radiographs of the hips and knees at T0, T1, T1* and T2; radiographs of the hands and 
spine at T1, T1*, and T2; physical examination of the hips, knee, hands; blood tests to 
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test for factors and genes related to OA; urine tests; collection of toe nails to measure 
metals related to OA (selected participants at T1* and T2); and functional tests, including 
collection of gait parameters.  A second home interview lasting 60-90 minutes was 
conducted.  This sequence of testing is repeated approximately every 5 years. 
B.  Methods Addressing Specific Aim 1 – Biomarkers and Osteoarthritis 
B.1. Study Participants 
 A total of 3,187 individuals were recruited for the Johnston County Osteoarthritis 
Project between May 1991 and December 1997.    Among the 3,187 participants with 
baseline data, 1,329 were not eligible or available for follow-up assessments.   Reasons 
that participants were not eligible or available included emigration from study area 
(N=161), refusal (N=435), inability to participate due to physical or mental conditions 
(N=234), death (N=411), and inability to contact or find (N=88).  Assessments at follow-
up were completed from 1999-2003.   
B.1. 1.  Biomarker Sub-Study 
 Participants in the Johnston County Osteoarthritis Project Biomarker Sub-study 
were selected from participants in the project at T0 (N=3,187).   All participants had 
serum drawn at the time of radiographic assessment, and biomarker levels were measured 
for 388 African Americans and 820 Caucasians.  All African Americans and 394 
randomly selected Caucasians have available data that were used in prior analyses, 
allowing approximately equal numbers from cross-classification by gender, age group 
(45-54 years, 55-64 years, more than 65 years), and OA status (affected or unaffected).   
Selection was independent of joint symptoms. 
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Baseline biomarker assessments were completed for 803 participants.  These 
participants were selected to represent roughly equal proportions of African Americans, 
Whites, women, and men with and without radiographic OA, representing a range of 
ages, with complete radiographic data at baseline.  Individuals with rheumatoid arthritis 
or other inflammatory arthropathies were not included in the subsample.    
B.2.  Measures 
B.2.1. Baseline Biomarker Assessment  
  The 803 baseline serum samples of COMP, HA, hsCRP, and KS were collected, 
spun, and stored at -86ºC.  Serum COMP was measured using an in-house sandwich 
enzyme linked immunosorbent assay (ELISA)(Vilím, Vobůrka, Vytásek, LSenolt, 
Tchetverikov, Kraus & Pavelka, 2003).  The reported precision is 5.8-6.6% intra-assay 
variability and between 8.7-9.7% inter-assay variability.  Serum HA was measured with 
the Hylauronic Acid Test kit (Corgenix, Westimister, CO).  The reported precision is 3.6-
4.7% intra-assay variability and between 5.7-7.0% inter-assay variability.  Serum hsCRP 
was measured with the UBI Magiwel Enzyme Immunoassay (United Biotech Inc. 
Mountain View, CA).  The minimum detectable concentration for this assay is 0.35 
nanograms/milliliter (ng/ml), and the inter-assay precision was 7.4% (N=20) at a 
concentration of 3 ng/ml in the Johnston County  OA project biomarker substudy(Kraus, 
Stabler, Luta, Renner, Dragomir & Jordan, 2007).  Serum KS was measured using an in-
house competitive ELISA as previously described (Lindhorst, Vail, Guilak, Wang, 
Setton, Vilim & Kraus, 2000) . The inter-assay precision was 14.4%, and the intra-assay 
precision was 3.2% (Lindhorst et al., 2000).  
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 The mean, standard deviations, and range of each biomarker are presented in 
Table 4.1.  The distribution of each biomarker is right-skewed, and HA has one missing 
value and one value that appears to be an outlier (1125.3 nanograms/milliliter (ng/ml)), 
since the next highest value is 471.7 ng/ml.   COMP has one value that is a possible 
outlier of 7667.4 ng/ml.  At T1, 420 participants with biomarker data returned for follow-
up assessments, and 358 participants had linked baseline and follow-up knee radiographs.  
The participants with the missing HA value and the potential outlier COMP and HA 
values did not return for follow-up, and thus, were not eligible for analyses.  The range of 
follow-up times was 3.0-10.2 years (median time 6.2 years), which is similar to the 
overall cohort.  The distribution of each biomarker is shown in Figures 4.3-4.6.  
B.2.2. Radiographic Assessment of Incident Knee OA 
 Participants completed bilateral anteroposterior radiography of the knee in weight 
bearing.  Baseline and follow-up radiographs were read together without knowledge of 
participant clinical status and blinded to time sequence by a single musculoskeletal 
radiologist (Jordan B. Renner, MD) using the K-L radiographic atlas for overall knee 
radiographic grades (Jordan et al., 2007).  
  Radiographs without the features of OA were defined as Kellgren-Lawrence (K-
L) grade of 0 (normal findings).  A minute radiographic osteophyte of doubtful 
pathologic significance or a joint with definite joint space narrowing was assigned a K-L 
grade of 1 (questionable).  Radiographs showing an osteophyte without joint space 
narrowing were assigned a K-L grade of 2 (mild).  A moderate decrease of the joint space 
was assigned a K-L grade of 3 (moderate). K-L grade 4 (severe) was defined as severe 
joint space narrowing with subchondral bone sclerosis (Kellgren & Lawrence, 1963).  
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The incidence of radiographic OA was defined as a K-L grade ≥2 at follow-up among 
participants with K-L grade <2 at baseline.  Incident OST and JSN were identified in 
joints with grade=0 at baseline and ≥1 at follow-up , based on the Burnett atlas (Burnett 
et al., 1994). 
B.2.2.1. Reliability of Radiographic Assessment of Knee OA 
   Inter-rater reliability (comparison of radiograph readings between Dr. Renner 
and another radiologist) and intra-rater reliability (comparison of radiograph readings 
completed by Dr. Renner at two separate times) for the radiologist were high (weighted 
kappa for inter-rater reliability 0.859; kappa for intra-rater reliability 0.886) (Jordan, 
Linder, Renner & Fryer, 1995). 
B.2.3. Baseline History of Lower Extremity Injury 
Participants completed an interviewer-administered questionnaire in which they  
responded whether they had a history of knee injury [‘‘Have you ever injured your 
right/left knee?’’], knee fracture [‘‘Has a doctor ever told you that you had broken or 
fractured your right/left knee?’’], hip injury [‘‘Have you ever injured your right/left 
hip?’’], or hip fracture [‘‘Has a doctor ever told you that you had broken or fractured 
your right/left hip?’’].  A participant was considered to have a history of lower extremity 
injury if they answered “yes” to at least one of these four questions.   
B.2.4. Baseline Chronic Knee Symptoms 
 Participants completed an interviewer-administered questionnaire in which they 
answered “Yes” or “No,” separately for left and right knees, to the question: “On most 
days do you have pain, aching or stiffness in your [left/right] knee? 
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B.2.5. Baseline Demographic and Clinical Characteristics 
 The following participant characteristics were examined as potential covariates in 
our analyses because they have been associated with biomarkers of OA and knee 
radiographic OA: gender; self-reported race (African American or Caucasian); age 
(continuous variable in years); and body mass index at baseline (BMI: continuous 
variable calculated as weight in kilograms/height in meters squared).  Height without 
shoes was measured in centimeters and weight was measured in kilograms using a 
balance beam scale.   
B.3.  Statistical Analyses 
The natural logarithm transformation was used to produce nearly normal 
distributions for COMP (lnCOMP), HA (lnHA), hsCRP (lnhsCRP), and KS (lnKS) in 
analyses.  Descriptive statistics were calculated for race, gender, age, BMI, lower 
extremity injury history, and chronic knee symptoms.  Due to the wide range of follow-
up times for participants (mean = 6.3 years; standard deviation ± 1.4 years; range= 3.0 – 
10.2 years) and interval censoring (i.e., the exact time of the occurrence of the outcome is 
unknown), separate multivariable Cox models (with the midpoint of each individual’s 
follow-up period as the approximated endpoint) were used to estimate hazard ratios for a 
1-unit increase in the natural log of each biomarker with each radiographic knee outcome.  
We accounted for bilateral clustering of knees in subjects using robust variance estimates 
(Lin & Wei, 1989).  Estimates from the Cox model were compared to those from Weibull 
models that explicitly accounted for interval censoring(Odell, Anderson & D'Agostino, 
1992).  
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 Covariates included in adjusted models were race, gender, age, and BMI, which 
were identified by their association with both the biomarkers and radiographic OA (K-L 
grade or radiographic features), either based on statistical significance in bivariate 
associations or on prior published knowledge of each covariate.  If there were notable 
associations between any of the biomarkers and OST, we examined this association 
among those with no baseline JSN to determine independence of the association.  
Similarly, associations between biomarkers and JSN were examined among those with no 
baseline OST.  
A Cox model explored for examining the longitudinal association between 
biomarkers and OA is: 
log hi(t) = α + β1lnbiomarker + β2age + β3BMI + β4gender + β5race 
where log hi(t) = hazard of OA 
           α = baseline hazard of OA = h0(t) 
 lnbiomarker = natural log of continuous measure of biomarker level in ng/ml 
          age = continuous variable for age in years 
 BMI= continuous variable for BMI in kg/m2  
 gender = numerical variable for sex (gender=1(male), =0 (female)) 
          race= numerical variable for race (race=1(African-American), =0(Caucasian)) 
 t = time 
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A Weibull model explored for examining the longitudinal association between 
biomarkers and OA is: 
fT(t)= g (β1lnbiomarker + β2age + β3BMI + β4gender + β5race)  
where g(βX) = α e-βX (te-βX )α-1 e- e-βXt^α 
where fT(t)= hazard of OA 
           α = baseline hazard of OA 
 lnbiomarker = natural log of continuous measure of biomarker level in ng/ml 
          age = continuous variable for age in years 
 BMI= continuous variable for BMI in kg/m2  
 gender = numerical variable for sex (gender=1(male), =0 (female)) 
          race= numerical variable for race (race=1(African-American), =0(Caucasian)) 
 t = time 
Multiplicative interaction terms of each biomarker (lnCOMP, lnHA, lnhsCRP, 
lnKS) with each covariate (race, gender, age, BMI, history of lower extremity injury, 
chronic knee symptoms) were examined.  If the interaction term was statistically 
significant (p<0.10), then it was included in models.  Additionally, the association of 
each biomarker and outcome were stratified by: 1) history of lower extremity injury and 
2) chronic knee symptoms, to explore patterns of potential modification of the association 
by either of these covariates.   
C.   Methods Addressing Specific Aim 2 – Injury and Osteoarthritis 
C.1. Study Participants 
Among the 3,187 participants with baseline data, 1,329 (41.7%) were not eligible 
or available for follow-up assessments.   Assessments at follow-up were completed from 
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1999-2003 (median time from baseline to follow-up = 5.6 years, range=3.0-13.1 years).  
Linked baseline and follow-up interview data were available for 1,858 participants, and 
linked knee and hip radiograph assessments were available for 1,726 participants.  At 
baseline, joint injury data for the knee were available for 1,802 participants and for the 
hip for 1,803 participants.   
C. 2.  Measures 
C.2.1. Radiographic Assessment 
 Participants completed bilateral anteroposterior radiography of the knee in weight 
bearing.  Women over 50 years of age and all men completed supine anteroposterior 
pelvic radiography. 
  Radiographs were read linked and blinded to time sequence without knowledge 
of participant clinical status by a single muscuoloskeletal radiologist (Jordan B. Renner, 
MD) using the K-L radiographic atlas for overall knee radiographic grades, as described 
in Section B.2.2 (Jordan et al., 2007).  As stated in Section B.2.2.1, inter-rater reliability 
and intra-rater reliability were high (Jordan et al., 1995).  
C.2.2. Chronic Knee and Hip Symptoms 
 Participants completed an interviewer-administered questionnaire in which they 
answered “Yes” or “No,” separately for left and right knees and left and right hips, to the 
question: “On most days do you have pain, aching or stiffness in your [left/right] 
[knee/hip]?”  The presence of groin pain was recorded for right and left sides.  
Participants were considered to have chronic knee symptoms if they answered 
affirmatively to the knee symptoms question and to have chronic hip symptoms if they 
answered affirmatively to the hip symptoms question or reported groin pain.    
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C.2.3.  Definitions of Osteoarthritis Outcomes  
  The exploration of OA outcomes was performed separately for the knee and the 
hip joints and was based on various combinations of radiographic OA and/or symptom 
onset as described below.  
1. Radiographic OA.  The prevalence of radiographic OA was defined as K-L grade 
≥2 at follow-up.   The incidence of radiographic OA was defined as a K-L grade 
≥2 at follow-up among participants with K-L grade <2 at baseline.  The risk 
group is shown in Table 4.2. 
2. Chronic Symptoms.  The prevalence of chronic joint symptoms was defined as an 
affirmative response to the symptoms questions at follow-up.   The incidence of 
chronic joint symptoms was defined as an affirmative response to the symptoms 
questions at follow-up among participants who reported no symptoms at 
baseline.  The risk group is shown in Table 4.3. 
3. Radiographic OA or Symptoms.  The prevalence of radiographic OA or symptoms 
in the same joint was defined as K-L grade ≥2 at follow-up or as an affirmative 
response to the chronic joint symptoms questions at follow-up.   The incidence 
of radiographic OA or symptoms was defined as a K-L grade ≥2 at follow-up 
among participants with K-L grade <2 at baseline or the presence of symptoms 
at follow-up among those without symptoms at baseline.  The risk group is 
shown in Table 4.4. 
4. Radiographic OA with Symptoms.  The prevalence of radiographic OA with 
symptoms in the same joint was defined as K-L grade ≥2 at follow-up and an 
affirmative response to the chronic joint symptoms questions at follow-up.   The 
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incidence of radiographic OA with symptoms was defined as a K-L grade ≥2 at 
follow-up and the presence of symptoms at follow-up among those with K-L 
grade <2 or without symptoms at baseline.  The risk group is shown in Table 
4.5. 
C.2.4.  History of Knee or Hip Injury 
Participants completed an interviewer-administered questionnaire at baseline and 
follow-up visits in which they responded whether they had a history of knee injury 
[‘‘Have you ever injured your right/left knee?’’] and a hip injury [‘‘Have you ever 
injured your right/left hip?’’].  A participant was considered to have the injury of interest 
if he or she answered “yes”.   
C.2.5.  Covariates 
C.2.5.1. Demographic and Clinical Characteristics 
  The following participant characteristics were collected at baseline: gender; self-
reported race (African American or Caucasian); age (continuous variable in years); and 
body mass index at baseline (BMI: continuous variable calculated as weight in 
kilograms/height in meters squared).  Height without shoes was measured in centimeters 
and weight was measured in kilograms using a balance beam scale.   
C.2.5.2. Current Vigorous Occupational Activity 
Participants completed an interviewer-administered questionnaire at baseline in 
which they answered: 1) whether they were employed, and 2) “never”, “seldom”, 
“sometimes”, “often”, or “always” to separate questions about often they performed 
lifting, standing, walking, or squatting at their current job, if employed.  If a participant 
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answered that he or she was employed and “often” or “always” to any of the activity 
questions, he or she was classified as currently engaged in vigorous occupational activity.   
C.2.5.3. Current Smoker 
Participants were asked at baseline whether they currently smoked.  Those who 
responded “yes” were classified as current smokers. 
C.3. Statistical Analysis 
C.3.1.  Specific Aim 2A – Longitudinal Analyses 
Descriptive statistics (proportions for categorical variables and means and 
standard deviations for continuous variables) were calculated for the covariates of age, 
BMI, race, gender, current smoker status, and current vigorous occupational activity for 
the whole sample and for those with injury data.  Pearson’s chi-square test for categorical 
variables and t-tests for continuous variables were used to compare these covariates in the 
injured vs. the uninjured.  Differential participation was examined by comparing the 
baseline variables (age, BMI, race, gender, current smoker status, current vigorous 
occupational activity, and injury status) of participants who returned to follow-up visit to 
those who did not return by using Pearson’s chi-square test for categorical variables and 
t-tests for continuous variables. 
Due to the wide range of follow-up times for participants (mean = 5.9 years; 
standard deviation ± 1.4 years; range= 3.0 – 13.2 years) and interval censoring (i.e., the 
exact time of the occurrence of the outcome is unknown), separate multivariable Cox 
models (with the midpoint of each individual’s follow-up period as the approximated 
endpoint) were used to estimate hazard ratios.   Unilateral analyses were conducted to 
examine the associations between injury and radiographic OA in the ipsilateral (same) 
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joint and in the contralateral (opposite; e.g. right knee injury and left knee OA) joint.  
Additionally, the association between ipsilateral knee injury and hip OA, ipsilateral hip 
injury and knee OA, contralateral knee injury and hip OA, and contralateral hip injury 
and knee OA were explored.  Bilateral clustering of knees and bilateral clustering of hips 
was accounted for using the robust variance estimation (Lin & Wei, 1989).  Covariates 
included in adjusted models were identified by their plausible association with both 
injury and the outcome of interest, either based on observed strength of association in 
bivariate associations or on prior published knowledge of each covariate.  Multiplicative 
interactions of injury with each covariate (race, gender, baseline age, baseline BMI, 
baseline current vigorous occupational activity, baseline current smoking status) were 
examined.  If the interaction term had a p-value <0.10, then it was included in models.   
A Cox model formula used in this research for examining the longitudinal 
association between injury and OA is: 
log hi(t) = α + β1injury + β2age + β3BMI + β4gender + β5smoker + β6occupat 
where log hi(t) = hazard of OA 
           α = baseline hazard of OA = log h0(t) 
 injury = categorical variable for history of joint injury (injury=1(yes), =0(no)) 
          age = continuous variable for age in years 
 BMI= continuous variable for BMI in kg/m2  
 gender = numerical variable for sex (gender=1(male), =0 (female)) 
 smoker= numerical categorical variable for current smoker versus current non- 
                         smoker  
       (smoker=1(current smoker), =0(non-smoker)) 
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 occupat= numerical categorical variable for current occupational vigorous activity  
                      (stand, squat, lift, or walk at current job at least sometimes) versus no  
                       vigorous activity (stand, squat, lift, and walk never or seldom)   
                         (occupant=1 (vigorous occupational activity), =0 (no vigorous activity) 
C.3.2.  Specific Aim 2B – Cross-Sectional Analyses 
Descriptive statistics (proportions for categorical variables and means and 
standard deviations for continuous variables) were calculated for the covariates of age, 
BMI, race, gender, current smoker status, and current vigorous occupational activity for 
the whole sample and for those with injury data.  Pearson’s chi-square test for categorical 
variables and t-tests for continuous variables were used to compare these covariates in the 
injured vs. the uninjured.   
Separate multivariable logistic regression models were used to estimate odds 
ratios.   Unilateral analyses were conducted to examine the associations between: knee 
injury and ipsilateral (same) radiographic knee OA, knee injury and contralateral 
(opposite; e.g. right knee injury and left knee OA) radiographic knee OA,  knee injury 
and ipsilateral radiographic hip OA,  knee injury and contralateral radiographic hip OA,  
hip injury and ipsilateral radiographic hip OA,  hip injury and contralateral radiographic 
hip OA, hip injury and ipsilateral radiographic knee OA,  and hip injury and contralateral 
radiographic knee OA.  Bilateral clustering of knees and bilateral clustering of hips was 
accounted for using the robust variance estimation (Lin & Wei, 1989).  Covariates and 
interaction terms included in adjusted models were the same as those identified and 
included in longitudinal analyses (from Specific Aim 2a). 
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A logistic regression model formula used in this research for examining the cross-
sectional association between injury and OA is: 
logit(OA) = α + β1injury + β2age + β3BMI + β4gender + β5smoker + β6occupat 
where logit (OA)= ln prevalence of OA 
           α = baseline ln prevalence of OA 
 injury = categorical variable for history of joint injury (injury=1(yes), =0(no)) 
           age = continuous variable for age in years 
 BMI= continuous variable for BMI in kg/m2  
 gender = numerical variable for sex (gender=1(male), =0 (female)) 
 smoker= numerical categorical variable for current smoker versus current non- 
                        smoker (smoker=1(current smoker), =0(non-smoker)) 
 occupat= numerical categorical variable for current occupational vigorous activity  
                        (stand, squat, lift, or walk at current job at least sometimes) versus no  
                        vigorous activity (stand, squat, lift, and walk never or seldom)   
                         (occupant=1 (vigorous occupational activity), =0 (no vigorous activity) 
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Figure 4.1.  Identified Households (N=14,297). 
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Figure 4.2. Timeline for Johnston County Osteoarthritis Project Data Collection. 
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Figure 4.3.  Distribution of COMP (ng/ml). 
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Figure 4.4.  Distribution of HA (ng/ml). 
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Figure 4.5.  Distribution of hsCRP (ng/ml). 
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Figure 4.6.  Distribution of KS (ng/ml). 
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Table 4.1. Summary of Biomarker Levels (ng/ml), N=803. 
ng/ml COMP HA hsCRP KS 
Mean (± SD*)  3097.8 (± 1392.7) 5351.0 (± 9253.0) 1101.7 (± 645.3) 47.5 (± 64.0) 
Median    2786.2   2419.1   968.9     29.7 
Minimum     990.5       50.2   170.3      0.1 
Maximum  10706.0 91057.0 7667.4 1125.3 
*SD = standard deviation 
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Table 4.2.  Risk Group for Radiographic Osteoarthritis.  Risk group highlighted in 
gray.  Prevalent or incident radiographic OA would be defined as radiographic OA only 
or radiographic OA with symptoms.    
 
Kellgren-Lawrence Symptoms Most Days No Symptoms Most Days 
>2 Radiographic OA with 
Symptoms 
Radiographic OA Only 
 
<2 Symptoms Only Neither radiographic OA 
nor symptoms 
 
Table 4.3.  Risk Group for Chronic Symptoms. Risk group highlighted in gray.  
Prevalent or incident chronic symptoms would be defined as radiographic OA with 
symptoms or symptoms only. 
 
Kellgren-Lawrence Symptoms Most Days No Symptoms Most Days 
>2 Radiographic OA with 
Symptoms 
Radiographic OA Only 
 
<2 Symptoms Only Neither radiographic OA 
nor symptoms 
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Table 4.4.  Risk Group for Radiographic Osteoarthritis or Symptoms. Risk group 
highlighted in gray.  Prevalent or incident radiographic OA would be defined as 
radiographic OA only, symptoms only, or radiographic OA with symptoms. 
 
Kellgren-Lawrence Symptoms Most Days No Symptoms Most Days 
>2 Radiographic OA with 
Symptoms 
Radiographic OA Only 
 
<2 Symptoms Only Neither radiographic OA 
nor symptoms 
 
Table 4.5.  Risk Group for Radiographic Osteoarthritis with Symptoms. Risk group 
highlighted in gray.  Prevalent or incident radiographic OA would be defined as 
radiographic OA with symptoms. 
 
Kellgren-Lawrence Symptoms Most Days No Symptoms Most Days 
>2 Radiographic OA with 
Symptoms 
Radiographic OA Only 
 
<2 Symptoms Only Neither radiographic OA 
nor symptoms 
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Table 4.6.  Variables Collected by the Johnston County Osteoarthritis Project. 
 
Category Variable 
Name 
Measure Time 
Point  
Coding 
Radiographic 
OA 
Right Knee 
K-L Grade 
Right Knee Grade 
0 - No OA 
1 - Questionable OA 
2 - Mild OA 
3 - Moderate OA 
4 - Severe OA 
5 - Non OA 
 
T0, 
T1 
Right Knee OA 
No=K-L 0, 1 
Yes= K-L 2, 3, 4 
 
 Left Knee 
 K-L Grade 
Left Knee Grade 
0 - No OA 
1 - Questionable OA 
2 - Mild OA 
3 - Moderate OA 
4 - Severe OA 
5 - Non OA 
 
T0, 
T1 
Left Knee OA 
No=K-L 0, 1 
Yes= K-L 2, 3, 4 
 
 Right Hip  
K-L Grade 
Right Hip Osteoarthritis grade 
0 - No OA 
1 - Questionable OA 
2 - Mild OA 
3 - Moderate OA 
4 - Severe OA 
5 - Non 
 
T0, 
T1 
Right Hip OA 
No=K-L 0, 1 
Yes= K-L 2, 3, 4 
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 Left Hip K-
L Grade 
Left Hip Osteoarthritis grade 
0 - No OA 
1 - Questionable OA 
2 - Mild OA 
3 - Moderate OA 
4 - Severe OA 
5 - Non 
 
T0, 
T1 
Left Hip OA 
No=K-L 0, 1 
Yes= K-L 2, 3, 4 
 
Joint 
Symptoms 
Right knee 
symptoms 
On MOST days do you have pain, 
aching or stiffness in your RIGHT 
KNEE? 
Y - Yes 
N - No  
D - Don't know  
R - Refused  
 
T0, 
T1 
Chronic Right 
Knee Symptoms 
No=No 
Yes=Yes 
 Left knee 
symptoms 
On MOST days do you have pain, 
aching or stiffness in your LEFT 
KNEE? 
Y - Yes 
N - No  
D - Don't know  
R - Refused  
 
 
 
 
 
T0, 
T1 
Chronic Left 
Knee Symptoms 
No=No 
Yes=Yes 
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 Right hip 
symptoms 
On MOST days do you have 
pain, aching or stiffness in your 
RIGHT HIP? 
Y - Yes 
N - No  
D - Don't know 
R - Refused  
T0, 
T1 
Chronic Right 
Hip Symptoms 
No=No 
Yes=Yes 
 Left hip 
symptoms 
On MOST days do you have pain, 
aching or stiffness in your LEFT 
HIP? 
Y - Yes 
N - No  
D - Don't know  
R - Refused  
 
T0, 
T1 
Chronic Left Hip 
Symptoms 
No=No 
Yes=Yes 
Demographic 
Characteristics 
Gender Gender 
(Male/Female) 
 
T0, 
T1 
Female 
0=Male, 
1=Female 
 Date of birth When were you born? 
(MM/DD/YYYY) 
T0, 
T1 
Age 
Date of clinic 
exam – Date of 
birth 
 Race What groups best represents your 
race? 
W - White 
B - Black, African American 
O - Other 
D - Don't Know 
R – Refused 
T0, 
T1 
Black 
0=White, 1=Black 
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Anthropometry Height Standing Height (to the nearest cm) 
 
T0 Body Mass Index 
(BMI) 
  Standing Height (to the nearest .5 
inch) 
 
T1 Weight (in 
kilograms) / 
Height (in cm) 
squared 
 Weight Weight (to the nearest pound) 
 
T0, 
T1 
 
 
Injury Right knee 
ever injured 
Right Knee, Have you ever injured 
your KNEES? 
Y - Yes 
N - No  
 
T0, 
T1 
Right Knee 
Injury 
0=No, 1=Yes 
 Left knee 
ever injured 
Left Knee, Have you ever injured 
your KNEES? 
Y - Yes 
N - No  
 
T0, 
T1 
Left Knee Injury 
0=No, 1=Yes 
 Right hip 
ever injured 
Right Hip, Have you ever injured 
your HIP? 
Y - Yes 
N - No  
 
T0, 
T1 
Right Hip Injury 
0=No, 1=Yes 
 Left hip ever 
injured 
Left Hip, Have you ever injured 
your HIPS? 
Y - Yes 
N - No  
T0, 
T1 
Left Hip Injury 
0=No, 1=Yes 
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 Age of right 
knee injury 
Right Knee, At what age did you 
injure your KNEES? 
Enter age: 
 
T1 Time since Right 
Knee Injury 
Age – Age of 
injury 
 Age of left 
knee injury 
Left Knee, At what age did you 
injure your KNEES? 
Enter age: 
 
T1 Time since Left 
Knee Injury 
Age – Age of 
injury 
 Age of right 
hip injury 
Right Hip, At what age did you 
injure your HIPS? 
Enter age: 
 
T1 Time since Right 
Hip Injury 
Age – Age of 
injury 
 Age of left 
hip injury 
Left Hip, At what age did you 
injure your HIPS? 
Enter age: 
 
T1 Time since Left 
Hip Injury 
Age – Age of 
injury 
 Right knee 
fracture 
Right knee, Has a doctor ever told 
you that you had broken or 
fractured your KNEES? 
N - No  
Y - Yes 
D - Don't Know 
 
 
 
 
 
 
T0, 
T1 
Right knee 
fracture 
0=No, 1=Yes 
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 Left knee 
fracture 
Left knee, Has a doctor ever told 
you that you had broken or 
fractured your KNEES? 
N - No  
Y - Yes 
D - Don't Know 
 
T0, 
T1 
Left knee 
fracture 
0=No, 1=Yes 
 Right hip 
fracture 
Right hip, Has a doctor ever told 
you that you had broken or 
fractured your HIPS? 
N - No  
Y - Yes 
D - Don't Know 
 
T0, 
T1 
Right hip 
fracture 
0=No, 1=Yes 
 Left hip 
fracture 
Left hip, Has a doctor ever told 
you that you had broken or 
fractured your HIPS? 
N - No  
Y - Yes 
D - Don't Know 
 
T0, 
T1 
Left hip fracture 
0=No, 1=Yes 
 Age of right 
knee fracture 
Right Knee, At what age did you 
break or fracture your KNEES? 
Enter age: 
 
T1 Time since Right 
Knee Injury 
Age – Age of fracture 
 Age of left 
knee fracture 
Left Knee, At what age did you 
break or fracture your KNEES? 
Enter age: 
 
T1 Time since Left Knee 
Injury 
Age – Age of fracture 
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 Age of right 
hip fracture 
Right Hip, At what age did you 
break or fracture your HIPS? 
Enter age: 
 
T1 Time since Right Hip 
Injury 
Age – Age of Fracture 
 Age of left 
hip fracture 
Left Hip, At what age did you 
break or fracture your HIPS? 
Enter age: 
 
T1 Time since Left Hip 
Injury 
Age – Age of Fracture 
Smoking Current 
Smoker 
Do you smoke cigarettes now? 
N - No 
Y - Yes  
D - Don't Know 
R - Refused 
 
T0, 
T1 
Current Smoker 
0=No, 1=Yes 
Occupation Currently 
Employed 
Are you now employed? 
Y - Yes 
N - No 
X - Never employed  
D - Don't know  
R - Refused  
 
T0 Currently Employed 
0=N or X, 1=Y 
 Duties at 
Current Job 
At work how often do you have to 
squat? 
0 - Never 
1 - Seldom 
2 - Sometimes 
3 - Often 
4 – Always 
 
T0, 
T1 
Vigorous 
Occupational Activity 
Squat, Stand, Lift, and 
Walk Never or Seldom 
(0,1) = 0 
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  At work how often do you have to 
stand? 
0 - Never 
1 - Seldom 
2 - Sometimes 
3 - Often 
4 - Always 
T0, 
T1 
Squat, Stand, Lift, or 
Walk at least 
Sometimes (2, 3,4) = 1 
  At work how often do you have to 
lift have objects? 
0 - Never 
1 - Seldom 
2 - Sometimes 
3 - Often 
4 - Always 
T0, 
T1 
 
  At work how often do you have to 
walk? 
0 - Never 
1 - Seldom 
2 - Sometimes 
3 - Often 
4 - Always 
T0, 
T1 
 
Biomarkers COMP nanograms/milliliter T0 ln(COMP) 
continuous 
 HA nanograms/milliliter T0 ln(HA) 
continuous 
 KS nanograms/milliliter T0 ln(KS) 
continuous 
 hsCRP nanograms/milliliter T0 ln(hsCRP) 
continuous 
 1
  The results in this chapter have been submitted to Arthritis and Rheumatism on May 
21, 2010.  Authors include the committee members listed on the title page. 
 
 
 
 
 
 
V.   Results - Cartilage oligomeric matrix protein, hyaluronan, high-sensitivity C-
reactive protein, and keratan sulfate as predictors of incident radiographic knee 
osteoarthritis: Do they vary by lower extremity injury history and chronic knee 
symptoms?1 
 
A.  Introduction 
A.1.  Measuring Osteoarthritis 
Osteoarthritis (OA) is one of the most common causes of disability in the United 
States (CDC, 2009), but effective interventions for this disease are limited.  One 
difficulty that hinders the development of successful treatments is the lack of sensitive 
measures of incident or progressive OA.  Radiographic measures that are used include 
the Kellgren-Lawrence (K-L) score, which provides an overall measure of the presence 
of radiographic features of OA, or the Burnett atlas which measures radiographic 
features of osteophytes (OST) or joint space narrowing (JSN) that can be examined 
separately.   However, these radiographic measures are insensitive to changes over time, 
and studies using these outcomes become lengthy and costly because they require 
follow-up times that extend over many years (Mazzuca & Brandt, 2003; Mazzuca, 
Brandt, Katz, Lane & Buckwalter, 2005).   Magnetic resonance imaging (MRI) is more 
sensitive for detecting features of OA and changes in the disease than radiography, but a 
lack of accepted and widely validated scoring systems for MRI, long examination and 
interpretation times, and cost factors limit its current use in clinical trials, in 
observational studies, and in the clinic (Eckstein, Mosher & Hunter, 2007; Guermazi, 
Hunter & Roemer, 2009).  Biochemical markers (biomarkers) of joint metabolism 
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require only blood or urine collection, and thus, can be examined more quickly and at a 
lower cost than radiography or MRI.  Additionally, biomarkers may be more sensitive 
to detecting the development and progression of OA than current measures (Bauer et al., 
2006). 
A.2.   Biomarkers of Osteoarthritis 
Although several biomarkers have been prognostic of progressive OA (Clark et 
al., 1999; Vilím et al., 2002; Hunter et al., 2007), currently no studies have identified 
prognostic biomarkers of incident knee OA in men, and there has been only one 
positive study in women (Sowers et al., 2002).  Among likely candidates for biomarkers 
of incident knee OA in men and women are those prognostic of incident knee OA in 
women: serum high-sensitivity C-reactive protein (hsCRP) (Spector et al., 1997; Sowers 
et al., 2002); incident hip OA: serum cartilage oligomeric matrix protein (COMP) 
(Kelman et al., 2006); progressive knee OA: serum COMP (Sharif et al., 1995)and 
serum hyaluronan (HA) (Sharif et al., 1995); or altered early in the course of knee 
injury: serum keratan sulfate (KS) (Wakitani et al., 2007).    COMP is a protein found in 
all joint tissues and vascular smooth muscle (Williams & Spector, 2008).  Elevated 
levels of COMP in joint fluid and serum indicate a release of fragments of this protein 
and synovial inflammation, and higher levels of COMP have been associated with 
rheumatoid arthritis and primary OA (Lohmander et al., 1994).  HA is a 
glycosaminoglycan found in cartilage and synovium, and it may be a marker of 
localized joint inflammation(Elliott et al., 2005).  HA is found in connective tissues 
throughout the body, and serum levels of HA may vary with other medical disorders, 
including cancer, rheumatoid arthritis, liver disease, and kidney disease(Elliott et al., 
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2005).   Serum hsCRP is a protein that is an indicator of systemic inflammation.  KS, a 
glycosaminoglycan indicative of cartilage proteoglycan degradation.  
A.3.  Potential Modifiers of the Biomarker-Radiographic Osteoarthritis 
Association 
 In addition to biomarker levels, the presence of OA symptoms or a history of joint 
injury may be helpful for identifying individuals at risk of developing radiographic OA, 
including potential participants for clinical prevention trials in OA.   Symptoms in the 
joint may be early indicators of OA prior to the appearance of radiographic evidence of 
the disease.  A history of joint injury is associated with the development and 
progression of OA (Lohmander, Englund, Dahl & Roos, 2007).  Levels of serum 
COMP are higher in persons with hip-related symptoms but not knee-related symptoms 
(Dragomir et al., 2002). Serum COMP also tends to increase and remain elevated for 
years following injury (Lohmander et al., 1994).   Previous studies have examined the 
levels of biomarkers after knee injury and in radiographic knee OA in cross-sectional 
analyses or longitudinally in small samples(Lohmander et al., 1994; Lohmander et al., 
1999), but have not assessed longitudinally in population-based cohorts whether 
specific biomarkers may predict the development of OA.  The role joint injury history 
may play in this association is unknown. Lower extremity injury may accelerate the 
development of OA in a specific joint and may contribute to changes in biomechanics 
and joint metabolism in multiple joints.  
The purpose of this paper was to determine the hazard of incident radiographic 
knee OA and incident radiographic features (OST and JSN) of knee OA for four 
specific biomarkers (COMP, HA, hsCRP, and KS) measured 3-10 years previously in 
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a large community-based sample: the Johnston County Osteoarthritis Project.  
Previous analyses of data from this project demonstrated cross-sectional associations 
between OA and COMP(Clark et al., 1999), HA(Elliott et al., 2005), and hsCRP(Kraus 
et al., 2007); racial and gender differences in biomarker levels of COMP (Dragomir et 
al., 2002; Jordan, Luta, Stabler, Renner, Dragomir, Vilim, Hochberg, Helmick & Kraus, 
2003), HA(Elliott et al., 2005), and hsCRP(Kraus et al., 2007); and confounding by 
obesity, comordbid conditions, and medication in the association of hsCRP and 
OA(Kraus et al., 2007).  A secondary objective was to explore whether these 
associations were modified by a history of lower extremity injury or chronic knee 
symptoms. 
 
B.  Methods 
B.1.  Study Participants 
 The Johnston County Osteoarthritis Project is an ongoing, community-based 
study of the occurrence of knee and hip OA in African American and Caucasian 
residents in a rural county in North Carolina.  Details of this study have been reported 
previously (Jordan et al., 1995). Briefly, this study involved civilian, non-
institutionalized adults aged 45 years and older who resided in six townships in 
Johnston County.  Participants were recruited by probability sampling, with over-
sampling of African Americans.   A total of 3,187 individuals were recruited between 
May 1991 and December 1997.  All participants completed a baseline clinical 
evaluation.    Among the 3,187 participants with baseline data, 1,329 were not eligible 
or available for follow-up assessments.   Reasons that participants were not eligible or 
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available included emigration from study area (N=161), refusal (N=435), inability to 
participate due to physical or mental conditions (N=234), death (N=411), and inability 
to contact or find (N=88).  Assessments at follow-up were completed from 1999-2003.   
Baseline biomarker assessments were completed for 803 participants.  These 
participants were selected to represent roughly equal proportions of African Americans, 
Whites, women, and men with and without radiographic OA, representing a range of 
ages, with complete radiographic data at baseline.  Individuals with rheumatoid arthritis 
or other inflammatory arthropathies were not included in the subsample.    
B.2. Baseline Biomarker Assessment 
  The 803 baseline serum samples of COMP, HA, hsCRP, and KS were collected, 
spun, and stored at -86ºC.  Serum COMP was measured using an in-house sandwich 
enzyme linked immunosorbent assay (ELISA)(Vilím et al., 2003).  The reported 
precision is 5.8-6.6% intra-assay variability and between 8.7-9.7% inter-assay 
variability.  Serum HA was measured with the Hylauronic Acid Test kit (Corgenix, 
Westimister, CO).  The reported precision is 3.6-4.7% intra-assay variability and 
between 5.7-7.0% inter-assay variability.  Serum hsCRP was measured with the UBI 
Magiwel Enzyme Immunoassay (United Biotech Inc. Mountain View, CA).  The 
minimum detectable concentration for this assay is 0.35 nanograms/milliliter (ng/ml), 
and the inter-assay precision was 7.4% (N=20) at a concentration of 3 ng/ml in the 
Johnston County  OA project biomarker substudy (Kraus et al., 2007).  Serum KS was 
measured using an in-house competitive ELISA as previously described (Lindhorst et 
al., 2000). The inter-assay precision was 14.4%, and the intra-assay precision was 3.2% 
(Lindhorst et al., 2000).  
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B.3. Radiographic Assessment of Incident Knee OA 
 Participants completed bilateral anteroposterior radiography of the knee in weight 
bearing.  Radiographs were read linked without knowledge of participant clinical status 
and blinded to time sequence by a single musculoskeletal radiologist (Jordan B. Renner, 
MD) using the K-L radiographic atlas for overall knee radiographic grades (Jordan et 
al., 2007).  Inter-rater reliability (comparison of radiograph readings between JBR and 
another radiologist) and intra-rater reliability (comparison of radiograph readings 
completed by JBR at two separate times) for the radiologist were high (weighted kappa 
for inter-rater reliability 0.9; kappa for intra-rater reliability 0.9) (Jordan et al., 1995).  
Radiographs without the features of OA were defined as K-L grade of 0 (normal 
findings).  A minute radiographic osteophyte of doubtful pathologic significance was 
assigned a K-L grade of 1 (questionable).  Radiographs showing an osteophyte without 
joint space narrowing were assigned a K-L grade of 2 (mild).  A moderate decrease of 
the joint space was assigned a K-L grade of 3 (moderate). K-L grade 4 (severe) was 
defined as severe joint space narrowing with subchondral bone sclerosis (Kellgren & 
Lawrence, 1963).  The incidence of radiographic OA was defined as a K-L grade ≥2 at 
follow-up among participants with K-L grade <2 at baseline.  Incident OST and JSN 
were identified in joints with grade=0 at baseline and ≥1 at follow-up , based on the 
Burnett atlas (Burnett et al., 1994). 
Figure 5.1 details the selection of knee joints for analyses.  Knees with missing 
follow-up data were excluded from analyses.  Of the 1606 knees from the 803 
participants with biomarker data at baseline, 358 participants had linked baseline and 
follow-up knee radiograph assessments.  Among these participants, 298 participants had 
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available K-L grades, 233 had OST grades, and 238 had JSN grades (Table 1).  Three 
separate risk groups were created based on knees: 542 knees at risk for incident 
radiographic knee OA (baseline radiographic K-L grade ≥2), 349 at risk for incident 
OST (baseline OST grade > 0), and 440 at risk for incident JSN (baseline JSN grade 
>0).  Among the knees at risk for incident knee OA, two knees had a total knee 
arthroplasty by the follow-up visit.  Both knee replacement surgeries were indicated due 
to knee OA (per participant self-report), and thus, these knees were considered incident 
knee OA and included in analyses.      
B.4.  Baseline History of Lower Extremity Injury 
Participants completed an interviewer-administered questionnaire in which they  
responded whether they had a history of knee injury [‘‘Have you ever injured your 
right/left knee?’’], knee fracture [‘‘Has a doctor ever told you that you had broken or 
fractured your right/left knee?’’], hip injury [‘‘Have you ever injured your right/left 
hip?’’], or hip fracture [‘‘Has a doctor ever told you that you had broken or fractured 
your right/left hip?’’].  A participant was considered to have a history of lower 
extremity injury if they answered “yes” to at least one of these four questions.   
B.5.  Baseline Chronic Knee Symptoms 
Participants completed an interviewer-administered questionnaire in which they 
answered “Yes” or “No,” separately for left and right knees, to the question: “On most 
days do you have pain, aching or stiffness in your [left/right] knee? 
B.6.  Baseline Demographic and Clinical Characteristics 
The following participant characteristics were examined as potential covariates 
in our analyses because they have been associated with biomarkers of OA and knee 
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radiographic OA: gender; self-reported race (African American or Caucasian); age 
(continuous variable in years); and body mass index at baseline (BMI: continuous 
variable calculated as weight in kilograms/height in meters squared).  Height without 
shoes was measured in centimeters and weight was measured in kilograms using a 
balance beam scale.   
B.7.  Statistical Analysis 
 The natural logarithm transformation was used to produce nearly normal 
distributions for COMP (lnCOMP), HA (lnHA), hsCRP (lnhsCRP), and KS (lnKS) in 
analyses.  Descriptive statistics were calculated for race, gender, age, BMI, lower 
extremity injury history, and chronic knee symptoms.  Due to the wide range of follow-
up times for participants (mean = 6.3 years; standard deviation ± 1.4 years; range= 3.0 – 
10.2 years) and interval censoring (i.e., the exact time of the occurrence of the outcome 
is unknown), separate multivariable Cox models (with the midpoint of each individual’s 
follow-up period as the approximated endpoint) were used to estimate hazard ratios for 
a 1-unit increase in the natural log of each biomarker with each radiographic knee 
outcome.  We accounted for bilateral clustering of knees using robust variance 
estimates (Lin & Wei, 1989).  Estimates from the Cox model were compared to those 
from   models that explicitly accounted for interval censoring(Odell et al., 1992).  
Covariates included in adjusted models were race, gender, age, and BMI, which were 
identified by their association with both the biomarkers and radiographic OA (K-L 
grade or radiographic features), either based on statistical significance in bivariate 
associations or on prior published knowledge of each covariate.  If there were notable 
associations between any of the biomarkers and OST, we examined this association 
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among those with no baseline JSN to determine independence of the association.  
Similarly, associations between biomarkers and JSN were examined among those with 
no baseline OST.   Multiplicative interaction terms of each biomarker (lnCOMP, lnHA, 
lnhsCRP, lnKS) with each covariate (race, gender, age, BMI, history of lower extremity 
injury, chronic knee symptoms) were examined.  If the interaction term was statistically 
significant (p<0.10), then it was included in models.  Additionally, the association of 
each biomarker and outcome were stratified by: 1) history of lower extremity injury and 
2) chronic knee symptoms, to explore patterns of potential modification of the 
association by either of these covariates.  Cox models were fit using SAS Version 9.1 
software (SAS Institute, Cary, NC), and Stata/IC 10.1 software (Stata Corporation, 
College Station, TX) was used for Weibull model analyses.   
C.  Results 
The total study group comprised 358 participants with linked knee radiographs 
and biomarker data (62.9% female, 42.5% African American).   The mean age was 60.2 
years (range 45-84 years), and on average, participants were obese at baseline with a 
BMI of 30.5 kg/m2 (range 16.0-58.1 kg/m2, Table 5.1).  Nearly 22% of the total study 
group reported a history of lower extremity injury (knee or hip injury or fracture) and 
45% reported chronic knee symptoms at baseline.   Compared to the total study group, 
the subgroups at risk of incident knee outcomes (OA, OST, and JSN) were slightly 
younger, had a lower BMI, and had a lower proportion of females, African Americans, 
baseline lower extremity injuries, and baseline chronic knee symptoms.  Over an 
average period of 6 years, OA developed in 29% of participants at risk for knee OA 
 72 
 
based on K-L grade, in 30% of those at risk based on knee OST, and in 24% of those at 
risk based on knee JSN. 
 Table 5.2 displays the hazard ratios for incident radiographic knee outcomes by 
the natural log of each biomarker.  In adjusted models, the hazard of incident knee OST 
increased with higher baseline lnCOMP levels (adjusted HR [aHR] = 2.26, 95% 
confidence interval [CI]) = 1.45-3.53).  Among participants with no baseline JSN, the 
hazard of incident knee OST in adjusted models was 2.52 (95% CI = 1.50-4.23) with 
higher baseline lnCOMP levels (Table 5.3).  The hazard of incident knee JSN also 
increased with higher baseline lnCOMP levels (aHR=2.14, 95% CI= 1.32-3.47) and 
with higher baseline lnHA levels (aHR=1.63, 95% CI= 1.26-2.12).  Among participants 
with no baseline OST, the hazard of incident knee JSN in adjusted models was 5.48 
(95% CI = 2.72-11.03) with higher baseline lnCOMP levels and 1.43 (95% CI = 1.03-
1.97) with higher baseline lnHA levels (Table 5.4).   The hazard of incident knee OA 
based on K-L grade also increased with higher baseline lnCOMP levels (aHR=1.46, 
95% CI = 0.96-2.23) and with higher baseline lnHA levels (aHR=1.17, 95% CI = 0.94-
1.46), although these associations were not statistically significant.  Table 5.5 shows the 
addition of controlling for baseline lnHA levels in lnCOMP models and the adjustment 
for baseline lnCOMP levels in lnHA models; the association of each of these 
biomarkers with incident OA outcomes were independent of the other biomarkers.  In 
adjusted models, higher levels of baseline lnhsCRP and lnKS did not predict the 
incident knee outcomes.  No statistically significant interactions were observed between 
the natural logs of each biomarker and age, BMI, race, gender, history of lower 
extremity injury, or chronic knee symptoms.   
 73 
 
 Results of Cox models with midpoint estimation of endpoints and Weibull models 
for lnCOMP and OA outcomes are displayed in Table 5.6 and Figure 5.2.  Results from 
Weibull models were closer to the null with larger confidence limit ratios [upper 
confidence limit / lower confidence limit]) than those from Cox models.    
Table 5.7 shows the hazard ratios for incident radiographic knee outcomes, 
stratified by history of lower extremity injury.  At the baseline assessment, the mean 
time since injury was 21 years (standard deviation 14.5 years; range 2-59 years).  The 
adjusted HR estimates tended to be less than 1.0 for those with injury history and higher 
for those without injury history for lnHA across all three incident knee outcomes.  In 
other words, lnHA was protective for incident knee OA outcomes among those with 
injury history and predictive among those without injury history.  No clear pattern of 
injury as a potential modifier of the association emerged among the other biomarkers. 
 Table 5.8 shows the hazard ratios for incident radiographic knee outcomes, 
stratified by baseline chronic knee symptoms.  The adjusted HR estimates were higher 
among those with chronic knee symptoms than those without for lnHA and lnKS across 
all three incident knee outcomes, for lnhsCRP for incident knee OST, and for lnCOMP 
for incident knee OST and JSN. 
D.  Discussion 
The hazard of incident knee radiographic OA outcomes was elevated in those 
with higher baseline serum lnCOMP and lnHA levels.  Higher baseline serum COMP 
level may be a marker of changes in reactive bone formation and cartilage degradation 
since it was independently associated with both knee OST and JSN outcomes, while 
higher baseline serum HA level may suggest synovial inflammation as a mechanism for 
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cartilage degradation, as indicated by its association with knee JSN outcomes.  These 
results are consistent with prior studies that have shown an association between higher 
serum COMP levels and cartilage and subchondral bone turnover (Sharif et al., 1995) 
and a correlation between serum HA and joint space narrowing (Sharma, Hurwitz, 
Thonar, Sum, Lenz, Dunlop, Schnitzer, Kirwan-Mellis & Andriacchi, 1998). 
Levels of biomarkers shown to be associated with development of pre-
radiographic knee OA differ from those associated with progressive radiographic OA, 
emphasizing that prognostic biomarkers differ dependent on the stage of disease 
(Cibere, Zhang, Garnero, Poole, Lobanok, Saxne, Kraus, Way, Thorne, Wong, Singer, 
Kopec, Guermazi, Peterfly, Nicolaou, Munk & Esdaile, 2009).   The relationship 
between COMP and progression of knee OA has been well-documented (Vilím et al., 
2002; Sharif et al., 2004; Hunter et al., 2007), but no prior study has evaluated the 
prognostic utility of biomarkers for incident OA. One small Swedish study 
(females=17, males=21)  reported concurrent increase in serum COMP during the early 
phase of incident radiographic knee OA (Petersson, Boegard, Svensson, Heinegard & 
Saxne, 1998). In a study of hip OA, high levels of COMP were associated with incident 
radiographic disease (Kelman et al., 2006).   Previous studies of serum HA and knee 
OA demonstrate a relationship between higher HA levels and progressive disease 
(Sharif et al., 1995)  and prevalent disease (Elliott et al., 2005; Turan, Bal, Gurgan, 
Topac & Koseoglu, 2007), but serum HA and incident knee OA associations have not 
been reported.   
Baseline levels of lnhsCRP and lnKS in our study did not predict incident knee 
OA outcomes.  Serum hsCRP is recognized as one of the most sensitive measures of 
 75 
 
acute phase reaction and inflammation and has been associated with incident knee OA 
in studies of women (Spector et al., 1997; Sowers et al., 2002).  However, obesity is 
strongly correlated with higher hsCRP levels, and controlling for obesity has been 
shown to attenuate the association between hsCRP and prevalent (Kraus et al., 2007) 
and  incident knee OA (Sowers et al., 2002; Engstrom, GerhardssondeVerdier, Rollof, 
Nilsson & Lohmander, 2009).   In the present analyses, BMI was adjusted for in 
biomarker and radiographic knee outcome associations.  In unadjusted models, a one 
unit increase in lnhsCRP was not a predictor of incident knee OA or OST, but the 
hazard of incident knee JSN was 18% higher with increasing lnhsCRP levels.  
Controlling for BMI and other covariates reduced the associations between hsCRP and 
incident knee OA and JSN, but appeared to have minimal effect on the association with 
knee OST. As observed by Wakitani et al. (Wakitani et al., 2007), large variations in 
serum KS values among participants were observed in the present study.  The basis for 
this variability is unknown but may relate to presence of unaccounted disease in other 
joints increasing the potential utility of serum KS as a generalized OA biomarker but 
diminishing its ability to report on a specific joint, such as the knee, within a 
background of other OA. In an animal model of OA, synovial fluid KS correlated 
strongly with severity of histological OA (Huebner & Kraus, 2006). However, in man, 
serum KS measured using ELISA has not correlated well with localized radiographic 
knee OA severity in two prior studies (Thonar, Lenz, Klintworth, Caterson, Pachman, 
Glickman, Katz, Huff & Kuettner, 1985; Campion, McCrae, Schnitzer, Lenz, Dieppe & 
Thonar, 1991)., which may be due to diurnal variations in serum KS levels (Kong, 
Stabler, Criscione, Elliott, Jordan & Kraus, 2006). In contrast, serum KS measured by 
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high performance liquid chromatography, showed promise in early stages of 
chondropathy due to knee injury (Wakitani et al., 2007) suggesting it may be more 
valuable as an early disease marker in the context of joint injury and/or in a patient 
population without a high generalized OA background.   
Strengths of this study are several including that it is community-based, consists 
of African American and Caucasian men and women, includes longitudinal 
radiographic data and chronic symptoms data of the knee, and uses an analytical method 
that can accommodate the interval censoring of the study design and the bilateral 
clustering of knees within subjects.  Cox model estimates were reported rather than 
Weibull model estimates because of ease of explanation of the endpoint (i.e., the 
midpoint of the follow-up period for each knee at risk versus a Weibull distribution) and 
concern about oversmoothing data with Weibull models, resulting in less variance but 
possibly more bias. 
A novel approach to this study was the exploration of incident knee OA using 
three radiographic definitions K-L grade, OST formation, and JSN.  Several limitations 
restrict interpretations of the results.  The small number of knees with chronic knee 
symptoms and particularly, history of lower extremity injury, limited the power for 
assessment of these variables as potential modifiers of the association between 
biomarkers and the radiographic knee outcomes.  Chronic knee symptoms may be a 
modifier of the biomarker-incident knee OA association as indicated by an overall 
pattern of elevated aHRs among participant with symptoms compared to those without 
symptoms, particularly for higher baseline levels of HA and KS.   Results of 
associations with history of lower extremity injury suggest that this variable is not a 
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strong modifier, but this interpretation is incomplete due to power limitations (number 
of knees with lower extremity injury history was 46 compared to 479 without injury 
history) and the potential misclassification that comes with self-report.  Data were not 
available on lower extremity injuries other than the knee or hip (i.e., no ankle or foot 
injury data).  The average time from injury to baseline assessment was 21 years, and 
levels of biomarkers elevated by initial injury may have declined to approximately pre-
injury levels over that length of time.  Curiously, a pattern of a non-significant 
protective association between lnHA and the incident knee OA outcome was observed 
among participants with a history of lower extremity injury history.  Potentially, 
individuals with inflammation (as indicated by higher levels of serum HA at baseline) 
and a history of lower extremity injury may restrict behaviors that would increase their 
risk of developing knee OA (e.g., high impact physical recreation or work-related 
activities), or they may be taking an anti-inflammtory or other medication to treat the 
inflammation which could lead to less incident knee OA.   
 Another limitation of the present study is that only a single measurement of 
each biomarker was collected at baseline rather than repeated measures at multiple time 
points.  Due to the size and complexity of the parent study, measures that may alter 
serum biomarker levels, such as diurnal variation, exercise levels, postural changes, and 
dietary intake, were not controlled (Kraus, 2006).  Additionally, biomarkers collected in 
serum may be less sensitive to changes occurring in the joint of interest and more easily 
influenced by systemic or metabolic effects in other joints or body systems.  Synovial 
fluid, while more difficult to collect, likely enables more precise biomarker assessments 
of joint tissue turnover related to early knee OA.  Due to concerns about having too 
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many covariates in models, other medical disorders were not considered as covariates, 
although serum HA and serum hsCRP may be elevated with systemic inflammation 
related to several diseases.  However, individuals with cancer, rheumatoid arthritis, or 
other inflammatory arthropathies were not included in the subsample of 803 participants 
with biomarker data, and age and BMI, two factors associated with greater risk of 
multiple diseases and inflammation, were included as covariates in analyses.  
E.  Conclusion 
In this community-based sample, higher lnCOMP and lnHA levels predicted 
incident knee OA, OST and JSN.   Chronic knee symptoms as a modifier of the 
biomarker-incident knee OA association requires further exploration, as this variable 
may indicate early stages of OA disease in combination with higher biomarker levels.   
Future studies should examine biomarker-incident knee OA associations shortly after 
injury or after the initial appearance of knee symptoms, tracking biomarker levels over 
short, regular time intervals to determine the role these potential modifiers play to help 
identify individuals at risk of knee OA for clinical trials and interventions. 
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Figure 5.1.  Description of knees from N= 803 participants with baseline 
biomarker data. 
 
 
K-L Grade OST Grade 
Exclude 294 
participants with 
OST>0 at baseline   
JSN Grade 
Exclude 186 participants 
with K-L grade≥2 at 
baseline    
N=728 
1606 knees at Baseline 
Exclude participants with 
JSN>0 at baseline   
 
Exclude 878 knees with 
missing follow-up K-L 
N=542 
N=643 
Exclude 955 knees with 
missing follow-up OST 
N=349 
N=642 
Exclude 956 knees with 
missing follow-up JSN data 
N=44
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Figure 5.2.  Adjusted Hazard Ratios (HR) of Knee Outcomes and lnCOMP, Cox 
Model with Midpoint Estimation of Endpoints versus Weibull Model. 
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Table 5.1.  Characteristics of Participants with Biomarker Data and Baseline and Follow-Up Linked Knee 
Radiographs (N=358). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* K-L risk group: K-L grade of 0 or 1 in either knee at baseline  
† OST risk group: OST grade of 0 in either knee at baseline 
‡ JSN risk group: JSN grade of 0 in either knee at baseline  
 
 
  Subgroups at Risk of Incident Outcome 
 Characteristics 
Total 
(N=358) 
K-L Grade* 
(N=298) 
OST 
Grade† 
(N=233) 
JSN 
Grade‡ 
(N=238) 
Baseline Age (mean (SD)) 60.2 ( ±9.4) 58.8 (±8.8) 58.7 (±8.6) 59.2 (±8.9) 
Baseline BMI (mean kg/m2(SD)) 30.5 (±7.1) 29.8 (±6.7) 28.1 (±5.1) 29.0 (±5.9) 
Female (%) 62.9 59.7 56.4 58.2 
African American (%) 42.5 38.6 28.7 35.4 
Baseline Lower Extremity Injury (%) 21.6 17.6 16.3 16.4 
Baseline Chronic Knee Symptoms (%) 45.7 38.5 33.9 37.8 
Incident Knee Outcome* (%) -- 28.9 30.3 24.1 
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Table 5.2.  Unadjusted and Adjusted Hazard Ratios (HR) of Knee Outcomes, by Biomarker. 
 
Predictor Outcome # Knees 
at Risk 
# Knees 
with 
Outcome 
Unadjusted 
HR 
95% CI Wald 
Chi-square 
P-value 
Adjusted 
HR* 
95% CI Wald 
Chi-square 
P-value 
ln(COMP) Knee OA (K-L)  540 110 1.75 1.20-2.57 <0.01 1.46 0.96-2.23 0.08 
 Knee OST 347 94 2.02 1.36-3.00 <0.01 2.26 1.45-3.53 <0.01 
 Knee JSN 437 99 2.63 1.66-4.16 <0.01 2.14 1.32-3.47 <0.01 
ln (HA) Knee OA (K-L)  540 110 1.31 1.07-1.60 <0.01 1.17 0.94-1.46 0.16 
 Knee OST 347 94 1.17 0.95-1.45 0.15 0.90 0.69-1.17 0.42 
 Knee JSN 437 99 1.56 1.25-1.94 <0.01 1.63 1.26-2.12 <0.01 
ln(hsCRP) Knee OA (K-L)  540 110 1.09 0.95-1.24 0.21 0.99 0.85-1.17 0.93 
 Knee OST 347 94 0.95 0.82-1.09 0.46 0.94 0.79-1.12 0.48 
 Knee JSN  437 99 1.18 1.02-1.36 0.03 1.10 0.93-1.31 0.27 
ln (KS) Knee OA (K-L)  540 110 1.22 0.74-2.01 0.43 1.21 0.70-2.11 0.49 
 Knee OST 347 94 1.81 0.99-3.32 0.05 1.56 0.83-2.96 0.17 
 Knee JSN  437 99 1.17 0.67-2.05 0.58 1.22 0.68-2.19 0.50 
* Adjusted for age, BMI, race, and gender at baseline. 
  
83 
 
Table 5.3.  Adjusted Hazard Ratios (HR) of Knee Osteophyte Formation, by Biomarker, Stratified by Baseline Joint 
Space Narrowing. 
 
 Baseline JSN No Baseline JSN  
Exposure # 
Knees 
at Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI # 
Knees 
at Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI P-value of 
Interaction† 
ln (COMP) 34 18 0.39 0.09-1.64 314 76 2.52 1.50-4.23 0.04 
ln (HA) 34 18 0.44 0.17-1.15 314 76 0.91 0.68-1.22 0.84 
ln(hsCRP) 34 18 1.47 0.73-2.97 314 76 0.92 0.76-1.11 0.72 
ln (KS)  34 18 0.26 0.02-3.39 314 76 1.85 0.94-3.66 0.58 
* Adjusted for age, BMI, race, and gender at baseline. 
† Interaction of ln(biomarker) and baseline JSN variable. 
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Table 5.4.  Adjusted Hazard Ratios (HR) of Knee Joint Space Narrowing, by Biomarker, Stratified by Baseline 
Osteophyte Formation. 
  Baseline OST No Baseline OST 
Exposure # 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI # 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI P-value of 
Interaction† 
ln (COMP) 142 59 0.96 0.51-1.78 297 41 5.48 2.72-11.03 <0.01 
ln (HA) 142 59 1.40 0.85-2.30 297 41 1.43 1.03-1.97 0.58 
ln(hsCRP) 142 59 1.04 0.81-1.34 297 41 1.28 1.01-1.64 0.33 
ln (KS)  142 59 0.82 0.37-1.79 297 41 2.02 0.84-4.86 0.18 
* Adjusted for age, BMI, race, and gender at baseline. 
† Interaction of ln(biomarker) and baseline OST variable. 
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Table 5.5.  Adjusted Hazard Ratios (HR) of Knee Outcomes, by Biomarker. 
 
Predictor Outcome # Knees at 
Risk 
# Knees with 
Outcome 
Adjusted 
HR* 
95% CI Wald 
Chi-
square 
P-
value 
Adjusted 
HR 
95% CI Wald 
Chi-
square 
P-
value 
ln(COMP) OA (K-L)  540 110 1.46 0.96-2.23 0.08 1.37† 0.89-2.13 0.16 
 OST 347 94 2.26 1.45-3.53 <0.01 2.51† 1.58-4.00 <0.01 
 JSN 437 99 2.14 1.32-3.47 <0.01 1.93† 1.19-3.15 <0.01 
ln (HA) OA (K-L)  540 110 1.17 0.94-1.46 0.16 1.12‡ 0.89-1.40 0.34 
 OST 347 94 0.90 0.69-1.17 0.42 0.79 ‡ 0.61-1.03 0.08 
  JSN 437 99 1.63 1.26-2.12 <0.01 1.57 ‡ 1.21-2.03 <0.01 
* Adjusted for age, BMI, race, and gender at baseline. 
† Adjusted for age, BMI, race, gender, and ln(HA) at baseline. 
‡ Adjusted for age, BMI, race, gender, and ln(COMP) at baseline. 
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Table 5.6.  Unadjusted and Adjusted Hazard Ratios (HR) of Knee Outcomes and lnCOMP, Cox Model with Midpoint 
Estimation of Endpoints versus Weibull Model. 
 
 Cox Model Weibull Model 
Outcome Unadjusted HR  
(95% CI) 
CLR† Adjusted HR*  
(95% CI) 
CLR† Unadjusted 
HR  
(95% CI) 
CLR† Adjusted HR*  
(95% CI) 
CLR† 
OA (K-L) 1.75 (1.20-2.57) 2.14 1.46 (0.96-2.23) 2.32 1.40 (0.93-2.11) 2.27 1.11 (0.70-1.75) 2.50 
OST 2.02 (1.36-3.00) 2.21 2.26 (1.45-3.53) 2.43 1.43 (0.90-2.28) 2.53 1.18 (0.72-1.94) 2.69 
JSN 2.63 (1.66-4.16) 2.51 2.14 (1.32-3.47) 2.63 1.59 (0.98-2.58) 2.63 1.31 (0.75-2.30)  3.07 
* Adjusted for age, BMI, race, and gender at baseline. 
† CLR= Confidence Limit Ratio; Upper Limit / Lower Limit 
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Table 5.7.  Adjusted Hazard Ratios (HR) of Knee Outcomes, by Biomarker, Stratified by History of Lower Extremity 
Injury*. 
  Positive History of Lower Extremity Injury 
 
No History of Lower Extremity Injury 
 
 
Outco
me 
Predictor # 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI # 
Knees 
at Risk 
# Knees 
with 
Outcome 
Adjusted 
HR† 
95% CI P-value 
Inter-
action‡ 
OA  ln (COMP) 46 15 1.06 0.39-2.89 479 90 1.55 0.95-2.52 0.54 
by K-L ln (HA) 46 15 0.61 0.31-1.22 479 90 1.20 0.93-1.55 0.12 
 ln(hsCRP) 46 15 1.04 0.65-1.67 479 90 0.97 0.81-1.16 0.76 
 ln (KS)  46 15 0.92 0.17-5.00 479 90 1.31 0.72-2.39 0.48 
OST  ln (COMP) 28 12 5.34 0.79-35.93 314 80 2.12 1.30-3.47 0.54 
 ln (HA) 28 12 0.34 0.08-1.65 314 80 0.93 0.69-1.25 0.18 
 ln(hsCRP) 28 12 0.96 0.58-1.58 314 80 0.91 0.75-1.10 0.54 
 ln (KS)  28 12 1.25 0.21-7.68 314 80 1.64 0.82-3.28 0.42 
JSN ln (COMP) 33 11 9.82 0.96-100.8 393 83 2.01 1.18-3.44 0.26 
 ln (HA) 33 11 0.84 0.33-2.18 393 83 1.69 1.27-2.25 0.24 
 ln(hsCRP) 33 11 1.12 0.63-2.12 393 83 1.08 0.90-1.30 0.51 
 ln (KS)  33 11 6.23 0.65-59.76 393 83 1.08 0.58-2.01 0.64 
*  History of knee or hip injury or fracture at baseline. 
† Adjusted for age, BMI, race, and gender at baseline. 
‡  Interaction of ln(biomarker) and injury variable. 
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Table 5.8.  Adjusted Hazard Ratios (HR) of Knee Outcomes, by Biomarker, Stratified by Chronic Knee Symptoms at 
Baseline. 
  Chronic Knee Symptoms No Chronic Knee Symptoms  
Outcome Exposure # 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI # 
Knees 
at 
Risk 
# Knees 
with 
Outcom
e 
Adjuste
d HR* 
95% CI P-value 
Inter-
action† 
OA by  ln (COMP) 166 46 1.49 0.80-2.78 374 64 1.43 0.80-2.54 0.83 
K-L ln (HA) 166 46 1.30 0.91-1.87 374 64 1.02 0.77-1.35 0.81 
 ln(hsCRP) 166 46 0.98 0.76-1.27 374 64 1.00 0.80-1.24 0.67 
 ln (KS)  166 46 1.79 0.74-4.32 374 64 0.91 0.43-1.95 0.12 
OST  ln (COMP) 97 33 4.19 1.85-9.48 250 61 1.83 1.02-3.30 0.11 
 ln (HA) 97 33 1.13 0.67-1.89 250 61 0.86 0.63-1.17 0.29 
 ln(hsCRP) 97 33 1.03 0.75-1.41 250 61 0.88 0.71-1.10 0.23 
 ln (KS)  97 33 3.85 1.25-11.9 250 61 1.19 0.52-2.71 0.42 
JSN  ln (COMP) 129 35 2.47 1.08-5.65 308 64 1.98 1.07-3.66 0.46 
 ln (HA) 129 35 2.12 1.37-3.28 308 64 1.47 1.08-2.00 0.22 
 ln(hsCRP) 129 35 1.08 0.78-1.49 308 64 1.10 0.90-1.36 0.13 
 ln (KS)  129 35 2.78 0.98-7.90 308 64 0.86 0.41-1.83 0.24 
* Adjusted for age, BMI, race, and gender at baseline. 
† Interaction of ln(biomarker) and knee symptoms variable. 
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VI.  Results - Knee and Hip Osteoarthritis in Individuals with and without a History of 
Injury 2 
 
A.  Introduction 
Osteoarthritis (OA) is a leading cause of disability among older adults, with lower 
extremity OA limiting mobility, basic daily activities, and quality of life (deBock, Kaptein, 
Touw-Otten & Mulder, 1995; 2000; Dominck, Ahern, Gold & Heller, 2004).  Joint injury is 
one factor that may prompt the development of OA, potentially initiating or accelerating the 
pattern of changes in joint metabolism that lead to degeneration of cartilage and formation of 
osteophytes.  Larger population-based studies on the relationship between injury and OA have 
focused primarily on the knee (Davis et al., 1989; Felson et al., 1997; Hart et al., 1999; Gelber 
et al., 2000; Sowers et al., 2000; Wilder et al., 2002; Toivanen et al., 2010), with fewer studies 
of the hip (Tepper & Hochberg, 1993; Cooper et al., 1998; Gelber et al., 2000)and hand 
(Sowers et al., 2000; Jones et al., 2002), and have used an array of study designs, including 
cross-sectional (Davis et al., 1989; Tepper & Hochberg, 1993; Sowers et al., 2000; Jones et al., 
2002), case-control (Cooper et al., 1998), and longitudinal (Felson et al., 1997; Hart et al., 
1999; Gelber et al., 2000; Wilder et al., 2002; Toivanen et al., 2010).  The advantage of the 
cross-sectional study design is it does not require years of follow-up, which may be costly.  
Unfortunately, this design increases the likelihood of a recall bias that would inflate the 
estimate of the association because individuals may be more apt to recall injury in a joint with 
OA than individuals without OA.  Additionally, the direction of associations cannot be 
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established.  In the longitudinal study design, assessment of injury exposure precedes the 
development of OA, greatly reducing the potential for recall bias.    
 Defining OA is complex.  OA is clinically diagnosed based on patient symptoms, clinical 
signs, and radiographic evidence (Jordan et al., 2007), although these three aspects of disease 
may be discordant. For instance, individuals may have the signs and symptoms of OA, but no 
radiographic evidence.  Conversely, individuals may have radiographic evidence of OA, but no 
symptoms.  Several definitions of OA can be explored, such as radiographic evidence only, 
symptoms (i.e., pain, aching, and stiffness) only, and radiographic evidence of OA with 
symptoms.  Definitions that include symptoms are the most clinically relevant, but are also 
more subjective. 
Previous efforts to examine the association between injury and OA, either with cross-
sectional or longitudinal study designs, have resulted in a wide range of estimates.  
Additionally, prior longitudinal studies of the knee and hip have examined primarily Caucasian 
cohorts with middle to upper socioeconomic status (Felson et al., 1997; Hart et al., 1999; 
Gelber et al., 2000; Wilder et al., 2002; Toivanen et al., 2010).  Examining this relationship 
longitudinally in a more diverse population may help to quantify the risk of developing OA 
after injury.  Further, most studies have focused on knee OA, with far fewer examining hip OA.  
The association between injury and OA may vary by joint site because of the differences in 
joint structure, the typical mechanisms for injury to that joint, and the joint’s tendency to 
develop OA.  Finally, the association between injury and OA in the contralateral joint has not 
been previously explored in a population-based study.    
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 The purpose of this study was to compare the hazard of incident OA outcomes 
(reflecting radiographic evidence and/or symptoms) between individuals with and without 
history of injury of the knee or hip in a large community-based sample.  Additionally, the 
hazard of incident radiographic OA was explored in ipsilateral and contralateral joints.    
B.  Methods 
B.1. Study Participants 
The Johnston County Osteoarthritis Project is an ongoing, community-based study of 
the occurrence of knee and hip OA in African American and Caucasian residents in a rural 
county in North Carolina.  Details of this study have been reported previously (Jordan et al., 
1995).  The study involved civilian, non-institutionalized adults aged 45 years and older who 
resided in six townships in Johnston County.  Participants were recruited using probability 
sampling, with an over-sampling of African Americans.   A total of 3,187 individuals were 
recruited between May 1991 and December 1997.  All participants completed a baseline 
clinical evaluation.   
Among the 3,187 participants with baseline data, 1,329 (41.7%) were not eligible or 
available for follow-up assessments.   Reasons that participants were not eligible or available 
included emigration from study area (N=161), refusal (N=435), inability to participate due to 
physical or mental conditions (N=234), death (N=411), and inability to contact or find (N=88).  
Assessments at follow-up were completed from 1999-2003 (median time from baseline to 
follow-up = 5.6 years, range=3.0-13.1 years).  Linked baseline and follow-up interview data 
were available for 1,858 participants, and linked knee and hip radiograph assessments were 
available for 1,726 participants.  Among those with available radiograph data, joint injury data 
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for the knee were available for 1,570 participants and for the hip for 1,446 participants.  Figure 
6.1 details study participation for longitudinal analyses. 
B.2.  Radiographic Assessment 
 Participants completed bilateral anteroposterior radiography of the knee in weight 
bearing.  Women over 50 years of age and all men completed supine anteroposterior pelvic 
radiography.  Radiographs were read linked without knowledge of participant clinical status by 
a single muscuoloskeletal radiologist (Jordan B. Renner, MD) using the Kellgren-Lawrence (K-
L) radiographic atlas for overall knee radiographic grades (Jordan et al., 2007).  Inter-rater 
reliability (comparison of radiograph readings between JBR and another radiologist) and intra-
rater reliability (comparison of radiograph readings completed by JBR at two separate times) 
were high (weighted kappa for inter-rater reliability 0.9; kappa for intra-rater reliability 0.9) 
(Jordan et al., 1995).  Radiographs without the features of OA were defined as K-L grade of 0 
(normal findings).  A minute radiographic osteophyte of doubtful pathologic significance or a 
joint with definite joint space narrowing and no osteophyte were assigned a K-L grade of 1 
(questionable). Radiographs showing an osteophyte without joint space narrowing were 
assigned a K-L grade of 2 (mild).  A moderate decrease of the joint space was assigned a K-L 
grade of 3 (moderate). K-L grade 4 (severe) was defined as severe joint space narrowing with 
subchondral bone sclerosis (Kellgren & Lawrence, 1963).   
B.3. Chronic Knee and Hip Symptoms 
Participants completed an interviewer-administered questionnaire in which they 
answered “Yes” or “No,” separately for left and right knees and left and right hips, to the 
question: “On most days do you have pain, aching or stiffness in your [left/right] [knee/hip]?”  
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The presence of groin pain was recorded for right and left sides.  Participants were considered 
to have chronic knee symptoms if they answered affirmatively to the knee symptoms question 
and to have chronic hip symptoms if they answered affirmatively to the hip symptoms question 
or reported groin pain.    
B.4.  Definitions of Osteoarthritis Outcomes 
  The exploration of OA outcomes was performed separately for the knee and the hip 
joints and was based on various combinations of radiographic OA and/or symptom onset as 
described below. The incidence of radiographic OA was defined as a K-L grade ≥2 at follow-
up or a total joint replacement for OA among participants with K-L grade <2 at baseline. The 
incidence of chronic joint symptoms was defined as an affirmative response to the symptom 
question at follow-up among participants who reported no symptoms at baseline. 
1. Radiographic OA.  The incidence of radiographic OA at follow-up irrespective of 
symptoms status at baseline or follow-up. 
2. Chronic Symptoms.  The incidence of chronic joint symptoms at follow-up irrespective of 
radiographic OA status at baseline or follow-up. 
3. Radiographic OA or Symptoms.  The incidence of radiographic OA or symptoms, or their 
combination, at follow-up in participants without radiographic OA or symptoms at 
baseline.   
4. Radiographic OA with Symptoms.  Incidence of radiographic OA with symptoms at 
follow-up in participants with radiographic OA only, symptoms only, or neither 
radiographic OA nor symptoms at baseline.  
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B.5.  Main Exposure: History of Knee or Hip Injury 
Participants completed an interviewer-administered questionnaire at baseline and 
follow-up visits in which they responded whether they had a history of knee injury [‘‘Have you 
ever injured your right/left knee?’’] and a hip injury [‘‘Have you ever injured your right/left 
hip?’’].  A participant was considered to have the injury of interest if he or she answered “yes”.   
B.6.  Covariates 
Covariates associated with injury and radiographic OA or chronic symptoms of the knee 
and hip were considered in analyses as described below.   
Demographic and Clinical Characteristics.  The following participant characteristics were 
collected at baseline: gender; self-reported race (African American or Caucasian); age 
(continuous variable in years); and body mass index at baseline (BMI: continuous variable 
calculated as weight in kilograms/height in meters squared).  Height without shoes was 
measured in centimeters and weight was measured in kilograms using a balance beam scale.   
Current Vigorous Occupational Activity.  Participants completed an interviewer-administered 
questionnaire at baseline in which they answered: 1) whether they were employed, and 2) 
“never”, “seldom”, “sometimes”, “often”, or “always” to separate questions about how often 
they performed lifting, standing, walking, or squatting at their current job, if employed.  If a 
participant answered that he or she was employed and “often” or “always” to any of the activity 
questions, he or she was classified as currently engaged in vigorous occupational activity.   
Current Smoker.  Participants were asked at baseline whether they currently smoked.  Those 
who responded “yes” were classified as current smokers. 
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B.7.  Statistical Analysis 
Descriptive statistics (proportions for categorical variables and means and standard 
deviations for continuous variables) were calculated for the covariates of age, BMI, race, 
gender, current smoker status, and current vigorous occupational activity for the whole sample 
and for those with injury data.  Pearson’s chi-square test for categorical variables and t-tests for 
continuous variables were used to compare these covariates between those reporting an injury 
and those not reporting an injury at baseline.  Differential participation was examined by 
comparing the baseline variables (age, BMI, race, gender, current smoker status, current 
vigorous occupational activity, and injury status) of participants who returned for a follow-up 
visit to those who did not return by using Pearson’s chi-square test for categorical variables and 
t-tests for continuous variables. 
Due to the wide range of follow-up times for participants (mean = 5.9 years; standard 
deviation ± 1.4 years; range= 3.0 – 13.2 years) and interval censoring (i.e., the exact time of the 
occurrence of the outcome is unknown), separate multivariable Cox models (with the midpoint 
of each individual’s follow-up period as the approximated endpoint) were used to estimate 
hazard ratios.   Unilateral analyses were conducted to examine the associations between injury 
and radiographic OA in the ipsilateral (same) joint and in the contralateral (opposite; e.g. right 
knee injury and left knee OA) joint.  We accounted for bilateral clustering of knees and 
bilateral clustering of hips using the robust variance estimation (Lin & Wei, 1989).  Covariates 
included in adjusted models were identified by their plausible association with both injury and 
the outcome of interest, either based on observed strength of association in bivariate 
associations or on prior published knowledge of each covariate.  Multiplicative interactions of 
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injury with each covariate (race, gender, baseline age, baseline BMI, baseline current vigorous 
occupational activity, baseline current smoking status) were examined.  If the interaction term 
had a p-value <0.10, then it was included in models.  Cox models were fit using SAS Version 
9.1 software (SAS Institute, Cary, NC).   
A post-hoc sensitivity analysis was performed examining the association between injury 
and chronic knee symptoms because of concerns that chronic medication use for joint pain, 
aching, stiffness, or swelling may mask symptoms.  The pain medication question asked was 
not specific to joint site, and a definition of incident knee symptoms that included the use of 
medication for knee symptoms could not be created.  For the sensitivity analysis, it was 
assumed that all participants using pain medications but reporting no knee symptoms at 
baseline would have developed knee symptoms by the follow-up visit.   
C.  Results 
Characteristics of the sample are detailed in Table 6.1.  The total study group comprised 
1,625 participants with linked knee radiographs and knee injury data (64.5% female, 27.1% 
African American) and 1,489 participants with linked hip radiographs and hip injury data 
(61.6% female, 26.7% African American).  Among participants with linked knee radiographs, 
1,570 had baseline knee injury data (16.6% with knee injury history), and among participants 
with linked hip radiographs, 1,446 had baseline hip injury data (4.8% with hip injury history).   
Among participants with knee radiograph and knee injury data, participants with a history of 
knee injury had a higher mean BMI at both baseline and follow-up.  Participants with a history 
of hip injury at baseline had a higher mean age (64.0 vs. 61.0 years, p<0.01) among participants 
with hip radiograph and hip injury data.  Among participants who reported knee or hip injury, 
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the average time from injury to baseline assessment was 23.1 years (standard deviation [SD] = 
16.0) for the knee and 22.0 years (SD=18.2) for the hip. 
 Among participants with baseline knee or hip radiographs, those who did not return for 
follow-up were more likely than those who completed follow-up to be older, African-
American, male, current smokers at baseline, to not be involved in vigorous occupational 
activity at baseline, and to not be employed at baseline (Table 6.2).  There were no differences 
in the mean baseline BMI among those who did not return compared to those who returned for 
follow-up.  Among participants with baseline knee radiographs, the proportion with a knee 
injury history did not differ by likelihood of returning for follow-up, but among participants 
with baseline hip radiographs, participants who did not return for follow-up were more likely to 
report a history of hip injury than those who did return.   
The hazard ratios for incident knee outcomes by history of knee injury and incident hip 
outcomes by history of hip injury are displayed in Tables 6.3 and 6.4, respectively.  Age, BMI, 
gender, current smoking status, or current vigorous occupational activity status were included 
as covariates in adjusted models.  None of the injury by covariate interaction terms were 
p<0.10, indicating no evidence of departure from multiplicativity of effects.  In adjusted models 
accounting for bilateral clustering, the hazard of incident knee radiographic OA and OA or 
symptoms was higher among participants with knee injury at baseline compared to those 
without injury (adjusted HR [aHR] = 1.56, 95% confidence interval [CI]) = 1.15-2.12 and 
aHR=1.42, 95% CI=1.06-1.89, respectively).  The hazard of incident chronic knee symptoms 
was lower among participants with knee injury at baseline (aHR=0.43, 95% CI= 0.22-0.82).  
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 In a sensitivity analysis assuming that all participants using pain medications but 
reporting no knee symptoms at baseline (339 knees) would have developed knee symptoms by 
the follow-up visit, 27 knees had incident knee symptoms among those with injury to at least 1 
knee (N=87), and 789 knees had incident knee symptoms among those without injury 
(N=2039).  The adjusted HR was 0.76 (95% CI =0.51-1.14) 
 In adjusted models examining the ipsilateral and contralateral associations between 
injury and radiographic OA of the knee, injury was associated with incident ipsilateral 
(aHR=1.50, 95% CI=0.94-2.41) and contralateral (aHR=1.75, 95% CI=1.11-2.74) radiographic 
knee OA.  No associations were observed for any of the adjusted models for incident hip 
outcomes.  Only 2 cases of unilateral hip injury occurred among those with incident ipsilateral 
or contralateral radiographic hip OA, and thus, precise and informative hazard ratios could not 
be calculated.  
D.  Discussion 
In clustered analyses conducted separately for the knee and hip, the hazard of incident 
radiographic OA was generally higher in those with a history of injury compared to those 
without injury, although our number of cases of hip OA are small.  Prior population-based 
studies have reported odds ratios ranging from 0.7-16.3 for radiographic knee OA (Davis et al., 
1989; Felson et al., 1997; Wilder et al., 2002; Toivanen et al., 2010) and 3.5-7.8 for 
radiographic hip OA (Tepper & Hochberg, 1993; Cooper et al., 1998).  Our results are 
consistent with Gelber et al. (Gelber et al., 2000) (knee: aHR=5.17, 95% CI 3.07-8.71; hip: 
aHR=3.50, 95% CI 0.84-14.69) and Wilder et al. (Wilder et al., 2002) (knee: aHR=7.4, 
95%CI=5.9-9.4), the only other studies to report hazard ratios, but the estimates in the present 
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study are lower.  Gelber et al. (Gelber et al., 2000) relied on self-report of OA in their 
prospective study of former medical students.  Those with a medical background may be more 
accurate in their reporting of OA.  On the other hand, those who had a joint injury (and medical 
knowledge of the association between injury and OA) may be more likely to seek care for that 
joint or suspect they have OA, and this bias may inflate the association.  Our study used 
radiographic evidence to support the classification of OA rather than self-report.  Wilder et al. 
restricted their injury definition to severe injury (self-report of knee fracture or a knee injury 
that resulted in sprain or swelling lasting more than 2 weeks), and 11% of their participants 
reported this type of knee injury.  Our definition of knee injury was not restricted based on 
severity and likely included individuals with milder knee injuries, as suggested by our higher 
prevalence of knee injury at baseline (17%) and follow-up (20%) assessments.  It is 
biologically plausible that the more severe the injury, the more likely the risk of OA, and thus, 
the inclusion of milder knee injuries may attenuate the observed association. 
Injury predicted an increased hazard of incident radiographic OA for either the 
ipsilateral or contralateral joint.  To our knowledge, the hazard of incident radiographic OA in 
the joint contralateral to the injured joint has not been previously explored in other larger 
population-based studies, and the positive association is intriguing.  Our results are consistent 
with a study of 317 patients 15-22 years post meniscectomy in which the risk of symptomatic 
knee OA was increased in the nonoperated, uninjured contralateral knee (Englund & 
Lohmander, 2004).  After injury, individuals may change their movement patterns to protect 
their injured joint, and in doing so, change the mechanics and increase the loading on the 
uninjured joint.  Over time, this altered loading on the uninjured joint may initiate the 
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degeneration of joint tissues leading to OA.  Some studies have shown increased knee 
adduction moments in injured patients; however, these studies lack pre-injury data (Noyes, 
Schipplein, Andriacchi, Saddemi & Weise, 1992; Davies-Tuck, Wluka, Teichtahl, Martel-
Pelletier, Pelletier, Jones, Ding, Davis & Cicuttini, 2008).  Our finding that injury predicts 
contralateral, in addition to ipsilateral, OA suggests either that changes in movement dynamics 
after injury affect both limbs or that movement factors are independently associated with OA, 
independent of injury.       
 The hazard of incident chronic symptoms tended to be lower among those with injury 
versus those without injury.  At first glance, these results suggest that injury is protective for 
the outcome of chronic joint symptoms, but it is more likely that the close temporal sequence of 
joint injury followed by symptoms and the timing of the baseline study visit (which is on 
average 20 years since the injury) may contribute to these findings.  Most individuals who had 
experienced an injury would be expected to experience pain, aching, or stiffness at the joint of 
interest closer to the time of injury that may persist for many years and thus would not be 
eligible at baseline for inclusion in the injury-chronic symptoms analyses.  Participants who 
had a history of joint injury but did not develop symptoms over the nearly 20 years prior to our 
investigation were unlikely to ever develop the chronic symptoms, possibly due to some 
unidentified characteristic that made them less prone to chronic symptoms compared to others 
with injury and even those without injury.  Additionally, chronic use of medication for joint 
symptoms may occur among those with a history of injury.  These individuals may report no 
chronic symptoms at the time of interview because of their effective medication use.  No data 
were collected regarding pain medication use for each joint, but a sensitivity analysis that 
 101 
 
assumed all participants using pain medication would have developed knee symptoms by the 
follow-up visit shows that the adjusted HR shifts toward the null, a 43% change.  Potentially, 
individuals with knee injury without symptoms at baseline may not develop knee symptoms by 
follow-up.  
 Strengths of this study include that it is community-based, consists of African American 
and Caucasian men and women, includes radiographic data and chronic symptoms data of the 
knee and hip, and uses an analytical method that can accommodate the interval censoring of the 
study design and the bilateral clustering of joints (knees or hips) within subjects.  A limitation 
of this study is that approximately 42% of participants did not return for follow-up.  Among 
these participants, nearly 1/3 had died, 17% had decline in their health since baseline and were 
unable to participate at follow-up, and 1/3 refused.   Participants who did not return for follow-
up compared to those who completed the follow-up visit tended to be slightly older, African-
American, male, smokers, and not employed or retired at baseline.  Equal proportions of 
participants with knee injury history returned and did not return for follow-up, but a greater 
proportion of participants with a history of hip injury did not return for the follow-up visit.  
Essentially, the longitudinal analyses were limited to those participants who were more likely 
to be younger and healthier at baseline, and these selection factors may influence the observed 
association.  The loss of some participants by the follow-up visit reduced the power available 
for some of the outcome definitions, particularly for the hip, and this may explain the lower 
precision for the hip estimates.    
 Identifying the exposure of injury in a cohort study is difficult.  Ideally, a medical record 
review would be used to validate self-report, but not every joint injury is reported to a health 
 102 
 
care professional at the time of the injury, and thus, medical records may not be a reliable 
source.  Additionally, retrospective retrieval of some medical records may be extremely 
difficult if an individual sustained the injury at a young age and several decades have passed 
since time of injury.  Self-report may capture more occurrences of joint injury than medical 
records, but an individual’s recall of the details and date of the injury may not be reliable.  All 
prior population-based studies of the knee and hip (Davis et al., 1989; Tepper & Hochberg, 
1993; Felson et al., 1997; Cooper et al., 1998; Hart et al., 1999; Gelber et al., 2000; Sowers et 
al., 2000; Wilder et al., 2002; Toivanen et al., 2010), including the present study, utilized self-
report of injury.  Several studies used a cross-sectional study design to examine the association 
between injury and OA (Davis et al., 1989; Tepper & Hochberg, 1993; Sowers et al., 2000; 
Jones et al., 2002).  Potentially, this approach increases the likelihood of recall bias since 
individuals with OA may be more likely to recall injury in a joint with OA than individuals 
without OA.  Prospective studies are expected to be less prone to recall bias.  The present study 
did not account for joint injury severity (baseline questions did not ask about use of an assistive 
device or functional limitations after an injury) or surgical intervention for injury.  An 
additional limitation of this study is that the time of initial assessment was an average of 
approximately 20 years after the time of injury.  Ideally, to track the development of OA after 
injury, the injured joint should be followed prospectively starting from the time of the injury 
event.   
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E.  Conclusion 
 In this community-based sample, the hazard of incident radiographic knee OA was higher 
in those with a history of knee injury compared to those without injury.  Similar, although less 
precise, results were seen for hip injury.  Injury not only predicted an increased hazard of 
incident radiographic OA in the ipsilateral joint, but it predicted incident contralateral OA.   
These results are consistent with the hypothesis that changes in movement patterns after injury 
may affect both limbs and contribute to the development of lower extremity OA.  
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Figure 6.1.  Data Included in Longitudinal Analyses. 
 
*Linked = Baseline and follow-up. 
Participants with Linked* Knee 
Radiographs N= 1,625 
Participants not returning for 
Follow-Up  
N= 1,329 
 
Participants at Baseline 
N=3,187 
Participants missing linked* 
knee or hip radiographs 
N = 132 
Knees at Risk of 
Radiographic OA 
N =2,726 
 
Participants with Linked* Knee 
or Hip Radiographs  N =1,726 
 
Participants at Follow-Up 
N=1,858 
Participants with 
Baseline Knee 
Injury Data 
N= 1,570 
Knees N=3,140 
Knees with K/L≥2 
(not at risk)  
N= 414 
Participants with Linked* Hip 
Radiographs N = 1,489 
 
Participants with 
Baseline Hip 
Injury Data N= 
1,446 
Hips N= 2,292 
Hips with K/L≥2 
(not at risk)  
N = 70 
 
Hips at  
Risk of 
Radiographic OA 
 N= 2,222 
Knees with 
symptoms (not 
at risk) N = 
1,014 
Knees at Risk of 
Symptoms  
N= 2,126 
Hips with 
symptoms (not at 
risk)  N = 89 
Hips at Risk of 
Symptoms  
N= 2,203 
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Table 6.1. Characteristics of Participants with Baseline and Follow-Up Knee and Hip Radiograph Data. 
 
 Participants with Baseline and Follow-Up Knee 
Radiographs  
Participants with  Baseline and Follow-Up Hip 
Radiographs  
Baseline Variables for 
Longitudinal Analyses 
Total 
Sample 
Knee 
Injury 
No Knee 
Injury 
p-
value 
Total 
Sample  
Hip 
Injury 
No Hip 
Injury 
p-value 
 N=1625 N=260 N=1310  N=1489 N=69 N=1377  
Mean Age (±SD) (in 
years)  
60.2 (9.7) 60.4 (9.6) 60.1 (9.7) 0.65 61.1 (9.2) 64.0 
(10.3)  
61.0 (9.1) <0.01 
Mean BMI (±SD) 
(kg/m2)  
29.1 (5.8) 30.1 (6.3) 28.9 (5.7) <0.01 29.1 (5.6) 29.0 (6.9) 29.0 (5.5) 0.99 
African–American (%) 27.1 23.5 27.7 0.16 26.9 31.9 26.3 0.30 
Female (%) 64.5 59.6 65.6 0.07 61.6 59.4 61.8 0.69 
Current Smoker (%) 17.1 20.1 16.7 0.19 17.0 20.3 16.6 0.42 
Current Vigorous 
Occupational Activity 
(%): 
40.2 42.3 40.4 0.58 38.5 34.8 38.9 0.50 
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 Table 6.2. Characteristics of Participants who completed versus did not complete the Follow-Up Visit. 
 
*Knee injury among participants with baseline knee radiographs; hip injury among participants with baseline hip 
radiographs. 
 Participants with Baseline Knee Radiographs  Participants with Baseline Hip 
Radiographs  
Baseline Variables  Completed 
Follow-Up Visit 
Did not 
Complete 
Follow-Up Visit 
p-value Completed 
Follow-Up 
Visit 
Did not 
Complete 
Follow-Up 
Visit 
p-value 
 N=1625 N=1525  N=1489 N=1359  
Mean Age (±SD) (in years)  60.2 (9.7) 63.3 (11.4) <0.01 61.1 (9.2) 65.2 (10.6) <0.01 
Mean BMI (±SD) (kg/m2)  29.1 (5.8) 29.0 (6.2) 0.58 29.1 (5.6) 28.8 (6.1) 0.22 
African–American (%) 27.1 37.9 <0.01 26.9 36.3 <0.01 
Female (%) 64.5 59.3 <0.01 61.6 54.0 <0.01 
Current Smoker (%) 17.1 23.8 <0.01 17.0 22.9 <0.01 
Current Vigorous Occupational Activity (%) 
 
40.2 27.7 <0.01 38.5 25.0 <0.01 
Employed (%) 51.4 34.8 <0.01 47.8 29.4 <0.01 
Joint Injury (%)*  16.5 16.1 0.78 4.8 7.5 <0.01 
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Table 6.3.  Hazard Ratios for Longitudinal Analyses of Injury and Radiographic and Symptoms Outcomes of the 
Knee. 
 
Cluster Knee 
Outcome 
Injury to 
≥ 1 Knee 
# Knees at 
Risk 
# Knees 
with 
Outcome 
Unadjusted 
HR 
95% CI Wald 
Chi-
square 
Adjusted 
HR* 
95% CI Wald 
Chi-
square 
Radiographic 
OA 
Yes 222 52 1.71 1.28-2.29 <0.01 1.56 1.15-2.12 <0.01 
No 2504 357       
Symptoms Yes 87 9 0.41 0.21-0.80 0.02 0.43 0.22-0.82 0.01 
No 2039 470       
Radiographic 
OA or 
Symptoms 
Yes 89 44 1.49 1.11-2.01 <0.01 1.42 1.06-1.89 0.02 
No 1879 666       
Radiographic 
OA with 
Symptoms 
Yes 208 11 0.85 0.42-1.73 0.66 0.83 0.42-1.63 0.59 
No 2577 158       
Unilateral 
Knee 
Radiographic 
OA 
Injured to 
1 Knee 
Only 
# Knees 
at Risk 
# Knees 
with 
Outcome 
Unadjusted 
HR 
95% CI Wald 
Chi-
square 
Adjusted* 
HR 
95% CI Wald 
Chi-
square 
Ipsilateral 
Knee 
Radiographic 
OA 
Yes 142 19 1.61 0.99-2.63 0.06 1.58 0.96-2.59 0.07 
No 2204 184       
Contralateral 
Knee 
Radiographic 
OA 
Yes 149 21 1.76 1.11-2.78 0.02 1.80 1.14-2.86 0.01 
No 2201 182       
*Adjusted for baseline variables of gender, BMI, age, current smoking status, and current vigorous occupational activity 
status.   
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Table 6.4.  Hazard Ratios for Longitudinal Analyses of Injury and Radiographic and Symptoms Outcomes of the Hip. 
 
Clustered Hip 
Outcome 
Injury to 
≥ 1 Hip 
# Hips at 
Risk 
# Hips 
with 
Outcome 
Unadjusted 
HR 
95% CI Wald 
Chi-
square 
Adjusted* 
HR 
95% CI Wald 
Chi-
square 
Radiographic OA Yes 51 6 1.39 0.63-3.09 0.42 1.41 0.63-3.17 0.41 
No 2171 187       
Symptoms Yes 24 8 0.94 0.42-1.97 0.82 0.90 0.41-1.95 0.90 
No 2179 795       
Radiographic OA or 
Symptoms 
Yes 15 7 1.31 0.64-2.68 0.47 1.29 0.59-2.83 0.53 
No 1665 696       
Radiographic OA 
with Symptoms 
Yes 57 5 0.84 0.35-2.01 0.70 0.80 0.33-1.90 0.61 
No 2613 269       
*Adjusted for baseline variables of gender, BMI, age, current smoking status, and current vigorous occupational activity 
status.   
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Table 6.5.  Hazard Ratios for Longitudinal Analyses of Injury and Radiographic and Symptoms Outcomes of the 
Knee, by Race. 
 
  Caucasian 
 
African American 
 
 
Outcome Knee 
Injury 
# 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI # 
Knees 
at 
Risk 
# Knees 
with 
Outcome 
Adjusted 
HR* 
95% CI P-value 
Inter- 
action 
Knee OA Yes 189 47 1.81 1.32-2.50 43 10 1.54 0.79-2.98 0.62 
 No 1868 237   670 101    
Knee 
Symptoms 
Yes 80 8 0.37     0.18-0.74 21 5 1.32     0.54-3.23    0.02 
No 1632 405   679 138    
Knee OA 
or 
Symptoms 
Yes 78 41 1.31 0.97-1.78 15 7 1.48 0.76-2.88 0.85 
No 1462 553   508 186    
Knee OA 
with 
Symptoms 
Yes 168 8 0.76 0.34-1.70 40 3 1.18 0.38-3.66 0.58 
No 1895 106   682 52    
 
*Adjusted for age, BMI, gender, smoking, and vigorous occupational activity. 
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Table 6.6.  Hazard Ratios for Longitudinal Analyses of Injury and Radiographic and Symptoms Outcomes of the 
Knee, with and without Knees with Surgery at Baseline. 
 
Cluster Knee Outcome Adjusted HR 95% CI Wald Chi-
square 
Adjusted HR† 95% CI Wald Chi-
square 
Radiographic OA 1.56 1.15-2.12 <0.01 1.53 1.01-2.31 0.04 
      
Symptoms 0.43 0.22-0.82 0.01 0.61 0.34-1.07 0.09 
      
Radiographic OA or 
Symptoms 
1.42 1.06-1.89 0.02 1.39 1.05-1.83 0.02 
      
Radiographic OA with 
Symptoms 
0.83 0.42-1.63 0.59 0.69 0.33-146 0.34 
      
*Adjusted for age, BMI, race, gender, smoking, and vigorous occupational activity 
†Removing 60 knees with baseline knee surgery. 
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Table 6.7. Mean Time and Standard Deviation (SD) since Knee Injury by Outcome. 
 
Incident Outcome Present? Knees Mean years since knee injury (SD) t-test 
 p-value 
Knee OA Yes 46 21.0 (17.6) 0.39 
 No 
 
188 23.3 (15.2)  
Knee Symptoms Yes 41 25.0 (19.5) 0.24 
 No 
 
142 21.0 (14.9)  
Knee Symptoms or OA Yes 66 22.4 (17.3) 0.89 
 No 
 
80 22.0 (15.5)  
Knee Symptoms and OA Yes 21 25.2 (21.8) 0.38 
 No 209 22.0 (15.2)  
 2
 The results in this chapter will be submitted for publication in the peer-reviewed 
literature.  Authors will include committee members listed on the title page. 
 
 
 
 
 
VII.  Results - Comparisons of Estimates Generated by Cross-Sectional and 
Longitudinal Analyses of the Association between Knee and Hip Injury and 
Osteoarthritis2  
 
A.   Introduction 
Previous larger population-based studies examining the association between 
injury and OA of the knee (Davis et al., 1989; Felson et al., 1997; Hart et al., 1999; 
Gelber et al., 2000; Sowers et al., 2000; Wilder et al., 2002; Toivanen et al., 2010) and 
hip (Tepper & Hochberg, 1993; Cooper et al., 1998; Gelber et al., 2000) have resulted in 
a wide range of estimates.  Although differences in the populations may account for some 
of this variability, the study designs, cross-sectional (Davis et al., 1989; Tepper & 
Hochberg, 1993; Sowers et al., 2000) or longitudinal (Felson et al., 1997; Hart et al., 
1999; Gelber et al., 2000; Wilder et al., 2002; Toivanen et al., 2010), may contribute to 
the inconsistencies.  An advantage of the cross-sectional study design over the 
longitudinal design is it does not require years of follow-up, which may be costly.  
Unfortunately, this design increases the likelihood of a recall bias that would inflate the 
estimate of the association because individuals with OA may be more apt to recall injury 
in a joint with OA than individuals without OA.  Additionally, the direction of 
associations cannot be established; injury could contribute to the development of OA, but 
one who has OA in a joint with associated weakness and instability may be more prone to 
injury.  In the longitudinal study design, assessment of injury exposure precedes the 
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development of OA, greatly reducing the potential for recall bias and clarifying the 
direction of the association.      
Whether prevalence studies of injury and OA provide reasonable estimates of the 
association is unknown.  Potentially, this knowledge may explain results of previous 
studies and guide future research on injury and OA of all joint sites.  If prevalence studies 
provide comparable estimates of association to longitudinal studies, it may be efficient 
and appropriate to use prevalence studies for joint injury and OA research.  Alternatively, 
if estimates of the joint injury-OA association are not comparable between cross-
sectional and longitudinal designs, then longitudinal studies may be recommended for 
joint injury and OA research.   
 The purpose of this study was to compare the hazard of incident OA outcomes 
(reflecting radiographic evidence and/or symptoms) between individuals with and 
without history of injury of the knee or hip to the estimates of OA outcomes and injury 
generated in a cross-sectional analysis in a large, community-based sample. 
B.  Methods 
B. 1. Study Participants 
 The Johnston County Osteoarthritis Project is an ongoing, community-based 
study of the occurrence of knee and hip OA in African American and Caucasian residents 
in a rural county in North Carolina.  Details of this study have been reported previously 
(Jordan et al., 1995).  This study involved civilian, non-institutionalized adults aged 45 
years and older who resided in six townships in Johnston County.  Participants were 
recruited by probability sampling, with over-sampling of African Americans.   A total of 
3,187 individuals were recruited between May 1991 and December 1997.  All 
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participants completed a baseline clinical evaluation.    Among the 3,187 participants 
with baseline data, 1,329 were not eligible or available for follow-up assessments.   
Reasons that participants were not eligible or available included emigration from study 
area (N=161), refusal (N=435), inability to participate due to physical or mental 
conditions (N=234), death (N=411), and inability to contact or find (N=88).  Assessments 
at follow-up were completed from 1999-2003 (median time from baseline to follow-up = 
5.6 years, range=3.0-13.1 years).  Linked baseline and follow-up interview data were 
available for 1,858 participants.  Linked knee and hip radiograph assessments were 
available for 1,726 participants.  At baseline, joint injury data for the knee were available 
for 1,802 participants and for the hip for 1,803 participants.  Figure 7.1 details the 
selection of knees and hip for longitudinal and cross-sectional analyses. 
B.2. Measures 
B.2.1.  Radiographic Assessment 
 All participants completed bilateral anteroposterior radiography of the knee in 
weight bearing.  Women over 50 years of age and all men completed supine 
anteroposterior pelvic radiography.  Radiographs were read linked (baseline and follow-
up together) without knowledge of participant clinical status by a single muscuoloskeletal 
radiologist (Jordan B. Renner, MD) using the Kellgren-Lawrence (K-L) radiographic 
atlas for overall knee radiographic grades (Jordan et al., 2007).  Inter-rater reliability 
(comparison of radiograph readings between JBR and another radiologist) and intra-rater 
reliability (comparison of radiograph readings completed by JBR at two separate times) 
for the radiologist were high (weighted kappa for inter-rater reliability 0.9; kappa for 
intra-rater reliability 0.9) (Jordan et al., 1995).  Radiographs without the features of OA 
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were defined as K-L grade of 0 (normal findings).  A minute radiographic osteophyte of 
doubtful pathologic significance was assigned a K-L grade of 1 (questionable). 
Radiographs showing an osteophyte without joint space narrowing were assigned a K-L 
grade of 2 (mild).  A moderate decrease of the joint space was assigned a K-L grade of 3 
(moderate). K-L grade 4 (severe) was defined as severe joint space narrowing with 
subchondral bone sclerosis (Kellgren & Lawrence, 1963).   
B.2.2.  Chronic Knee and Hip Symptoms 
Participants completed an interviewer-administered questionnaire in which they 
answered “Yes” or “No,” separately for left and right knees and left and right hips, to the 
question: “On most days do you have pain, aching or stiffness in your [left/right] 
[knee/hip]?”  The presence of groin pain was recorded for right and left sides.  
Participants were considered to have chronic knee symptoms if they answered 
affirmatively to the knee symptoms question and to have chronic hip symptoms if they 
answered affirmatively to the hip symptoms question or reported groin pain.    
B.2.3.  Definitions of Osteoarthritis Outcomes 
 For the knee and the hip separately, four prevalence and four incidence outcomes 
were explored in analyses. 
Radiographic OA.  The prevalence of radiographic OA was defined as K-L grade ≥2 at 
follow-up.   The incidence of radiographic OA was defined as a K-L grade ≥2 at follow-
up among participants with K-L grade <2 at baseline.   
Chronic Symptoms.  The prevalence of chronic joint symptoms was defined as an 
affirmative response to the symptoms questions at follow-up.   The incidence of chronic 
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joint symptoms was defined as an affirmative response to the symptoms questions at 
follow-up among participants who reported no symptoms at baseline.   
Radiographic OA or Symptoms.  The prevalence of radiographic OA or symptoms was 
defined as K-L grade ≥2 at follow-up or as an affirmative response to the chronic joint 
symptoms questions at follow-up.   The incidence of radiographic OA or symptoms was 
defined as a K-L grade ≥2 at follow-up among participants with K-L grade <2 at baseline 
or the presence of symptoms at follow-up among those without symptoms at baseline.   
Radiographic OA with Symptoms.  The prevalence of radiographic OA with symptoms 
was defined as K-L grade ≥2 at follow-up and an affirmative response to the chronic joint 
symptoms questions at follow-up.   The incidence of radiographic OA with symptoms 
was defined as a K-L grade ≥2 at follow-up and the presence of symptoms at follow-up 
among those with K-L grade <2 or without symptoms at baseline. 
B.2.4.  Main Exposure: History of Knee or Hip Injury 
Participants completed an interviewer-administered questionnaire at baseline and 
follow-up visits in which they responded whether they had a history of knee injury 
[‘‘Have you ever injured your right/left knee?’’] and a hip injury [‘‘Have you ever 
injured your right/left hip?’’].  A participant was considered to have the injury of interest 
if he or she answered “yes”.   
B.2.5.  Covariates 
Covariates associated with injury and radiographic OA or chronic symptoms of 
the knee and hip were considered in analyses.  Since a goal of this research was to 
compare results from cross-sectional and longitudinal analyses, it was important that 
covariate definitions were similar at baseline and follow-up time points.  For example, 
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physical activity may confound the injury and radiographic OA association, but questions 
regarding exercise, sports, and vigorous physical activity were considerably different at 
baseline and follow-up.  We could not assume that the questions from baseline and 
follow-up reflected similar intensity, frequency, or duration of physical activity at the 
same periods in a participant’s life, and thus, we did not consider physical activity as a 
covariate in analyses. 
Demographic and Clinical Characteristics.  The following participant characteristics 
were collected at baseline and follow-up visits: gender; self-reported race (African 
American or Caucasian); age (continuous variable in years); and body mass index at 
baseline (BMI: continuous variable calculated as weight in kilograms/height in meters 
squared).  Height without shoes was measured in centimeters and weight was measured 
in kilograms using a balance beam scale.   
Current Vigorous Occupational Activity.  Occupational activity questions were 
comparable at the two time points, although the questions were more detailed at the 
follow-up visit.  The set of questions that were the most relevant for creating a covariate 
definition that would be a potential confounder of the injury-OA/symptoms association 
would be one that examines vigorous activities performed on the job.  Participants 
completed an interviewer-administered questionnaire at baseline and follow-up in which 
they answered: 1) whether they were employed, and 2) “never”, “seldom”, “sometimes”, 
“often”, or “always” to separate questions about often they performed lifting, standing, 
walking, or squatting at their current job, if employed.  If a participant answered that he 
or she was employed and “often” or “always” to any of the activity questions, he or she 
was classified as currently engaged in vigorous occupational activity.   
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Current Smoker.  Participants were asked at baseline and follow-up visits whether they 
currently smoked.  Those who responded “yes” were classified as current smokers. 
B.3. Statistical Analysis 
Descriptive statistics (proportions for categorical variables and means and 
standard deviations for continuous variables) were calculated for the covariates of age, 
BMI, race, gender, current smoker status, and current vigorous occupational activity for 
the whole sample and for those with injury data.  Pearson’s chi-square test for categorical 
variables and t-tests for continuous variables were used to compare these covariates in the 
injured vs. the uninjured.  Differential participation was examined by comparing the 
baseline variables (age, BMI, race, gender, current smoker status, current vigorous 
occupational activity, and injury status) of participants who returned to follow-up visit to 
those who did not return by using Pearson’s chi-square test for categorical variables and 
t-tests for continuous variables. 
Two sets of analyses were examined: 1) a longitudinal analysis examining the 
incidence of knee or hip outcomes from baseline to follow-up visits, and 2) 1) a cross-
sectional analysis to determine the odds of knee or hip outcomes using follow-up data. 
Analysis Set 1. Longitudinal Analysis.  Due to the wide range of follow-up times for 
participants (mean = 5.9 years; standard deviation ± 1.4 years; range= 3 .0 – 13.2 years) 
and interval censoring (i.e., the exact time of the occurrence of the outcome is unknown), 
separate multivariable Cox models (with the midpoint of each individual’s follow-up 
period as the approximated endpoint) were used to estimate hazard ratios.  
 119 
 
Analysis Set 2. Cross-Sectional Analysis.  The odds at follow-up of knee and hip OA and 
symptoms outcomes were examined by self-reported joint injury history at follow-up.  
Odds ratios were calculated with logistic regression.   
Both Sets of Analyses.  Unilateral analyses were conducted to examine the associations 
between: knee injury and ipsilateral (same) radiographic knee OA, knee injury and 
contralateral (opposite; e.g. right knee injury and left knee OA) radiographic knee OA,  
knee injury and ipsilateral radiographic hip OA,  knee injury and contralateral 
radiographic hip OA,  hip injury and ipsilateral radiographic hip OA,  hip injury and 
contralateral radiographic hip OA, hip injury and ipsilateral radiographic knee OA,  and 
hip injury and contralateral radiographic knee OA.  We accounted for bilateral clustering 
of knees and bilateral clustering of hips with robust variance estimates.  Covariates 
included in adjusted models were identified by their association with both injury and the 
outcome of interest, either based on statistical significance in bivariate associations or on 
prior published knowledge of each covariate.  Multiplicative interaction terms of injury 
with each covariate (race, gender, age, BMI, current vigorous occupational activity, 
current smoking status) were examined.  If the interaction term was statistically 
significant (p<0.10), then it was included in models.  Cox and logistic regression models 
were fit using SAS Version 9.1 software (SAS Institute, Cary, NC).   
C.  Results 
Characteristics of the sample are detailed in Table 7.1.  The total study group comprised 
1,625 participants with linked knee radiographs and knee injury data (64.5% female, 
27.1% African American) and 1,489 participants with linked hip radiographs and hip 
injury data (61.6% female, 26.7% African American).  Among participants with linked 
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knee radiographs, 1,570 had baseline knee injury data (16.6% with knee injury history) 
and 1,622 had follow-up knee injury data (20.2% with knee injury history).   Among 
participants with linked hip radiographs, 1,446 had baseline hip injury data (4.8% with 
hip injury history) and 1,479 had follow-up hip injury data (5.1% with hip injury history).  
Among participants who report knee or hip injury, the average time from injury to 
baseline assessment was 23.1 years (standard deviation [SD]= 16.0) for the knee and 22.0 
years (SD=18.2) for the hip. 
 Age, BMI, gender, current smoking status, or current vigorous occupational 
activity status were included as covariates in all adjusted models for the knee and the hip.  
No statistically significant interaction terms were observed between injury and these 
covariates.   
 Table 7.2 and Figures 7.2-7.4 display the hazard ratios for incident knee outcomes 
and odds ratios for prevalent knee outcomes by history of knee injury and history of hip 
injury.  A strong, positive association between knee injury and radiographic knee OA are 
suggested by the adjusted hazard ratio (HR= 1.56; 95% confidence interval [CI] = 1.15-
2.12) and the adjusted odds ratio (OR=2.17, 9% CI 1.69-2.79), but the OR estimate is 
higher than that of the HR and the 95% CI for the OR does not include the HR estimate 
(Table 7.2, Figure 7.2).  A comparable pattern for the HR and OR estimates is noted for 
the association between knee injury and ipsilateral knee OA (Table 7.2, Figure 7.3).  The 
HR and OR estimates and 95% CIs are similar for knee injury and the knee OA or 
symptoms outcome (Table 7.2, Figure 7.2) and contralateral knee OA (Table 7.2, Figure 
7.3).  The HR and OR estimates for the relationship between unilateral hip injury and 
ipsilateral knee OA suggest no association and between unilateral hip injury and 
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contralateral knee OA show a negative association (Table 7.2, Figure 7.4); the 95% CIs 
are wide due to low numbers of events.  No similarities are noted between the HR and 
OR estimates for knee symptoms (the 95% CIs do not overlap) and knee OA with 
symptoms (the estimates are on opposite sides of the null) (Table 7.2, Figure 7.2).   
 Table 7.3 and Figures 7.5-7.7 display the hazard ratios for incident hip outcomes 
and odds ratios for prevalent hip outcomes by history of hip injury and history of knee 
injury.  Hip injury is associated with radiographic hip OA (HR=1.41, 95% CI= 0.63-3.17; 
OR=1.56, 95% CI=1.15-2.12) and hip OA or symptoms (HR=1.29, 95% CI=0.59-2.83; 
OR=1.42, 95% CI=1.06-1.89) (Table 7.3, Figure 7.5); the OR estimates are higher values 
than the HR estimates.  The adjusted HR and adjusted OR are similar for the association 
between hip injury and hip OA with symptoms (Table 7.3, Figure 7.5).  The estimates for 
hip injury and hip symptoms suggest a negative association, but the OR estimate 
(adjusted OR=0.43) is over two times lower than the HR estimate (adjusted HR=0.90) 
(Table 7.3, Figure 7.5).  No similarities are noted between the HR and OR estimates for 
hip injury and ipsilateral hip OA or hip injury and contralateral hip OA (the estimates are 
on opposite sides of the null); very few incident hip OA events occurred among hips with 
unilateral hip injury, contributing to the wide 95% CIs (Table 7.3, Figure 7.6).  The 
adjusted HR and OR estimates for the relationship between unilateral knee injury and 
ipsilateral hip OA suggest no association (Table 7.3, Figure 7.7).   The adjusted HR for 
unilateral knee injury and contralateral hip OA show a higher, positive HR estimate than 
for the OR estimate of the association (Table 7.3, Figure 7.7). 
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D.  Discussion 
The HRs of the association between injury and OA of the knee and hip are 
consistent with Gelber et al. (Gelber et al., 2000) (knee: aHR=5.17, 95% CI 3.07-8.71; 
hip: aHR=3.50, 95% CI 0.84-14.69) and Wilder et al. (Wilder et al., 2002) (knee: 
aHR=7.4, 95%CI=5.9-9.4), but the estimates in the present study are lower.  Other 
population-based studies have reported ORs ranging from 0.7-16.3 for radiographic knee 
OA (Davis et al., 1989; Felson et al., 1997; Wilder et al., 2002; Toivanen et al., 2010) and 
4.3-7.8 for radiographic hip OA (Tepper & Hochberg, 1993; Cooper et al., 1998).  
Positive ORs for injury and OA of the knee and hip also were reported in the present 
study, but the OR for the relationship between hip injury and hip OA (adjusted OR=1.56, 
95% CI=1.15-2.12) was much lower than those of prior studies (Tepper & Hochberg, 
1993; Cooper et al., 1998).  All of these cross-sectional analyses were prone to recall 
bias, potentially resulting in inflated estimates of the association. 
 Similarities between the HR and OR estimates and their 95% CIs for the knee 
typically were noted when the number of outcome events among injured joints was not 
low.  The adjusted ORs for the associations between knee injury and knee OA or 
symptoms, knee injury and contralateral knee OA, and hip injury and hip OA and 
symptoms demonstrated similar estimates and 95% CIs to the adjusted HRs.  The HRs 
and ORs were positive for the associations of knee injury and knee OA, knee injury and 
ipsilateral knee OA, hip injury and hip OA, and hip injury and hip OA or symptoms, but 
the ORs were higher.  No remarkable similarities were noted for other injury and OA 
outcomes.  Interpretation of the hip comparisons should be made with a high degree 
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caution due to the low numbers of hip outcomes among those with history of hip injury, 
particularly for the longitudinal analyses.   
Few incident OA outcomes occurred, especially for the hip, during the study 
period.  Attrition may have contributed to the few events observed; approximately 42% 
of participants did not return for follow-up, and some of those who did not return may 
have had incident outcomes that we did not observe.  The average of 6 years follow-up 
may not have been long enough for the occurrence of new cases.  Currently, second 
follow-up visits are being completed in the Johnston County Osteoarthritis Project, and 
examining the data over this longer period (from baseline to second follow-up) may 
reveal more incident cases for HR calculations. 
E.  Conclusion 
Estimates calculated from a cross-sectional analysis may provide a fair 
approximation of the incidence of radiographic knee OA by knee injury status, although 
the estimates may be inflated.  Further investigation over a longer period of time with a 
larger number of hip outcomes among those with hip injury is needed to clarify the 
association longitudinally. 
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Figure 7.1.  Description of Knees and Hips Included in Longitudinal and Cross-
Sectional Analyses. 
 
            *Linked = Baseline and follow-up radiograph 
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 125 
 
 
Figure 7.2.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to at Least 1 Knee (Clustered Analyses) and 
Radiographic and Symptoms Outcomes of the Knee. 
 
 
Figure 7.3.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to 1 Knee Only (Unilateral Analyses) and Radiographic 
Knee Osteoarthritis. 
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Figure 7.4.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to 1 Hip Only (Unilateral Analyses) and Radiographic 
Knee Osteoarthritis. 
 
 
 
 
Figure 7.5.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to at Least 1 Hip (Clustered Analyses) and 
Radiographic and Symptoms Outcomes of the Hip. 
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Figure 7.6.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to 1 Hip Only (Unilateral Analyses) and Radiographic 
Hip Osteoarthritis. 
 
 
 
Figure 7.7.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-
Sectional Analyses of Injury to 1 Knee Only (Unilateral Analyses) and Radiographic 
Hip Osteoarthritis. 
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Table 7.1. Characteristics of Participants with Baseline and Follow-Up Knee and Hip Radiograph Data. 
 
 
         *Linked = Baseline and follow-up radiograph
 Participants with Linked* Knee Radiographs  Participants with Linked* Hip Radiographs  
Baseline Variables for 
Longitudinal Analyses 
Total Sample Knee Injury No Knee 
Injury 
p-
value 
Total Sample  Hip Injury No Hip 
Injury 
p-
value 
 N=1625 N=260 N=1310  N=1489 N=69 N=1377  
Mean Age (±SD) (in years)  60.2 (9.7) 60.4 (9.6) 60.1 (9.7) 0.65 61.1 (9.2) 64.0 (10.3)  61.0 (9.1) <0.01 
Mean BMI (±SD) (kg/m2)  29.1 (5.8) 30.1 (6.3) 28.9 (5.7) <0.01 29.1 (5.6) 29.0 (6.9) 29.0 (5.5) 0.99 
African–American (%) 27.1 23.5 27.7 0.16 26.7 31.9 26.3 0.30 
Female (%) 64.5 59.6 65.6 0.07 61.6 59.4 61.8 0.69 
Current Smoker (%) 17.1 20.1 16.7 0.19 17.0 20.3 16.6 0.42 
Current Vigorous 
Occupational Activity (%) 
40.2 42.3 40.4 0.58 38.5 34.8 38.9 0.50 
Follow-Up Variables for 
Cross-sectional Analyses 
Total Sample Knee Injury No Knee 
Injury 
p-
value 
Total Sample  Hip Injury No Hip 
Injury 
p-
value 
 N=1625 N=328 N=1294  N=1489 N=75 N=1404  
Mean Age (±SD) (in years)  66.0 (9.9) 65.0 (9.8) 66.2 (9.9) 0.05 67.0 (9.4) 68.5 (9.4) 66.9 (9.4) 0.14 
Mean BMI (±SD) (kg/m2) 30.2 (6.2) 31.8 (7.0) 29.8 (5.9) <0.01 30.1 (6.0) 30.0 (7.2) 30.1 (6.0) 0.95 
African–American (%) 27.1 29.0 26.6 0.39 26.7 24.0 26.9 0.58 
Female (%) 64.5 60.7 65.5 0.10 61.6 58.7 61.7 0.60 
Current Smoker (%) 12.7 14.2 12.3 0.36 12.6 15.5 12.5 0.46 
Current Vigorous 
Occupational Activity (%) 
30.5 32.0 30.2 0.53 28.6 24.0 28.9 0.37 
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Table 7.2.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-Sectional Analyses of Injury and 
Radiographic and Symptoms Outcomes of the Knee. 
 
Knee Outcome Injury to ≥ 
1 Knee 
# Knees 
with 
outcome/ at 
Risk 
Adjusted 
HR* 
95% CI CLR # Knees 
with 
outcome/ 
at Risk 
Adjusted 
OR* 
95% CI CLR 
Radiographic OA Yes 52/222 1.56 1.15-2.12 1.84 173/403 2.17 1.69-2.79 1.65 
No 357/2504    693/2840    
Symptoms Yes 9/87 0.43 0.22-0.82 3.73 139/403 1.01 0.82-1.25 1.52 
No 470/2039    984/2839    
Radiographic OA or 
Symptoms 
Yes 44/89 1.42 1.06-1.89 1.78 250/403 1.58 1.26-1.99 1.58 
No 666/1879    247/2840    
Radiographic OA 
with Symptoms 
Yes 11/208 0.83 0.42-1.63 3.88 62/403 1.59 1.13-2.23 1.97 
No 158/2577    247/2840    
Unilateral Knee 
Radiographic OA 
Injured to 
1 Knee 
Only 
# Knees 
with 
outcome/ at 
Risk 
Adjusted 
HR* 
95% CI CLR # Knees 
with 
outcome/ 
at Risk 
Adjusted 
OR* 
95% CI CLR 
Ipsilateral Knee 
Radiographic OA 
Yes 19/142 1.58 0.96-2.59 2.69 104/255 2.45 1.75-3.42 1.95 
No 184/2204    619/2606    
Contralateral Knee 
Radiographic OA 
Yes 21/1149 1.75  1.11-2.74 2.47 75/237 1.80 1.14-2.86 2.51 
No 200/2341    614/2590    
Unilateral Knee 
Radiographic OA 
Injured 
to 1 Hip 
Only 
# Hips with 
outcome/ at 
Risk 
Adjusted 
HR* 
95% CI CLR # Hips 
with 
outcome/ 
at Risk 
Adjusted 
OR* 
95% CI CLR 
Ipsilateral Knee 
Radiographic OA 
Yes 6/54 1.04    0.46-2.34 5.09 15/56 0.95 0.48-1.85 3.84 
No 229/2483    820/3075  
  
Contralateral Knee 
Radiographic OA 
Yes 3/52 0.56     0.18-1.71 9.43 14/56 0.71 0.38-1.33 3.49 
No 224/2430    820/3075  
  
*Adjusted for baseline variables of gender, BMI, age, current smoking status, and current vigorous occupational activity status. 
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Table 7.3.  Hazard Ratios for Longitudinal Analyses and Odds Ratios for Cross-Sectional Analyses of Injury and 
Radiographic and Symptoms Outcomes of the Hip. 
 
Hip Outcome Injury to ≥ 
1 Hip 
# Hips with 
outcome/ at 
Risk 
Adjusted 
HR* 
95% CI CLR # Hips with 
outcome/ at 
Risk 
Adjusted 
OR* 
95% CI CLR 
Radiographic OA Yes 6/51 1.41 0.63-3.17 5.03 52/222 1.56 1.15-2.12 1.84 
No 187/2171    357/2504    
Symptoms Yes 8/24 0.90 0.41-1.95 4.76 9/87 0.43 0.22-0.82 3.73 
No 795/2179    470/2039    
Radiographic OA or 
Symptoms 
Yes 7/15 1.29 0.59-2.83 4.80 44/89 1.42 1.06-1.89 1.78 
No 696/1665    666/1879    
Radiographic OA 
with Symptoms 
Yes 5/57 0.80 0.33-1.90 5.76 11/208 0.83 0.42-1.63 3.88 
No 269/2613 
  
 158/2577    
Unilateral Hip 
Radiographic OA 
Injured to 
1 Hip Only 
# Hips with 
outcome/ at 
Risk 
Adjusted* 
HR 
95% CI CLR # Hips 
with 
outcome/ 
at Risk 
Adjusted 
OR* 
95% CI CLR 
Ipsilateral Hip 
Radiographic OA 
Yes 2/40 0.71 0.18-2.91 16.63 22/50 2.01 1.06-3.81 3.59 
No 140/2085    813/2810    
Contralateral Hip 
Radiographic OA 
Yes 2/41 0.71 0.17-2.88 16.67 18/50 1.18 0.64-2.18 3.42 
No 139/2084    813/2810    
Unilateral Hip 
Radiographic OA 
Injured 
to 1 Knee 
Only 
# Knees 
with 
outcome/ at 
Risk 
Adjusted 
HR* 
95% CI CLR # Knees 
with 
outcome/ 
at Risk 
Adjusted 
OR* 
95% CI CLR 
Ipsilateral Hip 
Radiographic OA 
Yes 10/152 1.03 0.51-2.08 4.09 66/235 0.94 0.68-1.30 1.92 
No 117/1822    697/2385  
  
Contralateral Hip 
Radiographic OA 
Yes 15/141 1.67 0.95-2.95 3.10 66/217 1.07 0.76-1.50 1.97 
No 120/1823    691/2368  
  
*Adjusted for baseline variables of gender, BMI, age, current smoking status, and current vigorous occupational activity status. 
  
 
 
 
VIII.  Discussion 
A. Overview of Findings 
 The main objectives of the research were to 1) determine whether the serum 
biomarkers cartilage oligomeric matrix protein (COMP), hyaluronan (HA), high-
sensitivity C-reactive protein (hsCRP), and keratan sulfate (KS) predict incident 
radiographic OA at the knee, 2) examine whether the biomarker-OA associations vary by 
injury history and chronic knee symptoms at the knee or hip, 3) examine the association 
between injury and different incident OA outcome definitions (including ipsilateral and 
contralateral associations) and 4) to compare the estimates generated by cross-sectional 
and longitudinal designs of the association between injury and radiographic OA at the 
knee and hip.  All of these objectives were addressed using a large, community-based bi-
racial population: the Johnston County Osteoarthritis Project. 
 To address the first objective, the associations between baseline serum COMP, 
HA, hsCRP, and KS levels and the radiographic knee outcomes of incident OA 
(Kellgren-Lawrence [K-L] grade of 2 or more), osteophyte (OST) formation, and joint 
space narrowing (JSN) were examined using Cox models.  Higher baseline lnCOMP and 
lnHA levels predicted incident knee OA, OST, and JSN, but higher levels of lnhsCRP 
and lnKS did not predict these outcomes.   These results are consistent with prior studies 
that have shown an association between higher serum COMP levels and cartilage and 
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subchondral bone turnover (Sharif et al., 1995) and a correlation between serum HA and 
joint space narrowing (Sharma et al., 1998).    
 To address the second objective, history of lower extremity injury (injury at the 
knee or hip) and chronic knee symptoms were explored as potential modifiers of the 
association between the biomarkers and knee OA outcomes.  Neither factor was a strong 
modifier.  However, a pattern was observed of higher adjusted HRs among knees with 
chronic symptoms at baseline compared to knee without symptoms.  Potentially, higher 
baseline biomarkers in combination with chronic knee symptoms may be early pre-
radiographic OA, although further investigation is needed to confirm this suggestion.   
Contrary to our expectations, a pattern of a non-significant protective association between 
lnHA and the incident knee OA outcome was observed among participants with a history 
of lower extremity injury history.  One possible explanation is that individuals with 
inflammation (as indicated by higher levels of serum HA at baseline) and a history of 
lower extremity injury may restrict behaviors that would increase their risk of developing 
knee OA (e.g., high impact physical recreation or work-related activities).  Another 
explanation is that individuals with inflammations and lower extremity injury history 
may be taking an anti-inflammatory or other medication to treat the inflammation which 
could lead to less incident knee OA.       
 To address the third objective, the hazard of incident OA of the knee and hip by 
self-report of a history of injury were explored using four OA outcomes: radiographic 
OA (K-L grade of 2 or greater), chronic joint symptoms (pain, aching, or stiffness of the 
joint on most days), radiographic OA or symptoms, and radiographic OA with symptoms.  
The associations were examined by any knee or hip, ipsilateral knee or hip, and 
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contralateral knee or hip.  Bilateral clustering was controlled for in models that did not 
distinguish between ipsilateral or contralateral associations.  The hazard of incident 
radiographic knee and hip OA was higher in those with a history of injury compared to 
those without injury.   Also, knee injury predicted an increased hazard of incident 
radiographic knee OA in the ipsilateral joint and, most notably, the contralateral joint.   
 To address the fourth objective, the hazard estimates of the injury and OA 
association generated for the third objective were compared to odds estimates 
generated in a cross-sectional analysis derived from the same sample.  The adjusted 
odds ratios (ORs) for the associations between knee injury and knee OA or symptoms, 
knee injury and contralateral knee OA, and hip injury and hip OA and symptoms 
demonstrated similar estimates and 95% confident intervals to the adjusted hazard ratios 
(HRs).  The HRs and ORs were positive for the associations of knee injury and knee OA, 
knee injury and ipsilateral knee OA, hip injury and hip OA, and hip injury and hip OA or 
symptoms, but the ORs were higher.  No similarities were observed for other injury and 
OA outcomes.  Due to low incident events, especially for the hip, no definite conclusions 
can be made at this time regarding whether results from cross-sectional studies are a 
reasonable proxy for longitudinal estimates.  Currently, second follow-up data are being 
collected in the Johnston County Osteoarthritis Project, and we plan to re-examine the 
longitudinal association using this additional data to provide more incident OA events. 
B.  Implications for Public Health 
B.1.  Biomarkers of Osteoarthritis and Injury History 
 By the time patients have OA features observable on radiograph or MRI, the 
disease may have progressed to a point where few options are available for the treatment 
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of OA.  Elevated levels of COMP and HA appear to be promising biomarkers for the 
early identification of knee OA.  Biomarker assessment may be appropriate to target 
among individuals with other risk factors for OA, such as obesity, older age, or injury 
history, rather than assessing biomarkers among all patients visiting a clinic.  
Particular attention may be needed for individuals with elevated levels of COMP or 
HA in combination with the presence of chronic knee symptoms since these 
individuals may be demonstrating the early stages of OA.  Interventions (e.g., 
medications, rehabilitation) should be targeted to individuals with elevated COMP or 
HA levels, particularly with concurrent chronic knee symptoms, in an attempt to slow 
or prevent progression of OA.   
B.2.  Injury and Osteoarthritis 
Injury is an important risk factor for OA of the knee and hip, not only within 
the same joint, but also for the joint of the opposite limb.  Although the mechanism for 
this contralateral association is not clear, changes in movement dynamics after injury 
may affect both limbs.  Not receiving treatment for an injured lower extremity and 
relying on the other limb for weight-bearing and mobility may have long-term 
consequences, leading to a decline in the health and function of both limbs.  Individuals 
who experience injury may benefit from early interventions, including medications and 
rehabilitation, to aid in joint healing and equalizing movement patterns between limbs via 
exercise programs and gait retraining.   
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C. Strengths 
C.1. Parent Study 
The Johnston County Osteoarthritis Project is an ongoing, longitudinal, 
community-based study that consists of African American and Caucasian men and 
women age 45 years and older.  Although the study is not strictly population-based (due 
to over-sampling of  certain demographic groups in Johnston County), the study used a 
randomized design sampling from the population, and thus, there is less risk of selection 
bias when compared to other OA studies, such as the Clearwater Osteoarthritis Study, 
which recruited volunteers (Wilder et al., 2002).  The sampling strategy of the Johnston 
County Osteoarthritis Project included over-sampling of African Americans, a race that 
has not been well-explored previously in other OA studies.   The data collected are 
comprehensive and include, but are not limited to, clinical exams, radiography of knee 
and hips (plus hands and spine in follow-up visits), and questionnaires addressing 
demographics, health and co-morbid conditions, symptoms, injury history, physical 
function, and lifestyle characteristics (i.e., occupation, physical activity). 
C.2.  Study Design 
Some prior studies of the associations between injury and OA and biomarkers and 
OA have been cross-sectional designs.  The advantage of the cross-sectional design is 
efficiency, but the direction of the association is unknown.  The prospective longitudinal 
design of the current research allows for a clearly established temporal relationship when 
examining history of injury or biomarkers as predictors of incident OA outcomes.      
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C.3.  Analytical Approach 
The analytical methods used in this research had two strengths.  First, in models 
that examined all knees (or hips), not just unilateral associations, we accounted for 
bilateral clustering of knees (or hips) within subjects using robust variance estimates.  
Additionally, the methods used to determine incident outcomes accommodated the 
interval censoring of the longitudinal study design. 
 Time-to-event analysis is interval-censored in this study because the event of OA 
is difficult to determine (i.e., the moment at which a healthy joint develops OA is difficult 
to determine), and the time points of data collection in this study allow for wide time 
intervals (on average, 5-7 years) in which OA occurred.  OA is a progressive disease that 
does not have a defined initiation time point.  In a clinical setting, OA is defined at the 
time of diagnosis when a patient reports chronic symptoms and clinical evaluation and 
diagnostics confirm the presence of OA.  In research studies, OA is defined typically as 
an outcome at the time of interview or assessment when the participant first presents with 
symptoms, radiographic or MRI images, or self-report of physician-diagnosed OA.  
Neither of these definitions captures the time of the event of OA, which occurred after a 
clinic or research visit at which the individual did not have OA but prior to the visit at 
which the diagnosis of OA was made.  This scenario is described as interval censoring, 
where the event is known to have occurred during a certain period of time, but the exact 
time of the event is unknown.   
Three options were available for our research: 1) ignore interval censoring and 
consider the endpoint to be the first study visit where the outcome is noted, 2) estimate 
the endpoint as the mid-point of the follow-up period, or 3) use a continuous probability 
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distribution to estimate the missing event times by substituting interval based maximum 
likelihood estimates (the Weibull model) (Odell et al., 1992).   Estimating the endpoint 
during the follow-up period rather than at the end of the interval was preferable to 
improve the validity of the results.  The Weibull model, which is fit using statistical 
software, has been reported to produce estimates that are more accurate than other 
estimates based on substitution of mid-point data in interval-censored data (Odell et al., 
1992).  However, the advantage of mid-point data is that the researcher controls the 
endpoint estimation and, in turn, is able to discern the estimated time of each incident 
outcome.   
C.4. Defining Osteoarthritis 
In the clinic, OA is diagnosed based on a combination of patient symptoms, 
clinical signs, and radiographic evidence (Jordan et al., 2007), yet agreeing on a clear 
definition of OA is challenging.  Traditionally, researchers have used radiographic 
evidence based on a standard scoring system, most commonly the Kellgren-Lawrence (K-
L) score, to classify a joint as having or not having OA.  However, radiographic evidence 
does not necessarily mean that an individual has signs or symptoms of OA, and the 
question of whether a person with signs and symptoms of OA but no radiographic 
evidence should be categorized as not having OA. 
 A novel approach to this research was the exploration of multiple definitions of 
OA outcomes for both the biomarker-OA and injury-OA associations.  In the biomarker-
OA analyses, incident knee OA was defined using three radiographic definitions:  K-L 
grade, OST formation, and JSN.  The K-L grade relies on both OST and JSN evidence, 
and the advantage of including the other two scores is that the OST and JSN events could 
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be examined separately.  This approach allowed for determination of the association of 
COMP with both OST formation and JSN and HA with only JSN.  In the injury-OA 
analyses, four definitions of incident knee or hip OA were explored: radiographic 
evidence only, symptoms only, radiographic evidence or symptoms, and radiographic 
evidence with symptoms, and the association between injury and OA varied with each 
OA definition.    
D. Limitations  
D.1. Attrition 
From baseline to follow-up, approximately 42% (N=1,329) of participants in the 
Johnston County Osteoarthritis Project did not return for follow-up.   Differential 
participation was examined for the injury and OA analyses by comparing the baseline 
variables (age, BMI, race, gender, current smoker status, current vigorous occupational 
activity, and injury status) of participants who returned to the follow-up visit to those 
who did not return.  Participants who did not return for follow-up compared to those who 
completed the follow-up visit tended to be slightly older, African-American, male, 
smokers, and not employed or retired at baseline.  Equal proportions of participants with 
knee injury history returned for follow-up, but a greater proportion of participants with a 
history of hip injury did not return for the follow-up visit.  Essentially, the longitudinal 
analyses were limited to those participants who were more likely to be younger and 
healthier at baseline, and these selection factors may influence the observed association.  
The loss of some participants by the follow-up visit reduced the power available for some 
of the outcome definitions, particularly for the hip, and this explains the lower precision 
for the hip estimates.    
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D.2. Limitations of Injury Definition 
 Misclassification of injury is likely in the present study.  An individual’s recall of 
the details and date of the injury may not be reliable.  The agreement of self-report of 
injury was compared in our sample using baseline and follow-up data (Table 3, Appendix 
1).  Self-report of no injury was fairly consistent at both time points.  However, among 
knees with self-reported joint injury at baseline (N=49 for the right knee and N=38 for 
the left knee), 44% of right knees and 39% of left knees did not have self-reported injury 
at follow-up.  Additionally, recall of an injury may be more likely for a person who has 
OA than a person without OA, a concern with a retrospective, cross-sectional study 
design.   Conducting a prospective study may reduce this bias because the injury precedes 
the OA outcome.  The use of medical records for identifying injury events may offer little 
additional information for correct classification.  Generally, not every joint injury is 
reported to a health care professional at the time of the injury, and thus, medical records 
may not be a reliable source.  Additionally, retrospective retrieval of some medical 
records may be extremely difficult if an individual sustained the injury at a young age 
and several decades have passed since time of injury.  Self-report may capture more 
occurrences of joint injury than medical records.  
 One method for managing the potential misclassification of the injury exposure in 
the present study would be to determine the reliability and validity of the self-report 
measure.  Using a subsample of the larger cohort, self-report of joint injury could be 
collected at two time points relatively close in time (e.g., three months), additional 
questions could be asked to gain more information about the individual’s injury 
experience, and self-report of injury could be compared to medical records.  The 
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estimated validity could be used to conduct informed sensitivity analyses to determine 
whether estimates of association between injury and OA are robust when testing 
assumptions of exposure misclassification.   
 Although originally proposed, the present study did not conduct a sensitivity 
analysis to determine the robustness of estimates of association given different 
assumptions about the validity of the self-report of injury measure.  No clear method for 
performing a sensitivity analysis in a time-to-event model with bilateral clustering was 
found in the literature to guide this type of analysis.  This method will be developed in a 
future project, but was beyond the scope of the present dissertation project. 
D.3. Limitations in Injury Data in Biomarker-Osteoarthritis Analyses 
Results of biomarker-OA associations suggest that history of lower extremity 
injury is not a strong modifier, but this interpretation is incomplete due to power 
limitations (number of knees with lower extremity injury history was 46 compared to 479 
without injury history) and the potential misclassification that comes with self-report.  
Additionally, data were not available on lower extremity injuries other than the knee or 
hip (i.e., no ankle or foot injury data).  
An association between injury and elevated biomarkers would more likely be 
observed when the event of injury and collection of biomarker sample are closer together 
in time.  The average time from injury to baseline assessment was 21 years in this study, 
and levels of biomarkers elevated by initial injury may have declined to approximately 
pre-injury levels over that length of time.  Figure 8.1 illustrates the timing of injury, 
biomarker, and OA events.  Among participants who completed baseline and follow-up 
assessments and had baseline biomarker data (N=423), the mean age was 61.5 years (SD 
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= ± 9.9 years), and the mean age of injury in the right and left knees was 41.4 years (SD 
= ± 19.9 years) and 41.7 years (SD = ± 17.8 years), respectively.  The mean age at 
follow-up was 65.5 years (SD = ± 9.8 years), and the mean time of follow-up was 6.3 
years (SD = ±1.4 years).  The association between injury and elevated biomarkers was 
less likely to be observed in the present study based on the timing of biomarker collection 
relative to the events of knee injury and OA.  Thus, the association between the 
biomarkers and development of knee OA was examined, stratifiying by knee injury 
history, to accommodate these circumstances.      
E.  Conclusions 
 Elevated levels of COMP and HA are likely indicators of the early stages of 
knee OA, especially in the presence of chronic knee symptoms.  Lower extremity 
injury may play a role in the biomarker-OA association, but, due to power limitations, 
this relationship could not be established in the present study.   Injury not only 
predicted an increased hazard of incident radiographic OA in the ipsilateral joint, but it 
predicted incident contralateral OA.   Changes in movement patterns after injury may 
affect both limbs and contribute to the development of lower extremity OA, but further 
investigation is needed to determine the mechanisms involved with the contralateral 
injury-OA association.  
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Figure 8.1.  Timeline of Knee Injury Event, Biomarker Collection, and Follow-Up 
Assessment. 
Mean Age of 
Knee Injury
Mean Age at 
Biomarker 
Collection
Mean Age at 
Follow-Up
Age in Years
40 50 60 70
Mean Follow-Up 
Time = 6.3 Years
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Appendix.  Evaluation of Covariates as Confounders or Modifiers for the Biomarker and Radiographic Osteoarthritis 
(based on Kellgren-Lawrence grade) Association. 
 
Table 1.  Summary of Categorical Covariates among Participants with Baseline Biomarker Data (N=803).   
Variable Category Frequency Percent 
Gender Male 474 59.3 
 Female 326 40.7 
 Missing 3 -- 
Race African American 398 49.8 
 Caucasian 402 50.2 
 Missing 3 -- 
Baseline Right Knee  Yes 319 40.4 
Symptoms No 470 59.6 
 Missing 14 -- 
Baseline Left Knee Symptoms Yes 284 36.0 
 No 505 64.0 
 Missing 14 -- 
Baseline Right Knee Injury Yes 80 10.2 
 No 697 88.7 
 Don’t Know 9 1.2 
 Missing 17 -- 
Baseline Left Knee Injury Yes 78 10.0 
 No 697 89.1 
 Don’t Know 7 0.9 
 Missing 21 -- 
Follow-Up Right Knee Severe  Yes 15 3.7 
Injury No 390 96.1 
 Missing 398 -- 
Follow-Up Left Knee Severe  Yes 16 3.9 
Injury No 391 96.3 
 Missing 396 -- 
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Table 1 continued.  Summary of Categorical Covariates among Participants with Baseline Biomarker Data (N=803).   
Baseline Right Knee Fracture Yes 20 2.5 
 No 765 97.3 
 Don’t Know 1 0.1 
 Missing 17 -- 
Baseline Left Knee Fracture Yes 20 2.5 
 No 765 97.3 
 Don’t Know 1 0.1 
 Missing 21 -- 
Baseline Right Knee Surgery Yes 32 4.1 
 No 755 95.8 
 Don’t Know 1 0.1 
 Missing 15 -- 
Baseline Left Knee Surgery Yes 24 3.1 
 No 759 96.9 
 Missing 20 -- 
 
 
 
Table 2.  Summary of Continuous Covariates (N=803). 
Variable N Mean SD Media
n 
Range Q33 Q67 Skewness 
Age (years) 800 62.4 10.5 61.6 45.0-92.2 55.9 67.2 0.32 (right) 
BMI (kg/m2) 797 30.3 7.0 28.9 15.4-58.7 26.7 31.6 1.08   (left) 
Time since injury   
        (years) 
        
Right Knee 44 23.5 15.4 23.3 3.9-56.0 12.0 30.9 0.35 (right) 
Left Knee 52 19.9 13.9 18.2 1.8-56.0 10.0 25.3 0.69 (right) 
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Table 3.  Summary of Agreement between Baseline and Follow-Up Report of Injury (N=803). 
Variable Self-Report of Injury Frequency Percent 
Right Knee Injury Never Injured at Either Time Point 331 80.7 
 Injury at Follow-Up, not at Baseline 30 7.3 
 Consistent Injury Baseline to Follow-Up  27 6.6 
 Injured at Baseline not at Follow-Up 22 5.4 
 Missing 393 -- 
Left Knee Injury Never Injured at Either Time Point 335 81.5 
 Injury at Follow-Up, not at Baseline 38 9.3 
 Consistent Injury Baseline to Follow-Up  23 5.6 
 Injured at Baseline not at Follow-Up 15 3.7 
 Missing 392 -- 
Right Knee Fracture Never Fracture at Either Time Point 394 96.6 
 Fracture at Follow-Up, not at Baseline 6 1.5 
 Consistent Fracture Baseline to Follow-Up  4 1.0 
 Fractured at Baseline not at Follow-Up 4 1.0 
 Missing 395 -- 
Left Knee Fracture Never Fracture at Either Time Point 394 97.5 
 Fracture at Follow-Up, not at Baseline 4 1.0 
 Consistent Fracture Baseline to Follow-Up  4 51.0 
 Fractured at Baseline not at Follow-Up 2 0.5 
 Missing 399 -- 
Right Knee Surgery Never Surgery at Either Time Point 370 90.9 
 Surgery at Follow-Up, not at Baseline 18 4.4 
 Consistent Surgery Baseline to Follow-Up  15 3.7 
 Surgery at Baseline not at Follow-Up 4 1.0 
 Missing 396 -- 
Left Knee Surgery Never Surgery at Either Time Point 374 92.1 
 Surgery at Follow-Up, not at Baseline 16 3.9 
 Consistent Surgery Baseline to Follow-Up  13 3.2 
 Surgery at Baseline not at Follow-Up 3 0.7 
 Missing 397 -- 
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Table 4.  Association between Biomarkers and Knee Radiographic OA (Kellgren-Lawrence grade ≥ 2) (N=542 knees). 
 
Exposure Mean 
(SD) 
Incident OA 
(N=110) 
No OA 
(N=432) 
t-test 
 P-value 
Unadjusted 
HR 
95% CI CLR 
ln (COMP) 6.8 (0.5) 6.9 (0.5) 6.8 (0.5) 0.16 1.40 0.93-2.11 2.27 
ln (HA) 3.1 (0.9) 3.2 (0.9) 3.1 (0.9) 0.13 1.21 0.94-1.55 1.65 
ln(hsCRP) 7.5 (1.4) 7.7 (1.3) 7.4 (1.4) 0.02 1.16 0.99-1.37 1.38 
ln (KS) 7.9 (0.4) 8.0 (0.4) 7.9 (0.4) 0.02 1.83 0.97-3.46 3.57 
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Table 5. Covariate–Incident Knee Radiographic OA Associations (N=542 knees). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Fisher’s exact estimate
Covariate Category N Percent Incident 
OA 
(N=110) 
N (%) 
No OA 
(N=432) 
 
N (%) 
Chi-
square 
P-value 
Age <55.0 213 39.3 31(28.2) 182 (42.1)  
 55.0-<65.0 189 34.9 45 (40.9) 144 (33.3)  
 65.0+ 140 25.8 34 (30.9) 106 (24.5) 0.03 
Age <58 years 273 49.6 61 (55.5) 208 (48.2)  
 >=58 years 269 50.4 49 (45.5) 224 (51.9) 0.17 
BMI <25.0 126 23.3 16 (14.6) 110 (25.5)  
 25.0-<30.0 219 40.4 38 (34.6) 181 (41.9)  
 30.0+ 197 36.4 56 (50.9) 141 (32.6) <0.01 
BMI <28 kg/m2 272 49.8 75 (68.2) 195 (45.1)  
 >=28 kg/m2 270 50.2 35 (31.8) 237 (54.9) <0.01 
Gender Male 211 38.9 43 (60.9) 168 (61.1)  
 Female 331 61.1 67 (39.1) 264 (38.9) 0.97 
Race African American 200 36.9 54 (49.1) 146 (33.8)  
 Caucasian 342 63.1 56 (50.9) 286 (66.2) <0.01 
Baseline Knee  Yes 166 30.6 46 (41.8) 120 (27.9)  
Symptoms No 374 69.4 64 (58.2) 310 (72.1) <0.01 
 Missing 2 -- -- 2  
Baseline Knee  Yes 37 7.0 12 (11.4) 25 (5.9)  
Injury No 493 93.0 93 (88.6) 400 (94.1) 0.05 
 Missing 12 -- 5 7  
Follow-Up Knee  Yes 16 3.1 3 (2.8) 13 (3.2)  
Severe Injury No 502 96.9 103 (97.2) 99 (96.8) 0.99 
 Missing 24 -- 4 20  
Baseline Knee  Yes 6 1.1 2 (1.8) 4 (0.9)  
   Fracture No 265 98.9 108 (98.2) 422 (99.1) 0.61* 
 Missing 6 -- 0 6  
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Table 5 continued. Covariate–Incident Knee Radiographic OA Associations (N=542 knees). 
 
 
 
 
 
 
*Fisher’s exact estimate
Baseline Knee Surgery Yes 13 2.4 4 (3.7) 9 (2.1)  
 No 523 97.6 105 (96.3) 418 (97.9) 0.31* 
 Missing 6 -- 1 6  
Time Since Knee  <20.0 years 23 46.0 11 (64.7) 12 (36.4)  
Injury 20.0+ years 27 54.0 6 (35.3) 21 (63.6) 0.06 
 Missing 492 -- 93 399  
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Table 6.  lnCOMP-Covariate Associations (N=542 knees). 
 
Covariate Category N     Percent Mean 
(SD) 
t-test 
P-value 
Age <58 years 273 50.4 6.7 (0.5)  
 >=58 years 269 49.6 6.9 (0.5) <0.01 
BMI <28 kg/m2 272 50.2 6.7 (0.5)  
 >=28 kg/m2 270 49.8 6.9 (0.5) <0.01 
Gender Male 211 38.9 6.9 (0.5)  
 Female 331 61.1 6.7 (0.5) <0.01 
Race African American 200 36.9 6.9 (0.5)  
 Caucasian 342 63.1 6.7 (0.5) <0.01 
Baseline Knee Symptoms Yes 166 30.6 6.9 (0.5)  
 No 374 69.4 6.8 (0.5) 0.08 
 Missing 2 --   
Baseline Knee Injury Yes 37 7.0 7.0 (0.5)  
 No 493 93.0 6.8 (0.5) 0.05 
 Missing 12 --   
Follow-Up Knee Severe Injury Yes 16 3.1 6.9 (0.6)  
 No 502 96.9 6.8 (0.5) 0.36 
 Missing 24 --   
Baseline Knee Fracture Yes 6 1.1 6.5 (0.4)  
 No 265 98.9 6.8 (0.5) 0.18 
 Missing 6 --   
Baseline Knee Surgery Yes 13 2.4 6.6 (0.4)  
 No 523 97.6 6.8 (0.5) 0.21 
 Missing 6 --   
Time Since Knee Injury <20.0 years 23 46.0 6.8 (0.5)  
 20.0+ years 27 54.0 6.8 (0.6) 0.92 
 Missing 492 --   
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Table 7.  lnHA-Covariate Associations (N=542 knees). 
 
Covariate Category N Percent Mean 
(SD) 
t-test 
P-value 
Age <58 years 273 50.4 3.3 (1.0)  
 >=58 years 269 49.6 2.9 (0.8) <0.01 
BMI <28 kg/m2 272 50.2 3.0 (1.0)  
 >=28 kg/m2 270 49.8 3.2 (0.8) 0.10 
Gender Male 211 38.9 3.3 (0.9)  
 Female 331 61.1 2.9 (0.9) 0.01 
Race African American 200 36.9 2.8 (1.2)  
 Caucasian 342 63.1 3.2 (0.7) 0.01 
Baseline Knee Symptoms Yes 166 30.6 3.2 (0.8)  
 No 374 69.4 3.0 (1.0) 0.01 
 Missing 2 --   
Baseline Knee Injury Yes 37 7.0 3.2 (0.9)  
 No 493 93.0 3.1 (0.9) 0.81 
 Missing 12 --   
Follow-Up Knee Severe Injury Yes 16 3.1 3.2 (0.8)  
 No 502 96.9 3.1 (0.9) 0.54 
 Missing 24 --   
Baseline Knee Fracture Yes 6 1.1 2.7 (0.7)  
 No 265 98.9 3.1 (0.9) 0.24 
 Missing 6 --   
Baseline Knee Surgery Yes 13 2.4 3.3 (0.8)  
 No 523 97.6 3.1 (0.9) 0.51 
 Missing 6 --   
Time Since Knee Injury <20.0 years 23 46.0 3.1 (1.0)  
 20.0+ years 27 54.0 3.3 (0.7) 0.39 
 Missing 492 --   
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Table 8.  lnhsCRP-Covariate Associations (N=542 knees). 
 
 
Covariate Category N Percent Mean 
(SD) 
t-test 
P-value 
Age <58 years 273 50.4 7.4 (1.4)  
 >=58 years 269 49.6 7.6 (1.3) 0.07 
BMI <28 kg/m2 272 50.2 7.0 (1.4)  
 >=28 kg/m2 270 49.8 7.9 (1.2) <0.01 
Gender Male 211 38.9 7.1 (1.2)  
 Female 331 61.1 7.7 (1.4) <0.01 
Race African American 200 36.9 7.7 (1.6)  
 Caucasian 342 63.1 7.3 (1.6) <0.01 
Baseline Knee Symptoms Yes 166 30.6 7.8 (1.4)  
 No 374 69.4 7.3 (1.3) <0.01 
 Missing 2 --   
Baseline Knee Injury Yes 37 7.0 7.9 (1.4)  
 No 493 93.0 7.4 (1.4) 0.06 
 Missing 12 --   
Follow-Up Knee Severe Injury Yes 16 3.1 7.9 (1.3)  
 No 502 96.9 7.5 (1.4) 0.18 
 Missing 24 --   
Baseline Knee Fracture Yes 6 1.1 7.3 (1.4)  
 No 265 98.9 7.5 (1.4) 0.78 
 Missing 6 --   
Baseline Knee Surgery Yes 13 2.4 8.8 (1.0)  
 No 523 97.6 7.4 (1.4) <0.01 
 Missing 6 --   
Time Since Knee Injury <20.0 years 23 46.0 7.7 (1.6)  
 20.0+ years 27 54.0 7.4 (1.5) 0.38 
 Missing 492 --   
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Table 9.  lnKS-Covariate Associations (N=542 knees). 
 
 
Covariate Category N Percent Mean 
(SD) 
t-test 
P-
value 
Age <58 years 273 50.4 7.9 (0.4)  
 >=58 years 269 49.6 8.0 (0.4) <0.01 
BMI <28 kg/m2 272 50.2 8.0 (0.4)  
 >=28 kg/m2 270 49.8 7.9 (0.4) 0.03 
Gender Male 211 38.9 8.0 (0.4)  
 Female 331 61.1 7.9 (0.4) <0.01 
Race African American 200 36.9 8.0 (0.4)  
 Caucasian 342 63.1 7.9 (0.4) 0.10 
Baseline Knee Symptoms Yes 166 30.6 7.9 (0.4)  
 No 374 69.4 8.0 (0.4) 0.37 
 Missing 2 --   
Baseline Knee Injury Yes 37 7.0 7.9 (0.40)  
 No 493 93.0 7.9 (0.40) 0.36 
 Missing 12 --   
Follow-Up Knee Severe Injury Yes 16 3.1 7.9 (0.5)  
 No 502 96.9 8.0 (0.4) 0.42 
 Missing 24 --   
Baseline Knee Fracture Yes 6 1.1 7.8 (0.3)  
 No 265 98.9 7.9 (0.4) 0.53 
 Missing 6 --   
Baseline Knee Surgery Yes 13 2.4 7.8 (0.3)  
 No 523 97.6 7.9 (0.4) 0.08 
 Missing 6 --   
Time Since Knee Injury <20.0 years 23 46.0 8.0 (0.4)  
 20.0+ years 27 54.0 7.9 (0.3) 0.45 
 Missing 492 --   
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Table 10.  Assessment of Potential Confounders for lnCOMP. 
Covariate Potential to be Confounder 
(High, Medium, or Low) 
Justification 
Age High Age and incident Radiographic OA strongly 
associated (p=0.03); Age and lnCOMP strongly 
associated (t-test p=<0.01) 
BMI High BMI and incident Radiographic OA strongly 
associated (p<0.01); BMI and lnCOMP strongly 
associated (p<0.01) 
Gender Low Gender and lnCOMP strongly associated 
(p<0.01), but weak association between gender 
and Radiographic OA (p=0.97) 
Race High Race and incident Radiographic OA strongly 
associated (p<0.01); Race and lnCOMP strongly 
associated (p<0.01) 
Baseline Knee Symptoms Medium Knee symptoms and Radiographic OA strongly 
associated (p<0.01); knee symptoms and 
lnCOMP associated (p=0.08)  
Baseline Knee Injury Medium Knee injury and Radiographic OA associated 
(p=0.05); knee injury and lnCOMP associated 
(p=0.05) 
Follow-Up Knee Severe Injury Low Weak associations between knee severe injury 
and Radiographic OA (p=0.99) and knee severe 
injury and lnCOMP (p=0.36) 
Baseline Knee Fracture Low Weak associations between knee fracture and 
Radiographic OA (p=0.61) and knee fracture 
and lnCOMP (p=0.18) 
Baseline Knee Surgery Low Weak associations between knee surgery and 
Radiographic OA (p=0.31) and knee surgery 
and lnCOMP (p=0.21) 
Time Since Knee Injury Low Time since injury and Radiographic OA 
associated (p=0.06), but weak association time 
since injury and lnCOMP (p=0.92) 
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Table 11.  Assessment of Potential Confounders for lnHA. 
Covariate Potential to be Confounder 
(High, Medium, or Low) 
Justification 
Age High Age and incident Radiographic OA associated 
(p=0.03); Age and lnHA associated (t-test 
p=<0.01) 
BMI Medium BMI and incident Radiographic OA strongly 
associated (p<0.01); BMI and lnHA associated 
(p=0.10) 
Gender Low Gender and lnHA strongly associated (p<0.01), 
but weak association between gender and 
Radiographic OA (p=0.97) 
Race High Race and incident Radiographic OA strongly 
associated (p=0.01); Race and lnHA strongly 
associated (p<0.01) 
Baseline Knee Symptoms High Knee symptoms and Radiographic OA strongly 
associated (p<0.01); knee symptoms and lnHA 
strongly associated (p=0.01)  
Baseline Knee Injury Low Knee injury and Radiographic OA associated 
(p=0.05), but knee injury and lnHA weakly 
associated (p=0.81) 
Follow-Up Knee Severe Injury Low Weak associations between knee severe injury 
and Radiographic OA (p=0.99) and knee severe 
injury and lnHA (p=0.54) 
Baseline Knee Fracture Low Weak associations between knee fracture and 
Radiographic OA (p=0.61) and knee fracture and 
lnHA (p=0.24) 
Baseline Knee Surgery Low Weak associations between knee surgery and 
Radiographic OA (p=0.31) and knee surgery and 
lnHA (p=0.51) 
Time Since Knee Injury Low Time since injury and Radiographic OA 
associated (p=0.06), but weak association time 
since injury and lnHA (p=0.39) 
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Table 12.  Assessment of Potential Confounders for lnhsCRP. 
Covariate Potential to be Confounder 
(High, Medium, or Low) 
Justification 
Age Medium Age and incident Radiographic OA associated 
(p=0.03); Age and lnCRP associated (t-test 
p=0.07) 
BMI High BMI and incident Radiographic OA strongly 
associated (p<0.01); BMI and lnCRP strongly 
associated (p<0.01) 
Gender Low Gender and lnCRP strongly associated 
(p<0.01), but weak association between 
gender and Radiographic OA (p=0.97) 
Race High Race and incident Radiographic OA strongly 
associated (p<0.01); Race and lnCRP strongly 
associated (p<0.01) 
Baseline Knee Symptoms High Knee symptoms and Radiographic OA 
strongly associated (p<0.01); knee symptoms 
and lnCRP strongly associated (p<0.01)  
Baseline Knee Injury Medium Knee injury and Radiographic OA associated 
(p=0.05) and knee injury and lnCRP 
associated (p=0.06) 
Follow-Up Knee Severe Injury Low Weak associations between knee severe injury 
and Radiographic OA (p=0.99) and knee 
severe injury and lnCRP (p=0.18) 
Baseline Knee Fracture Low Weak associations between knee fracture and 
Radiographic OA (p=0.61) and knee fracture 
and lnCRP (p=0.78) 
Baseline Knee Surgery Medium Weak association between knee surgery and 
Radiographic OA (p=0.31); strong association 
knee surgery and lnCRP (p<0.01) 
Time Since Knee Injury Low Time since injury and Radiographic OA 
associated (p=0.06), but weak association time 
since injury and lnCRP (p=0.38) 
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Table 13.  Assessment of Potential Confounders for lnKS. 
Covariate Potential to be Confounder 
(High, Medium, or Low) 
Justification 
Age High Age and incident Radiographic OA associated 
(p=0.03); Age and lnKS associated (t-test 
p=<0.01) 
BMI High BMI and incident Radiographic OA strongly 
associated (p<0.01); BMI and lnKS strongly 
associated (p=0.03) 
Gender Low Gender and lnKS strongly associated (p<0.01), 
but weak association between gender and 
Radiographic OA (p=0.97) 
Race Medium Race and incident Radiographic OA strongly 
associated (p<0.01); Race and lnKS strongly 
associated (p=0.10) 
Baseline Knee Symptoms Medium Knee symptoms and Radiographic OA strongly 
associated (p<0.01); knee symptoms and lnKS 
weakly associated (p=0.37)  
Baseline Knee Injury Low Knee injury and Radiographic OA associated 
(p=0.05) and knee injury and lnKS weakly 
associated (p=0.36) 
Follow-Up Knee Severe Injury Low Weak associations between knee severe injury 
and Radiographic OA (p=0.99) and knee severe 
injury and lnKS (p=0.42) 
Baseline Knee Fracture Low Weak associations between knee fracture and 
Radiographic OA (p=0.61) and knee fracture 
and lnKS (p=0.53) 
Baseline Knee Surgery Medium Weak association between knee surgery and 
Radiographic OA (p=0.31); associated knee 
surgery and lnKS (p=0.08) 
Time Since Knee Injury Low Time since injury and Radiographic OA 
associated (p=0.06), but weak association time 
since injury and lnKS (p=0.45) 
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Table 14. Assessment of Potential Modifiers for lnCOMP. 
Covariate Strata N HR for main 
exposure  
(95% CI; CLR*) 
Potential to 
be a 
Modifier 
(High, 
Medium, or 
Low) 
Justification 
Age 45.0-<55.0 213 2.03 (0.99-4.18; 4.24) High The unadjusted HRs differ 
considerably across levels of age; 
the precision does not vary much 
across levels.  This covariate is 
highly likely to be a modifier. 
55.0-<65.0 189 0.92 (0.45-1.89; 4.19) 
65.0+ 138 1.48 (0.69-3.17; 4.58) 
Age <58 years 273 1.16 (0.57-2.36; 4.13) Medium HR is 1.3 times greater for 58+ 
group than <58; 95% CIs overlap 
and each contains the others’ point 
estimate.  Medium likelihood of 
being a modifier. 
>=58 years 267 1.56 (0.95-2.55; 2.67) 
BMI <25.0 126 3.17 (0.67-15.1; 22.5) Medium The unadjusted HRs differ across 
levels of BMI, especially <25.0 
level compared to other two 
levels; precision is much wider for 
<25.0 than other two levels.  
Medium likelihood of being a 
modifier. 
25.0-<30.0 219 1.13 (0.59-2.20; 3.76) 
30.0+ 195 1.36 (0.77-2.40; 3.12) 
BMI <28 kg/m2 272 1.71 (0.63-4.67; 7.42) Low HR is 1.5 times greater for <28 
group than 28+, but one 95% CI 
subsumes the other; unlikely 
modifier. 
>=28 kg/m2 268 1.12 (0.73-1.72; 2.35) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
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Table 14 continued. Assessment of Potential Modifiers for lnCOMP. 
Gender Male 211 1.20 (0.54-2.70; 4.99) Low HR is 1.3 times greater for female 
than male, but one 95% CI 
subsumes other; unlikely modifier. 
Female 329 1.60 (0.97-2.62; 2.70) 
Race African 
American 
198 1.48 (0.74-2.98; 4.04) Low HR is 1.1 times greater for 
Caucasian group than AA (not 
greatly different); 95% CIs 
overlap and each contains the 
others’ point estimate; unlikely 
modifier. 
Caucasian 342 1.60 (0.94-2.73; 2.92) 
Baseline 
Knee 
Symptoms 
Yes 166 1.42 (0.85-2.35; 2.76) Low HRs do not vary considerably 
across strata; one 95% CI 
subsumes the other; unlikely 
modifier. 
No 374 1.37 (0.76-2.47; 3.27) 
Baseline 
Knee Injury 
Yes 37 0.75 (0.25-2.29; 9.33) Medium HR is 2 times greater in “No” 
group than in “Yes” group; 95% 
CIs overlap and each contains the 
others’ point estimate; medium 
likelihood of being a modifier. 
No 493 1.53 (0.98-2.40; 2.44) 
Follow-Up 
Knee Severe 
Injury 
Yes 16 2.50 (0.07-94.6; 
1427.47) 
Low Low cell count for ‘yes’ group; 
unlikely modifier. 
No 500 1.33 (0.88-2.02; 2.31) 
Baseline 
Knee 
Fracture 
Yes 6 1.26 (0.04-40.0; 
1007.13) 
Low Low cell count for ‘yes’ group; 
unlikely modifier. 
No 530 1.41 (0.93-2.14; 2.28) 
Baseline 
Knee 
Surgery 
Yes 13 0.62 (0.11-3.67; 
34.91) 
Low Low cell count for ‘yes’ group; 
unlikely modifier. 
No 523 1.46 (0.96-2.22; 2.31) 
Time Since 
Knee Injury 
<20.0 years 23 1.52 (0.26-9.08; 
35.57) 
Low Low cell counts for both groups; 
comparable point estimates; 
unlikely modifier. 20.0+ years 27 1.56 (0.40-6.11; 
15.35) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
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Table 15. Assessment of Potential Modifiers for lnHA. 
Covariate Strata N HR for main 
exposure (95% CI; 
CLR*) 
Potential to 
be a 
Modifier 
(High, 
Medium, or 
Low) 
Justification 
Age 
 
45.0-<55.0 213 1.27 (0.82-1.96; 2.39) High The unadjusted HRs differ 
somewhat across levels of age; the 
precision does not vary much 
across levels.  Highly likely to be 
a modifier. 
55.0-<65.0 189 1.06 (0.69-1.64; 2.38) 
65.0+ 138 1.33 (0.86-2.03; 2.35) 
Age <58 years 273 0.94 (0.66-1.35; 2.05) High HRs on opposite sides of the null. 
95% CIs overlap, but neither 
includes the other point estimate. 
Highly likely to be a modifier. 
>=58 years 267 1.39 (0.96-1.99; 2.07) 
BMI <25.0 126 2.57 (1.14-5.79; 5.10) High The unadjusted HRs differ 
considerably across levels of BMI; 
the precision is less for <25.0 than 
other categories, but the point 
estimate is not in the interval for 
the other two categories.  This 
covariate is highly likely to be a 
modifier. 
25.0-<30.0 219 1.34 (0.91-1.96; 2.15) 
30.0+ 195 0.77 (0.50-1.18; 2.34) 
BMI <28 kg/m2 272 1.95 (1.19-3.19; 2.68) High HRs on opposite sides of null and 
<28 is 2.3 times greater than 28+; 
95% CIs do not overlap; likely 
modifier. 
>=28 kg/m2 268 0.86 (0.63-1.18; 1.87) 
Gender Male 211 1.26 (0.76-2.09; 2.76) Low Male interval subsumes female 
interval; point estimates are close 
to each other in value.  Unlikely 
modifier. 
Female 329 1.16 (0.88-1.54; 1.76) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
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Table 15 continued. Assessment of Potential Modifiers for lnHA. 
Race African 
American 
198 1.11 (0.85-1.44; 1.70) Medium HR for Caucasian is 1.5 times 
greater than for AA; precision is 
somewhat wider for Caucasian 
than AA. One interval includes 
other point estimate and the two 
intervals overlap; medium 
likelihood to be modifier. 
Caucasian 342 1.61 (1.07-2.44; 2.28) 
Baseline 
Knee 
Symptoms 
Yes 166 1.31 (0.91-1.90; 2.10) Low Each interval includes other point 
estimate, but neither subsumes 
other.  “Yes” group HR =1.15 
times “no”. Unlikely modifier. 
No 374 1.14 (0.85-1.51; 1.77) 
Baseline 
Knee Injury 
Yes 37 0.48 (0.25-0.95; 3.85) High Intervals do not overlap.  Point 
estimates on opposite sides of the 
null and very disparate. Highly 
likely modifier.  
No 493 1.31 (1.00-1.72; 1.73) 
Follow-Up 
Knee Severe 
Injury 
Yes 16 1.16 (0.14-9.89; 72.3) Low Low cell count for ‘yes’ group 
with very wide 95% CI; similar 
HRs.  Unlikely modifier. 
No 500 1.23 (0.95-1.58; 1.66) 
Baseline 
Knee 
Fracture 
Yes 6 Not able to estimate in 
Stata-many iterations 
of log pseudolikelihood 
Low Very low cell count for ‘yes’ 
group. Unlikely modifier. 
No 530 1.22 (0.95-1.58; 1.67) 
Baseline 
Knee 
Surgery 
Yes 13 0.32 (0.08-1.36; 17.6) Low Low cell count for ‘yes’ group 
with wide 95% CI.  Intervals 
overlap.  One interval includes the 
other’s point estimate. 
No 523 1.22 (0.94-1.59; 1.69) 
Time Since 
Knee Injury 
<20.0 years 23 0.63 (0.29-1.37; 4.75) Low Low cell counts for both groups 
with wide 95% CIs.  HRs on 
opposite sides of null; but 
intervals overlap & each includes 
the other’s point estimate. 
20.0+ years 27 1.13 (0.47-2.69; 5.68) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit) 
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Table 16. Assessment of Potential Modifiers for lnhsCRP. 
Covariate Strata N HR for main 
exposure (95% CI; 
CLR*) 
Potential to 
be a 
Modifier 
(High, 
Medium, or 
Low) 
Justification 
Age 45.0-<55.0 213 1.32 (0.99-1.75; 1.76) High The unadjusted HRs differ 
somewhat across levels of age; the 
precision does not vary much 
across levels.  Highly likely to be 
a modifier. 
55.0-<65.0 189 1.22 (0.90-1.66; 1.85) 
65.0+ 138 0.93 (0.71-1.23; 1.74) 
Age <58 years 273 1.32 (1.03-1.70; 1.66) Medium <58 HR is 1.3 times 58+ HR.  58+ 
interval includes <58 HR.  
Medium likelihood to be modifier. 
58+ years 267 1.04 (0.84-1.30; 1.55) 
BMI <25.0 126 1.15 (0.85-1.55; 1.80) High The unadjusted HRs differ 
considerably across levels of BMI 
with a U-shape pattern; the 
precision does not vary much 
across levels.  Highly likely. 
25.0-<30.0 219 0.88 (0.65-1.19; 1.83) 
30.0+ 195 1.30 (0.98-1.74; 1.77) 
BMI <28 kg/m2 272 0.99 (0.76-1.29; 1.69) Low 28+ HR is 1.16 times the <28 HR. 
Each interval includes the other’s 
point estimate.  Unlikely modifier. 
28+ kg/m2 268 1.15 (0.90-1.48; 1.65) 
Gender Male 211 0.97 (0.70-1.33;1.89) Medium Female HR is 1.35 times the HR 
for males; on opposite sides of the 
null.  Male interval includes the 
female’s point estimate. Medium 
likelihood to be modifier.  
Female 329 1.31 (1.08-1.59; 1.47) 
Race African 
American 
198 1.22 (0.95-1.56; 1.64) Low AA HR is 1.13 times the 
Caucasian HR. Each interval 
includes the other’s point estimate.  
Unlikely modifier. 
Caucasian 342 1.08 (0.87-1.34; 1.54) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
  
176 
Table 16 continued. Assessment of Potential Modifiers for lnhsCRP. 
Baseline 
Knee 
Symptoms 
Yes 166 1.16 (0.94-1.41; 1.50) Low Minimal difference of HR by 
strata.  Each interval includes the 
other’s point estimate.  Unlikely 
modifier. 
No 374 1.11 (0.89-1.38; 1.56) 
Baseline 
Knee Injury 
Yes 37 1.40 (0.81-2.44; 3.01) Low HR for “yes” 1.2 times HR for 
“no”.  “Yes” interval subsumes 
“no” interval.  Unlikely modifier. 
No 493 1.13 (0.95-1.35; 1.42) 
Follow-Up 
Knee Severe 
Injury 
Yes 16 0.87 (0.38-1.94; 5.02) Low Low cell count for ‘yes’ group 
with very wide 95% CI.  “Yes” 
interval subsumes “no” interval. 
Unlikely modifier. 
No 500 1.15 (0.96-1.37; 1.42) 
Baseline 
Knee 
Fracture 
Yes 6 1.23 (0.45-3.37; 7.51) Low Very low cell count for ‘yes’ 
group; similar HRs.  Unlikely 
modifier. 
No 530 1.16 (0.99-1.37; 1.39) 
Baseline 
Knee 
Surgery 
Yes 13 0.47 (0.14-1.59; 11.57) Low Low cell count for ‘yes’ group 
with wide 95% CI; “yes” interval 
includes “no” point estimate.  
Unlikely modifier. 
No 523 1.17 (0.99-1.39; 1.41) 
Time Since 
Knee Injury 
<20.0 years 23 1.48 (0.98-2.22; 2.26) Low HRs on opposite sides of null and 
substantially different (<20 HR is 
2.0 times 20+ HR).   Possible 
modifier but limited in these 
analyses because of low cell 
counts for both groups.   
20.0+ years 27 0.71 (0.32-1.57; 4.86) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit) 
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Table 17. Assessment of Potential Modifiers for lnKS. 
Covariate Strata N HR for main 
exposure (95% CI; 
CLR*) 
Potential to 
be a 
Modifier 
(High, 
Medium, or 
Low) 
Justification 
Age 45.0-<55.0 213 2.17 (0.57-8.30; 14.6) High Widest 95% CIs for highest and 
lowest age groups.  Both of these 
categories have HRs that are 1.9 
times the HR of the middle age 
category (U-shaped pattern).  
Highly likely to be modifier. 
55.0-<65.0 189 1.15 (0.45-2.97; 6.64) 
65.0+ 138 2.22 (0.67-7.37; 11.07) 
Age <58 years 273 1.28 (0.46-3.54; 7.66) Medium Each interval includes the others’ 
point estimate.  HR of 58+ is 1.9 
times HR of <58.  Medium 
likelihood of being modifier. 
>=58 years 267 2.45 (1.05-5.71; 5.44) 
BMI <25.0 126 6.89 (1.63-29.17; 
17.94) 
High Widest 95% CIs for two lowest 
BMI groups.  Lowest category has 
HR 4-5 times the HRs of the other 
two categories. Likely modifier. 
25.0-<30.0 219 1.37 (0.37-5.00; 13.42) 
30.0+ 195 1.66 (0.79-3.47; 4.39) 
BMI <28 kg/m2 272 3.03 (0.96-9.55; 9.95) Medium Each interval contains other’s 
point estimate, but neither interval 
subsumes the other’s interval.  
95% CI wider for <28 than 28+ 
group. HR of <28 is 1.8 times HR 
of 28+.  Medium likelihood. 
>=28 kg/m2 268 1.65 (0.81-3.36; 4.12) 
Gender Male 211 0.89 (0.32-2.43; 7.51) High Intervals overlap but neither 
contains the other’s point estimate.  
Female HR 2.9 times male HR and 
on opposite sides of null.  Highly 
likely to be modifier. 
Female 329 2.62 (1.21-5.66; 4.66) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
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Table 17 continued. Assessment of Potential Modifiers for lnKS. 
Race African 
American 
198 1.91 (0.80-4.59; 5.77) Low Each interval includes the other’s 
point estimate; neither interval 
subsumes other’s interval.  HR for 
AA is 1.2 times HR for 
Caucasians.  Unlikely modifier. 
Caucasian 342 1.58 (0.62-4.07; 6.61) 
Baseline 
Knee 
Symptoms 
Yes 166 1.69 (0.71-3.99; 5.59) Low Each interval includes the other’s 
point estimate; neither interval 
subsumes other’s interval. HR for 
“no” is 1.2 times HR for “yes”.  
Unlikely modifier.  
No 374 1.97 (0.84-4.61; 5.50) 
Baseline 
Knee Injury 
Yes 37 0.43 (0.09-2.02; 22.59) High Wider 95% CI for “yes” than “no” 
due to lower cell count.  “Yes” HR 
is 5.4 times “no” HR; HRs are on 
opposite sides of the null. Intervals 
overlap; neither includes other’s 
point estimate.  Likely modifier. 
No 493 2.33 (1.16-4.68; 4.03) 
Follow-Up 
Knee Severe 
Injury 
Yes 16 28.9 (0.42-1971.9; 
4653.6) 
Low Low cell count for ‘yes’ group 
with very wide 95% CI.  “Yes” 
interval includes “no” point 
estimate.  Unlikely modifier. 
No 500 1.66 (0.86-3.19; 3.70) 
Baseline 
Knee 
Fracture 
Yes 6 Not able to determine 
HR 
Low Very low cell count for ‘yes’ 
group.  Unlikely modifier. 
No 530 1.88 (0.99-3.56; 3.58) 
Baseline 
Knee 
Surgery 
Yes 13 0.39 (0.05-3.44; 76.28) Low Low cell count for ‘yes’ group 
with wide 95% CI.  “Yes” interval 
includes “no” point estimate.  
Unlikely modifier. 
No 523 1.95 (1.02-3.73; 3.67) 
Time Since 
Knee Injury 
<20.0 years 23 1.41 (0.32-6.19; 19.17) Low Low cell counts for both groups; 
very wide 95% CI for 20+ group.  
Each interval contains others point 
estimate.  Unlikely modifier. 
20.0+ years 27 13.4 (0.27-653.4; 
2387.7) 
*CLR=Confidence Limit Ratio (Upper limit/lower limit)
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Table 18.  Summary of Likelihood of Confounding or Modifying by Covariate. 
 COMP HA hsCRP KS 
Covariate Confounder Modifier Confounder Modifier Confounder Modifier Confounder Modifier 
Age High High High High  Medium High High High 
BMI High Medium Medium High High High High High 
Gender Low Low Low Low Low Medium Low High 
Race High Low High Medium High Low Medium Low 
Symptoms Medium Low High Low High Low Medium Low 
Injury Medium Medium Low High Medium Low Low High 
Severe 
Injury 
Low Low Low Low Low Low Low Low 
Fracture Low Low Low Low Low Low Low Low 
Surgery Low Low Low Low Medium Low Medium Low 
Time since 
surgery 
Low Low Low Low Low Low Low Low 
Covariates 
for Each 
Model 
Age, BMI, Race, Symptoms, 
Injury 
Age, BMI, Race, Symptoms, 
Injury 
Age, BMI, Race, Symptoms, 
Injury, Surgery 
Age, BMI, Gender, Race, 
Symptoms, Injury, Surgery 
Covariates 
to be used in 
all 
biomarkers 
models  
Age, BMI, Gender*, Race, Symptoms†, Injury† 
* Gender has been used as a confounder in the biomarkers and OA literature. 
†Chronic knee symptoms and injury history will be explored as modifiers of the biomarker-OA association.  
